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USING MASS SPECTROMETRY TO QUANTIFY CHANGES IN HISTONE POST-
TRANSLATIONAL MODIFICATIONS AS A RESULT OF DNA DOUBLE-
STRANDED BREAKS 
 
The structure of DNA is under constant threat from both extracellular and intracellular 
sources, causing mutations that could result in the reduced viability of the cell. In the 
nucleus of eukaryotes, DNA wraps around histone proteins 1.67 times. Two copies of 
Histone H2A, H2B, H3 and H4 congregate to form an octomer: along with the DNA strand 
together make the nucleosome. It has been shown that via histone post-translational 
modifications (HPTM), the nucleosome will signal to recruit biological machinery to 
process DNA such as during transcription or repair. One of the most characterised HPTM 
is phosphorylation of serine 139 of H2AX (γH2AX), which is indicative of a DNA strand 
break — single or double. Subsequent to the phosphorylation, the cell’s DNA damage 
response (DDR) will proceed to recruit proteins that repair the damage. 
 
 
Recent studies have implicated a myriad of HPTMs in the DDR. However, many of the 
putative DDR HPTM were described with various immunoassays such as western blot and 
immunofluorescence. Immunoassays are notorious for reproducibility issues and 
experimental design biases. Comparatively, mass spectrometry is renowned for its 
precision and its ability to accommodate high throughput analysis of many datasets in an 
unbiased manner. We utilise MS to quantify γH2AX changes after DNA damage and show 
that H2AX tyrosine 142 phosphorylation is not as abundant as previously shown. We also 
developed a method for simultaneously quantifying many HPTMs changes that occur as 
a result of the DDR at both proximal to the site of damage and a genomic scale. The 
developed method of quantifying DDR HPTM accommodates future experiments such as 
determining whether DDR HPTMs are old or new (with SILAC) or be adapted to analyse 
HPTMs as a result of transcription, translation or development. A translational aspect 
would be to quantify the epigenetic marks of cancer patients before and post-treatment. 
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Chapter 1: Introduction 
1.1. DNA and the Damage Response 
Deoxyribonucleic acid (DNA) is present in every living organism and is the set of 
instructions to create proteins, the building blocks of life. In brief, DNA is a double-
stranded molecule that has each strand running anti-parallel to each other (WATSON & 
CRICK 1953). DNA is composed of four different nucleotides– guanine, adenine, thymine, 
and cytosine (Figure 1.1a). Genes of particular sequences of bases encode proteins. 
Critically, the two strands of DNA are held together via hydrogen bonding and the bases 
within a strand are bonded together via phosphodiester bonds. Information is stored in 
DNA using a triplet code: every three nucleotides within transcribed genes can be 
translated into one of twenty amino acid (Travers & Muskhelishvili 2015) (Figure 1.1b).  
 
There are 64 different possible combinations that are used to code for one of twenty 
different amino acids (or a stop codon) during translation (Figure 1.1c). Therefore, DNA 
can be used  to store information about which different protein sequences are in the 
repertoire of the cell i.e., which proteins the DNA encodes (Jackson, 2010). DNA is not 
only used for storing information; it can also be used to regulate gene expression 
depending on the specific promoter at the start of a gene; specific sequences of DNA can 
be used to initiate DNA replication; and the sequence can be repetitive in nature which 
gives it a structural function such as at the centromeres (Verdaasdonk & Bloom 2011) 
and telomeres (Lewis & Wuttke 2012). 
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Therefore, it is imperative that the sequence of DNA is maintained with high-fidelity:  
mutations in the sequence can impair gene regulation or protein structure and function. 
However, the maintenance of genome stability poses a unique challenge as the structure 
of DNA is under constant attack from both endogenous and exogenous sources. Below, I 
will briefly summarise the sources of DNA damage, the molecular consequences of this 
damage, how the cell defends itself from daily attacks, and the clinical consequences if 
the cell’s defences are compromised.   
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Figure 1.1: DNA, RNA and Protein 
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Figure 1.1 Legend: DNA, RNA and Protein 
 
a) Structure of DNA: Nucleotides are the most fundamental units of inheritance. 
Used both to transmit information and instruct cells. DNA is made up of four 
different nucleotides: adenine, guanine, cytosine and thymine. Guanine and 
adenine are purines, while cytosine and thymine are pyrimidines. Two DNA 
strands form a double helix and run anti-parallel to each other. The two strands 
bind together via hydrogen bonding. Adenine and thymine bond via two 
hydrogen bonds while cytosine and guanine use three hydrogen bonds. The 
sugar phosphate backbone gives DNA an overall negative charge. 
 
b) Codon Code Chart: During transcription (not shown) the DNA sequence is 
repeated in RNA. Thymine base is replaced with uracil. Three nucleotides in a 
sequence can either code for the start of translation (i.e. RNA to protein), for a 
particular amino acid or stop the translation altogether. Four bases picked three 
times leads to a maximum of 64 different combinations. However, there is 
redundancy because there are only twenty amino acid possibilities and a stop 
codon. Therefore, several amino acids can be encoded for by multiple codons. 
 
c) Twenty Amino Acids: The chemical properties of an amino acid is dependent on 
its R-group. As a result, the amino acids can be categorised according to the 
similarities of their properties. There are amino acids with hydrophobic side-
chains; negatively charged side chains; positively charged side chains; uncharged 
side chains; and amino acids that cannot be categorised in the aforementioned 
groups.  
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1.2. DNA damage formation 
1.2.1. Ultra-Violet Rays 
As mentioned, DNA is continuously under attack from endogenous and exogenous agents 
i.e. sources of damage from within the cell and from the surrounding environment. One 
of the most well-known causes of DNA damage is UV radiation (Sinha & Hader 2002). 
Ultra-Violet B (UVB) light causes two adjacent thymine base pairs to bond to each other, 
forming pyrimidine dimers. If this aberrant structure is not resolved, a mutation can be 
introduced at the site of damage as the lesion can distort the structure of DNA by 
inserting bends, which prevents the replication or transcription machinery from being 
able to process the DNA at the site of the pyrimidine dimer (Sinha & Hader 2002) (Figure 
1.2). 
1.2.2. High Energy Radiation (γ-rays and x-rays) 
Like UV and visible light, both γ-rays and x-rays are also on the electromagnetic spectrum 
but have much smaller wavelengths. Visible light has a wavelength ranging from 
approximately 400-700 nm compared to 10 pm (smaller than an atom) and 0.01-10 nm 
for γ-rays and x-rays, respectively. The shorter wavelengths lead to higher frequencies: 
300 Exahertz (γ-rays) and 0.3-30 EHz (x-rays) compared to 300 THz (visible light). As a 
result of their higher frequencies, γ-rays and x-rays have higher energies compared to 
visible light: 1.24 MeV, 1.24-124 KeV and ~2.5 eV for γ-rays, x-rays, and visible light, 
respectively (Drake 2014). These higher energies are responsible for causing DNA damage 
that would not be possible with visible light or even UV. Such radiation may damage DNA 
through several means simultaneously: free radicals formed from nearby water 
molecules, which go on to react with the DNA molecule; directly ionising the DNA 
molecule by knocking-off electrons, leading to side reactions; or by disrupting the 
chemical bonds of the DNA molecule, such as hydrogen bonds or phosphodiester bonds. 
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If the noncovalent hydrogen bonds are broken, the strands of the DNA come apart (Vallur 
et al. 2002), but this is less deleterious compared to the phosphodiester bonds breaking. 
If the covalent phosphodiester bond is broken, it will result in the DNA molecule being 
physically broken. If only one of the two strands are broken, a single strand break (SSB) 
occurs and the cell can quickly repair the molecule by using the complementary strand 
as a template to synthesise a new strand and ligate the nicked DNA. However, if two 
phosphodiester bonds break on opposite strands in close proximity within the double 
helix, a double-strand break (DSB) is formed. The average dividing human cell would 
experience approximately 50 DSBs and 50,000 SSBs per day (Vilenchik & Knudson 2003; 
Caldecott 2008). Even though SSBs occur at a rate of three orders of magnitude higher, 
DSBs are the most cytotoxic form of DNA damage (Huertas 2010) (Figure 1.2). 
1.2.3. Free radicals 
Another source of DNA damage is oxidative damage from free radicals, which can either 
be from exogenous sources (via tobacco, pollutants, drugs, etc) or endogenous 
metabolism (Dizdaroglu & Jaruga 2012b). Free radicals are classed as reactive oxygen 
species and can react with double bonds within the structure of the DNA. These reactions 
can lead to adducts on the DNA molecule, which have to be removed for normal 
biological processes to proceed (Dizdaroglu & Jaruga 2012a). Peroxides (e.g. hydrogen 
peroxide, H2O2) are one such example of free radicals responsible for damage to the 
genome. Peroxides can form from one of two ways: radiolysis of intracellular water 
molecules by ionising radiation (IR), resulting in the formation of intermediates that then 
go on to form peroxides; or from normal cellular metabolism of oxygen (Sonntag 2006). 
In respiration, oxygen acts as an electron sink that is then reduced to form water. 
However, on rare occasions, the reduced oxygen molecule can be reduced to a 
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superoxide (O2*-). If the superoxide leaks from the mitochondria into the rest of the cell, 
the superoxide can potentially be catalysed into peroxide (Sonntag 2006).  
 
Another intrinsic free radical that can induce DNA damage is the hydroxyl radical (OH*), 
which is an intermediate in the radiolysis reaction from water to oxygen. Hydroxyl is also 
able to cause oxidative damage to DNA. However, whilst hydroxyl is a more reactive 
species compared to peroxide, it is also short-lived because of its very reactive nature 
(Gligorovski et al. 2015). In contrast, peroxide is able to remain stable long enough to 
enter the nucleus and get within close proximity to DNA, which makes peroxide more 
hazardous to the integrity of the genome compared to hydroxyl. To react with DNA, 
hydroxyl must be produced adjacent to the DNA molecule for it to have a chance to 
damage DNA as a consequence (Rogakou et al. 1998) (Figure 1.2). 
1.2.4. Perturbed biological processes 
When cells undergo processes that involve interacting with the DNA molecule directly, 
such as transcription or replication, it is not unusual for the cellular process to fail and 
damage the DNA as a consequence. DNA replication occurs during S-phase of the cell 
cycle and is initiated at specific sites known as replication origins (Podhorecka et al. 2010). 
The process of replication starting at the origin is termed origin firing and prior to origin 
firing, the replication proteins assemble themselves into a complex. It is here that the 
unwinding and synthesis of DNA takes place. During replication, it is possible for the 
replication fork to stall or collapse. A replication fork stalls when it encounters an 
impediment such as a damaged strand, resulting in the activity of the helicase and/or 
polymerase coming to an abrupt halt. The timeframe for the pause can be as long as it 
takes for the blockage to be removed (it is even possible for the pause to be maintained 
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indefinitely). Under conditions in which the replication fork persists for too long, a 
collapse can occur as a result of a single strand break being processed into a double 
strand break by endonucleases such as Mus81 (Gambus et al. 2009), (Labib & Hodgson 
2007) & (Ciccia et al. 2003). Experimental approaches to initiate replication fork stalling  
use chemicals such as aphidicolin (DNA polymerase inhibitor) or hydroxyurea (HU, a 
ribonucleotide reducatase inhibitor) (Heylmann & Kaina 2016).  
 
Once the replication fork stalls, there is the potential for DNA damage signalling to occur. 
The minichromosome maintenance (MCM) helicase persists with unwinding DNA in the 
presence of stalled replication forks. The unwound DNA-primed for replication is single-
stranded DNA (ssDNA)(Smith et al. 2009). Replication protein A (RPA) binds to ssDNA to 
protect it and prevent it from reannealing during homologous recombination. Similarly, 
RPA is recruited to stalled replication forks to bind to the ssDNA (Kanoh et al. 2006). RPA-
bound ssDNA has the potential to induce the DNA damage response as it mimics the 
resected ends of a double strand break and activates ATR, as well as the Rad9-Rad1-Hus1 
(9-1-1) complex. The recruitment of DNA damage-specific proteins to a replication 
environment demonstrates that damage to the DNA is an inevitable consequence of DNA 
metabolism and the cell has evolved an error-check system (Figure 1.2). 
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Figure 1.2: Map of sources of DNA Damage, Their Molecular Consequences and Possible 
Repair Pathways 
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Figure 1.2 Legend: Map of sources of DNA Damage, Molecular Consequences and 
Possible Repair Pathways. Adapted from (Curtin 2012) 
 
a) Left: Endogenous and exogenous sources of DNA damage. Some DNA damaging 
agents can lead to multiple types of damage and have been colour coded to 
indicate possible outcomes e.g. Ionizing radiation (in green) can cause both DNA 
double-strand breaks, single-strand breaks and various adducts. As a result the 
multi-headed green arrow stems from the green box. 
 
b) Middle: Various forms of damages as a result of the exogenous and endogenous 
DNA damaging agents. 
 
c) Right: Organisms have evolved various and bespoke DNA Repair pathways to 
protect the genome from the different forms of DNA damage. 
  
 11 
1.3. Double Strand Break Repair Strategies 
1.3.1. Double Strand Break 
In nature, there are various forms of damage repair pathways that take place. However, 
in this thesis, we will be focussing on Double Strand Breaks (DSB) and repair mechanisms 
pertaining to DSBs. A DSB is defined as a simultaneous break in both strands of the DNA 
molecule. DSBs can be induced by chemical agents, X-rays, y-rays (Figure 1.3a), biological 
processes such as stalling of replication forks and induced by the cell during meiosis for 
meiotic recombination (Figure 1.3b). The reason DSBs are seen as the most hazardous 
form of DNA damage is due to the mutation and deletions that can arise as a result of the 
repair mechanisms that are recruited to repair the breaks. The mutations can then have 
downstream effects at both cellular and organismal levels. Moreover, DSBs can result in 
either acentric or dicentric chromosomes, which is where the chromosomes have either 
lost their centromere or fused with a fragment of another chromosome to gain a second 
centromere, respectively. Both scenarios can have devastating effects.  During cell 
division, acentric fragments would result in a loss of genetic information as the 
chromosomes may not be distributed evenly between the daughter cells (Kaye et al. 
2004). If fidelity of the repair mechanism has been compromised as a consequence of 
having lost genetic material, inter-chromosomal fusions (Robertsonian translocation) can 
take place, leading to genomic rearrangements, which are potentially carcinogenic if not 
dealt with by one of many cellular mechanisms evolved to deal with such an occurrence. 
In humans, Robertsonian translocations can potentially result in Down Syndrome (Celeste 
et al. 2002). If the DSB cannot be repaired, then the cell may induce apoptosis. At times, 
the breaks are deliberate and the exchange of genetic information is encouraged, but this 
programmed phenomenon is tightly regulated and temporally confined to a specific point 
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in meiosis (Celeste, Difilippantonio, et al. 2003) and VDJ Recombination. Repair pathways 
depend on which stage of the cell cycle the cell is in. DSB repair in mammalian systems is 
a complex process and the molecular mechanisms of the proteins involved are not well 
understood. Below, I summarise what is known about DSB repair in mammalian systems. 
 
1.3.2. Non-Homologous End-Joining  
The vast majority of DSBs in cycling cells are repaired by Non-Homologous End-Joining 
(NHEJ). NHEJ is most prominent in G1 and G2. In G1, NHEJ repairs nearly all DSBs and in 
G2, >80% of DSBs are repaired via NHEJ (Petersen et al. 2001). In terms of maintaining 
genomic fidelity, NHEJ can be either quick and efficient for 80% of breaks induced by IR 
where no resection takes place, or it can result in genetic deletion due to resection being 
activated. 53BP1 is believed to promote NHEJ over HR as the DSB repair pathway. (Panier 
& Boulton, 2014).  NHEJ can occur during G1 where there is no template to copy a 
sequence from, unlike HR which requires a template to copy from (discussed below). The 
initial step of NHEJ is the recruitment of the heterodimer Ku70/Ku80 which will bind to 
the DSB to inhibit resection (Mimori & Hardin, 1986). The DNA-PKcs, belonging to the 
PIKK class of kinases, is recruited by Ku70/80 to the site of damage (Bassing et al. 2002). 
DNA-PKcs facilitates the interaction of Ku70/80 with XRCC4, Ligase IV and XLF. The BRCT 
domain of Ligase IV interacts with Ku70/80 only when Ku is a dimer. The interaction is 
catalysed by DNA-PKcs (Bassing et al. 2002). As a result, the interaction of XRCC4 with 
LigIV is then activated directly. Lig IV docks with XRCC4 via two BRCT domains that are 
present in the C-terminal region of DNA ligase IV. XLF then binds to both Ligase IV and 
XRCC4 to form a DNA ligation complex, which will ligate the broken DNA strands together 
(Petersen et al. 2001). Although this method of repairing DSBs is quick and efficient for 
most cases of NHEJ mediated repair of DSBs, approximately 20% of DSBs that are induced 
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by IR require a more intricate method of NHEJ repair (Riballo et al. 2004). A DSB may 
require further processing depending on the complexity of the situation. DSBs in 
heterochromatin may require additional processing. Therefore, more DDR response 
proteins involved in NHEJ will be recruited to the site (Riballo et al. 2004). If the site of 
damage is located in heterochromatic region and the cell is in G1 then the break will take 
longer to repair (Helt et al. 2005) (Figure 1.3c). 
 
In addition to facilitating repair of DSBs via NHEJ, ATM and other repair proteins have 
been implicated in VDJ recombination. VDJ recombination is required for the generation 
of antigen receptor diversity and always occurs during the formation of new lymphocytes 
(Lou et al. 2006). RAG recombinase initiates VDJ recombination by binding and cleaving 
at specific sites known as recombination signal sequences that are located on either side 
of the V, D and J gene sections. Upon initiation of VDJ recombination by RAG 
recombinase, which induces a DSB, the RAG protein works in tandem with NHEJ repair 
machinery to ligate the newly recombined region together.  
1.3.3. Homologous Recombination 
By definition, homologous recombination-mediated repair can only take place when 
there is a sister chromatid present to copy a new sequence from. Thus, HR is discouraged 
in G1 as there is no sister chromatid. HR-mediated repair predominantly occurs during S-
phase and G2 in the cell cycle. HR is a central component of meiosis, where instead of 
sister chromatids being used as a template, strand invasion between homologous 
chromosomes takes place (Kobayashi et al. 2004). In addition to being used for 
generating genetic diversity in meiosis, HR is also important for the repair of DSBs 
generated as a result of collapsed replication forks (Lou et al. 2006). HR is thought to be 
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a higher fidelity repair mechanism than NHEJ. However, it is only used in 20% of DSBs 
generated by IR in G2-phase of cells (Stewart et al. 2003). For HR to occur, single-stranded 
DNA is required. The single-stranded DNA can be generated from 5' resection during a 
DSB (Goldberg et al. 2003) or from a processed replication fork that collapsed. Replication 
Protein A (RPA) then coats the ssDNA. The Rad52/BRCA2 family of proteins and Rad51 
paralogues then displace RPA and assist in the formation of the Rad51 nucleoprotein 
filament (Sung JBC 2003). Rad51 is the central protein in HR and serves two functions. 
Firstly, Rad51 conducts a homology search to identify a sequence similar to the 3' 
overhang. Secondly, upon finding a DNA strand with high sequence identity, which is 
normally a sister chromatid, the Rad51 filament invades the intact duplex DNA and pairs 
with the complementary strand (Stucki et al. 2005). As a result, the non-complementary 
strand, whose sequence is identical to the DNA comprising the Rad51 nucleoprotein 
filament, is displaced, forming a displacement loop (D-loop). Pol δ then utilises the 3’ 
overhang as a primer and extends it. Depending on the processivity of this extension, a 
Holliday junction may or may not form. Importantly, the completion of HR without a 
Holliday junction always results in non-crossover outcomes, whereas the formation and 
subsequent resolution of a Holliday junction can result in either a crossover or non-
crossover (B. Wang & Elledge 2007; Mattiroli et al. 2012) (Figure 1.3e).   
1.3.4. Microhomology-mediated end joining 
Microhomology-mediated end joining (MMEJ), also known as alternative NHEJ, is a 
secondary method for repairing double-strand breaks via end-joining. It is believed that 
MMEJ takes over repair when regular NHEJ is compromised (Lee & Paull 2007). Exactly 
how MMEJ is chosen currently remains unknown. MMEJ is highly error-prone as its 
modus operandi results in deletions of biological information from the DNA sequence as 
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the pathway tends to delete approximately 5-25 base pairs flanking the site of damage in 
search of small tracts of homology (Ward et al. 2003). MMEJ's high propensity for error 
stems from the crude method in which the pathway will search for homology upstream 
and downstream of the relevant damaged strand. Upon finding 5-25 complementary 
base pairs on both strands, the strands will be aligned. Inevitably, there will be overhangs 
and mismatched bases, which are excised and removed respectively, resulting in deletion 
of the DNA in the intervening region between the repeats  (Kleiner et al. 2015).  In recent 
years, proteins implicated in other pathways have been shown to be involved in MMEJ 
such as ATM (Baldock et al. 2015) and 53BP1 (Baldock et al. 2015) (Figure 1.3d).   
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Figure 1.3: Causes of DSB and Possible Repair Pathways 
 
 
  
a) b) 
c) d) e) 
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Figure 1.3 Legend: Causes of DSB and Possible Repair Pathways. Adapted from: 
(Ceccaldi et al. 2016) and (Chapman et al. 2012) 
 
a) Exogenous causes of DSBs: Ionising radiation and X-Ray can lead to DSBs. Most 
DSBs are repaired via NHEJ. However a proportion of DSB in G2 are repaired via 
HR and MMEJ 
 
b) Endogenous causes of DSBs: (i) Organisms have evolved auto-induction of DSBs 
to increase viability. During meiosis DSBs are induced for cross-over events to 
increase gene-pool variability. Also, developing lymphocytes will generate DSBs 
to randomly assemble different sections of genes to increase the different 
combinations of antigen receptors; thus reinforcing the immune system’s 
defences. (ii) However, not all endogenous damage is scheduled. DSBs can be 
generated as a result of endogenous  spontaneous damage such as ROS (not 
shown) or stalling of DNA processing such as during replication. 
 
c) Repair via Non-Homologous End Joining (abridged): Ku70 and Ku80 are recruited 
for end binding. Followed by Artemis and DNA-PKcs for End Processing. Gap 
filling carried out by DNA Pol λ and Pol μ. Ligation is completed by DNA Ligase IV. 
 
d) Repair via Micro-Homology Mediated End-Joining (abridged): CtIP and MRN 
induce limited end resection followed by PARP 1 for recognition of the lesion. 
Pol θ and other factors are recruited to complete annealing and gap filling. 
Ligation carried out by DNA Ligase III. 
 
e) Repair via Synthesis-dependent strand annealing (Abridged). There are several 
pathways with in HRR. SDSA is one form. CtIP and MRN induce end resection. 
RPA protects single strand overhangs. BRCA1, BRCA2, and PALB2 recruit Rad51. 
Rad51 filament formation induces homology searching. Upon D-loop formation, 
Pol δ and DNA Ligase I complete fill-in synthesis and ligation of the two ends, 
respectively. In some circumstances such as compromised HR pathway in cells, 
the D-loop may be aborted, resulting in recruitment of Pol θ where lesion is 
processed by the MMEJ pathway. 
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1.4. Histone Variants and Their Post-Translational Modifications  
1.4.1. Introduction to HPTMs 
 
DNA within the nucleus of eukaryotes is packaged within a molecular complex known as 
chromatin. The nucleosome, the principal component of chromatin, is comprised of an 
octamer that contains two copies of each of the four core histone proteins: H2A, H2B, 
H3, and H4. 147 base pairs of DNA is wrapped around a single octamer, which amounts 
to a strand of DNA encircling the octamer approximately 1.67 times (Goodarzi et al. 2008) 
(Figure 1.4b&c). When observed under a microscope, chromatin fibres have been 
documented to take shape in low ionic-strength environments. The appearance of the 
chromatin fibre has been described as "beads on a string'. Chromatin fibre is the first level 
of chromatin compaction. A structure known as a solenoid (Figure 1.4e), which is a 30 nm 
fibre, can be observed when the ionic-strength is increased, which constitutes the second 
level of compaction (Kouzarides 2007) (Figure 1.4f). 
 
The core histones are primarily globular. However, their N-terminals "tails" do not form 
a stable 3D structure but instead protrude out from the core. DNA binds to the 
nucleosome octomer through its minor groove, which has an electrostatic affinity for 
arginine residues (West et al. 2012). Many of the amino-acid residues of the N-terminal 
tails are receptive to a wide array of post-translational modifications (PTMS), including 
acetylation, methylation, and phosphorylation (Bannister & Kouzarides 2011) (Figure 
1.4d).  
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Figure 1.4: DNA Packaging, Nucleosome and Histone Post-Translational Modifications 
 
   
a) 
b) 
c) 
d) 
e) 
f) 
g) 
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Figure 1.4 Legend: DNA Packaging, Nucleosome and Histone Post-Translational 
Modifications 
 
a) DNA Double Helix: the most simplest form of chromatin 
 
b) Nucleosome: 147 base pairs of DNA wrap around a histone octomer 1.67 times 
to form a nucleosome. This is recognised as the first level of chromatin 
compaction. 
 
c) Histone Octomer: Each octomer is comprised of two copies of each of the four 
histone variants: H2A, H2B, H3 and H4. These four histones are known as the 
core histones. In some organisms, Histone H1 (not shown) will seal the 
nucleosome 
 
d) Histone Post-Translational Modifications: Each histone has a terminus 
protruding from the octomer globular. These histone tails are subject to post-
translational modifications. Highlighted are well-characterised HPTM of the core 
histones. Shown are lysine methylation, lysine acetylation, lysine ubiquitination, 
arginine methylation, and serine phosphorylation 
 
e) Second level of chromatin compaction: Nucleosomes fold to form solenoids. 
Solenoids fold further to forms 30 nm fibre 
 
f) Third level of chromatin compaction: 30 nm chromatin fibre folds further every 
300 nm, which in turn forms 700 nm coils. 
 
g) Final level of chromatin compaction: a supercoiled chromosome found during 
metaphase in a eukaryotic cell 
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To illustrate their importance in maintaining genome stability, it is necessary to briefly 
cover the evolutionary history of histones. Histones are found in all eukaryotes and even 
some archaebacteria (Eirín-López et al. 2009). Even though eubacteria have been 
observed to have a form of chromatin compaction, it is different to the system used by 
archaebacteria and eukaryotes. Escherichia coli, which has been studied extensively, uses 
supercoiling for compaction; as its genome is only 4.6 Mega bases, this level of 
compaction is adequate (Sandman & Reeve 2000). Euryarchaea have been characterised 
to possess proto-histones that have the same function of wrapping DNA but they were 
missing eukaryotic features such as unfolded N-terminal and C-terminal tails (Arents & 
Moudrianakis 1995) and are wrapped by a shorter amount of DNA: 60 bp as opposed to 
147 bp. This would imply that histone proteins evolved very early on as genome 
complexity grew with time. The importance of histones to eukaryotes in regards to 
organising a large genome can be properly highlighted when examining their genomes. 
As eukaryotes have grown more complex and become multicellular, their genomes have 
also had to increase in complexity. to illustrate this complexity, an E. coli cell has 4.6 
million base pairs, whereas a haploid human cell possesses approximately 3 billion base 
pairs, which is several magnitudes larger. The human genome also contains 
approximately 20,000 genes (Lander et al. 2001) compared to an E. coli which only has 
about 4000 genes (Blattner et al. 1997). To assist with organising the genome, complex 
eukaryotes have not only evolved to increase the number of histone variants, which as 
this chapter will highlight have specialised roles, but have also increased the copy number 
of the same variants. Yeast, a simple eukaryote, possesses two copies of each of the four 
core histones. On the other hand, human Histone H4 alone is encoded by 14 genes 
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(The UniProt Consortium, 2017). The rise in copy number of histone genes can be partly 
attributed to whole genome duplication events (Malik and Henikoff 2003). 
 
After a whole genome duplication event, evolutionary selective pressure would probably 
steer towards the genome keeping multiple copies of the histones for one of two reasons: 
it is better to have redundancy for crucial proteins, and with an increased genome size, 
it is necessary for the cell to have higher levels of histone proteins to protect the newly 
synthesised DNA. Through compaction, the DNA is protected from biological machinery 
that may process the DNA resulting in deletion or incorrect expression of a gene. For this 
same reason, as newly synthesised DNA strands emerge after DNA replication, the 
demand for histones would more than double immediately as the newly synthesised DNA 
would need to be protected and the cell needs to ensure that supply can keep up with 
demand. Possessing multiple copies of histone genes also allows for the emergence of 
histone variants. There are 15 genes that encode for Histone H4, which has no variants. 
Histone H3 has three variants encoded by 12 genes (The UniProt Consortium 2017) & 
(Marzluff et al. 2002). However, H2A and H2B have many different variants. Recent 
evidence also suggests that there is a proportional relationship between the size of the 
genome and the number of arginine residues present in its histone H2A variants, whereas 
an inversely proportional relationship has been observed between genome size and 
serine/tyrosine residues (Macadangdang et al. 2014). Histone variants can serve different 
functions. For instance, Histone H2AZ has been implicated in several biological contexts: 
chromatin compaction (Fan et al. 2002), the DNA Damage Response (DDR)(Y. Xu et al. 
2012), meiosis (Yamada et al. 2017), and demarcating transcriptional start sites and gene 
bodies (Gervais & Gaudreau 2009) (Coleman-Derr & Zilberman 2012). Another variant, 
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H2AX, has been implicated in the DDR (Rogakou & Bonner 2000) and development 
(Cowell et al. 2007). The functions of the different variants will be discussed in detail 
further on. Selective pressures on histone function have resulted not only in them being 
highly conserved in their sequences but also in their PTMs. In mammals, it was found that 
not only was the function conserved at a molecular level but there was conservation for 
which cell types are regulated by the presence of a PTM (Baldeyron et al. 2011).  
 
There are many sites at which histones can be modified and the number of known sites 
may be expected to increase with time (Table 1.1). In addition to the sites, the different 
types of modifications add complexity to histone PTMs. For example, lysine can be 
methylated in one of three ways: monomethylation, dimethylation and trimethylation, 
whilst arginine can also be methylated or dimethylated, asymmetrically or symmetrically 
i.e. where S-Adenosyl methionine (SAM) I dimethylates one amines exclusively in the R-
group or where SAM II methylates methylates the two terminal amines in the R-group, 
respectively (Figure 1.5 J-M). Functionally, the histone PTMs can be divided into two 
categories: demarcation of global chromatin environments and managing DNA-protein 
based biological processes  
 
The DNA wrapped around histones can become inaccessible which can hinder molecular 
functions such as transcription and repair. Some PTMs of histones weaken the interaction 
with DNA, which then allows access to biological machinery. Modifications can affect the 
structure of chromatin through one of two ways: perturbing the compaction between 
nucleosomes, which reveals chromatin, or by recruiting non-histone proteins. The loosely 
packed chromatin is known as euchromatin and the tightly bound chromatin is known as 
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heterochromatin (Bannister & Kouzarides 2011). A large number of different 
modifications allow for numerous possible functional responses. Even though there are 
numerous histone PTMs, in the context of the DNA damage response, the PTMs that we 
will be focussing on are acetylation, methylation, and ubiquitination of lysine residues, 
and phosphorylation of serine, threonine and tyrosine residues. Different domains are 
capable of recognising different PTMs. PHD and ATRX-DNMT3-DNMT3L recognise 
unmodified lysines, while Bromodomain and YEATs bind to acetylated lysines.  There is a 
larger group of domains that can recognise methylation. These include: chromodomains, 
Tudor and Bromo-adjacent. 
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Figure 1.5: Post-translational modification of lysine, serine, arginine, and their mass 
changes 
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Figure 1.5 Legend: Post-translational modification of lysine, serine, arginine, and their 
mass changes 
 
a) Unmodified lysine: Nucleophilic residue. Susceptible to many PTMs 
 
b) Acetylated lysine: Δ mass of 42.0106 Da. Results in reduced overall positive 
charge. In regards to histones, results in opening up of chromatin. Usually 
results in transcriptional activation. 
 
c) Ubiquitinated lysine: Δ mass of 114.0428 Da. Involved in recruiting other factors 
e.g. during DDR H2AK15ubi acts as a docking site for 53BP1. Full ubiquitin not 
shown. Gly-Gly is artefact left covalently attached after tryptic digest 
 
d) Methylated lysine: Δ mass of 14.0157 Da. Associated with chromatin 
compaction but in certain cases can result in transcriptional activation e.g. 
H3K4me 
 
e) Dimethylated lysine: Δ mass of 28.0313 Da. Requires lysine monomethylation. 
Can be involved in transcriptional activation or repressed. Also involved in DDR 
e.g. H4K20me2. 
 
f) Trimethylated: Δ mass of 42.0470 Da. Requires lysine dimethylation. Can be 
involved in transcriptional activation or repression e.g. H3K36me3 and 
H3K9me3, respectively 
 
g) Unmodified serine: Highly polar residue. 
 
h) Phosphorylated serine: Δ mass of 79.96633 Da. Involved in signalling. Present in 
DDR e.g. H2AXS139phos and cell-cycle e.g. H3S10phos. 
 
i) Propionylated lysine: Δ mass of 42.0106 Da. In-vitro modification utilised to 
block unmodified histones to give uniform sized peptides after tryptic peptide. 
Presence is indicative of unmodified or mono-methylated lysines 
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Figure 1.5: Post-translational modification of lysine, serine, arginine, and their mass 
changes (continued) 
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Figure 1.5 Legend: Post-translational modification of lysine, serine, arginine, and their 
mass changes (continued) 
 
j) Unmodified arginine: Nucleophilic residue. Susceptible to PTMs 
 
k) Monomethylated arginine: Δ mass of 14.0157 Da. In regards to histones, 
regarded as an intermediate PTM to further demethylation. Methylated by both 
type I and II S-Adenosyl methionine (SAM) 
 
l) Asymmetric dimethylated arginine: Δ mass of 28.0313 Da. Can act as a docking 
site for DNMT3A, a DNA methyltransferases, as seen on histone H4R3me2. 
Methylated exclusively by type I SAM 
 
m) Symmetric dimethylated arginine: Δ mass of 28.0313 Da. Can block readers of 
adjacent residues carrying PTMs e.g. hinders access to H3K4me3. Methylated 
exclusively by type II SAM 
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1.4.2. Histone Acetylation 
Histone acetylation involves the addition of an acetyl group to lysine residues (Figure 
1.5b).  The acetyl group is composed of a methyl doubled bonded to a carbonyl group. 
Histone acetylation or deacetylation of lysine residues is known to regulate gene 
expression. Enzymes responsible for histone acetylation and histone deacetylation are 
known as histone acetyltransferases (HATs) and histone deacetylases (HDACs), 
respectively (Allfrey et al. 1964). HATs attach acetyl groups, which originate from acetyl-
CoA, to lysines. HDACs carry out the opposite function of HATs by removing acetyl groups 
from lysines via hydrolysis. PTMs that alter the histone charge may change the 
compaction of chromatin (Kouzarides 2007). Histone acetylation and deacetylation are 
implicated in many biological processes such as nucleosome assembly, DNA replication, 
and transcription. HATS and HDACs work in an antagonizing fashion in the context of 
biological tasks that require chromatin to be relaxed. For example, HATs play a huge role 
during replication, but during transcriptional silencing, HDAC activity predominates.   
There are two characterised families of HATs that add acetyl groups on to histone lysine 
residues. The variants known as Type-B HATs are responsible for transiently acetylating 
newly synthesised histones in the cytoplasm at sites H4K5 and H4K12. Once the histones 
have been deposited into the genome, the acetyl groups at these sites are removed 
almost instantaneously (Parthun 2007). There is more variety amongst the Type-A family 
of HATs, as Type-B family HATs share a lot of sequence homology within their group. 
Type-A HATs can then be categorised further (Hodawadekar & Marmorstein 2007). 
Acetylation can affect chromatin in one of two ways. The overt way is through 
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neutralisation of the positive charge on lysine, resulting in the histone protein interacting 
less strongly with the negatively charged phosphate group of DNA (Grunstein 1997). It 
was hypothesised that HATs were involved in DNA transcription in some way (Luan et al. 
2015). Transcription requires an open chromatin environment so that the machinery can 
get access to the DNA. Allis’s group demonstrated that Tetrahymena thermophilia 
possesses a gene that shares strong homology with GCN5 from yeast systems. Interaction 
of GCN5 with chromatin led to a reduction in chromatin compaction, making the DNA 
more accessible, and thus allowing the DNA to be available for biological processes such 
as transcription. These results directly demonstrated that acetylation and transcription 
occur concomitantly (Brownell et al. 1996). 
A less obvious way in which acetylation can alter the chromatin environment is through 
the binding of bromodomain-containing proteins. Bromodomains are highly conserved 
regions of proteins that can be considered readers of lysine acetylation. Owen, et al. 
(2000) showed that the yeast HAT GCN5 possessed a bromodomain and was able to 
recognise various lysine residues from histone H4 that have been acetylated; it is not 
uncommon for proteins possessing bromodomains to have affinities for various 
acetylated lysine residues (Josling et al. 2012). 
HDACs can counteract the activity of HATS. For instance, RNA polymerase needs to bind 
to the transcription start site so that other factors can be recruited downstream of it to 
initiate transcription. RNA pol II is required for the unwinding of the DNA double helix, 
otherwise processing of the template strand will not be possible (Pineda et al. 2015). 
However, nucleosomes act as hindrances to this and many other biological functions by 
physically blocking access to DNA. It is not uncommon for different HDACs to function 
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together in the same complex, which can result in more stringent removal of the 
acetylation (Miller et al. 2010). 
1.4.3. Histone Methylation 
Methylation involves the addition of a single or multiple methyl groups to an amino acid 
residue with a positively charged sidechain. Histidine, arginine and lysine can carry a 
maximum of one (monomethylation), two (dimethylation) or three (trimethylation) 
methyl groups, respectively (Figure 1.5 d,e & f). Even though methylation can take place 
at multiple amino acid residues (Greer et al. 2012) we will focus mostly on histone lysine 
methylation. Methylation can either promote transcription or suppress it. Complexity is 
added to its role since there are three possible modifications that can take place at the 
same lysine residue and multiple types of methyl-binding domains can distinguish these, 
allowing for the recruitment of a wide range of proteins.  
Importantly, lysine methylation and acetylation are mutually exclusive; they cannot 
occupy the same lysine residue simultaneously. Methylation works differently to lysine 
acetylation as methylation does not neutralise the positive charge as it does not possess 
a polar carbonyl component. Enzymes that are responsible for methylating lysines are 
known as lysine methyltransferases (KMT). Lysines can only be methylated and 
demethylated in a sequential fashion, which means that a methyl group is either added 
or removed one at a time. For example, a lysine residue cannot be trimethylated without 
prior mono- and dimethylation. Over thirty KMTs have been described (Black et al. 2012) 
and they mostly possess the catalytic SET domain. Evidence of the first lysine 
demethylases (KDMs) was first shown by Shi, et al. (Y. Shi et al. 2004) with the discovery 
of Lysine-specific histone demethylase 1A (LSD1). In a contextual manner, some 
methylation can be transient such as those responsible for temporary compaction of the 
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chromatin during cell differentiation after stem cell generation, while other methylation 
sites can be permanent to the point that they are inherited through meiosis and mitosis, 
effectively forming epigenetic sites. As a result of the different methylation sites, some 
post-transitional modifications will have faster turnover compared to others. 
Methylation can be deposited by one of three families of proteins known as histone 
methyltransferases (KMT). Methyl groups that are deposited on histone lysines are 
sourced from S-adenosylmethionine. Two families of KMTs have been found to catalyse 
the methyl deposition on lysine residues: SET domain-containing proteins (Rea et al. 
2000) and DOT1 (Feng et al. 2002). There are also two corresponding groups of proteins 
that carry out the opposite function of removing the methyl groups from lysines: amine 
oxidases such as LSD1 (Y. Shi et al. 2004) and Jmjc domain containing dioxygenases that 
are iron-dependent (Tsukada et al. 2006). Both the JmjC-domain-containing KDMT and 
amine-oxidases share homology in both function and sequence from yeast up to 
mammalian systems.  Some biological processes may require a permanent state of 
methylation such as structural regions, e.g. centromeres and telomere, or mitotically 
inherited silenced regions in differentiated cells that need to maintain uniformity of 
instructions with regards to gene expression and silencing. However, other regions may 
require sites of methylation to be malleable, such as: when cells are in the process of 
differentiating, which requires gene expression to differ from one cell type to another; or 
when cells are responding to environmental selective pressures including nutrient uptake 
and DNA damage. These factors result in there being large discrepancies between lysine 
residues for the duration of methylation turnover (Broering et al. 2015).  
Presently, six lysine methylation sites have been characterised in detail: H3K4, H3K9, 
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H3K27, H3K36, H3K79 and H4K20 (Black et al. 2012). Generally, methylation at H3K4, 
H3K36 and H3K79 have been related to activation of transcription (Martin & Y. Zhang 
2005), whilst H3K9, H3K27, and H4K20 have been implicated in repressing transcription. 
The presence of di- and trimethylation of H3K9 and H3K27 are indicative of 
heterochromatin and gene silencing (Kouzarides 2007). Both sites are susceptible to 
acetylation (Woo & W. H. Li 2012), so a rudimentary function would be to block lysines 
from being acetylated as both PTMs cannot occupy the same residue. Both sites being 
methylated would also function as signalling markers. When H3K9 has been methylated 
by Suv39-1, Heterochromatin Protein 1 (HP1) can dock on the methylated site, which 
initiates compaction by physically bringing the nucleosomes closer together via self-
aggregation as they have an affinity for chromo-shadow domains. HP1 has also been 
shown to be present when deacetylation takes place (Saksouk et al. 2015). H3K9 
methylation is found at sites of constitutive heterochromatin such as pericentromeric 
regions. Human Y chromosomes contain large regions of constitutive heterochromatin 
that are peppered with small regions that encode active genes (Quintana-Murci & Fellous 
2001). Histone H3K27 trimethylation is catalysed by EZH2 which is part of the Polycomb 
Repressive Complex 2. Both H2AK119Ub and H3K27 methylation can be found at sites of 
facultative heterochromatin such as Barr bodies. The presence of methylation of H3K4 is 
linked with euchromatin, and specifically with genes that are active or fated for 
expression (Bernstein et al. 2002). H3K4me1 has been found to be present at enhancer 
sites across the genome (Heintzman et al. 2007). In contrast, H3K4me3 was found to 
associate much closer to the site of transcription by occupying regions corresponding to 
gene promoters (Santos-Rosa et al. 2002). It is intriguing that the same amino acid 
residue possesses two highly similar modifications, yet the localization and function of 
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each modification varies, despite the same common goal (i.e., upregulation of 
transcription). H3K4me1 is required for the chromatin remodeller BAF (human 
homologue to yeast SWI/SNF) to associate with histones. In vitro assays showed that the 
BAF45C subunit of BAF possesses a binding site for the single methylation but it will not 
bind to H3K3me3 (Local et al. 2018). However H3K4me3 was also shown to be required 
for the global recruitment of Transcription Factor II D(TFII D) through the TAF subunit of 
TFII D. TAF possesses a PHD binding domain which recognises H3K4me3 (Lauberth et al. 
2013). In addition, H3K4me3 will recruit a different remodelling factor CHD1 which will 
loosen chromatin (Local et al. 2018) 
As stated, H3K4 methylation is indicative of gene expression but that is not always the 
case. It is a modification that is also associated with different functions altogether in a 
different context. A modification possessing an antagonistic function to itself is not out 
of the realm of possibility, especially when the proteins it recruits can change in different 
environments. Both di and trimethylation of H3K4 have been documented in partaking in 
transcriptional repression (X. Shi et al. 2006). The mercurial function of the modification 
could be explained by cell cycle stage and/or DNA metabolism. Different effector proteins 
are expressed throughout the cell cycle that their presence at different times is akin to 
shift-workers on an assembly line. So if the region is scheduled to undergo silencing for a 
given biological function, the cellular support network can shift to accommodate the 
process by expressing effector proteins to silence the regions ad hoc. For example, ING2 
repressor, which possesses a PHD domain that can read H3K4 methylation sites, will 
associate with HDAC at the same site (X. Shi et al. 2006). In another instance, H3K4me3 
can be found in a bivalent domain i.e., associating with H3K27me3 at the same promoter, 
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in genes associated with development (Berstain et al 2006). The purpose of bivalency 
could be explained with being associated with development or rapid differentiation. In 
an environment where genes need to be quickly switched off or on it would serve as an 
advantage to have either option ready to go. H3K4me3 blocks recruitment of Polycomb 
Repressor Complex 2, which is involved in epigenetically silencing genes with KMT 
activity. In essence, the bivalent domain could be seen as fine-tuning of expression (Voigt 
et al. 2013).   
Similarly to H3K4 methylation, H4K20 methylation is another example of a HPTM being 
involved in many cellular processes, which can also change with context: H4K20me1 is 
associated with transcriptional repression (Karachentsev 2005) and perturbed 
trimethylation H4K20 can have dire implications. Overexpression has been correlated 
with premature ageing of cells (Shumaker et al. 2006), whilst under expression has been 
linked to breast cancer (Tryndyak et al. 2006). H4K20me1/2 provides a binding site for 
53BP1 at sites of DSBs. In cells with reduced H4K20me2, the cells have delayed 53BP1 
focus formation, and thus lack an efficient repair system for DSBs (Panier & Boulton, 
2014).  
Methylation of the different residues gives an insight into how complex and intricate 
cellular instructions are and how much our understanding has progressed since simple 
Mendelian genetics. In turn, the complexities also demonstrate that our understanding 
of expression dynamics has shifted from binary (on/off) to a new paradigm of the cell’s 
instructions being determined not only by the DNA sequence but the presence of DNA 
methylation, the histone post-translational modification and now which combination of 
HPTM is present at a given site. Theoretically, with each new condition, the number of 
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permutations of what can take place as a result of chromatin dynamics increases 
exponentially. However, the actual observed combinations are not as vast. The dynamics 
and permutations that are at play are vastly more intricate than any piece of software 
code and elucidating the cross-talk with systems biology will be an arduous task for years, 
if not decades. To conclude with methylation, it is not the modification itself that dictates 
what happens at a local level but the reader of the modifications that are present at any 
given moment, which have downstream effects on other chromatin-associated proteins. 
1.4.4. Histone Phosphorylation 
All of the core histones possess sites along their tails that are susceptible to 
phosphorylation by a number of protein kinases and can also be dephosphorylated by 
numerous phosphatases. Phosphorylation occurs at serine, threonine and tyrosine 
residues in histones (Figure 1.5h). It comprises the addition of a phosphate group to the 
hydroxyl in a serine or tyrosine residue. Phosphorylation is one of the most understood 
HPTMs; for decades, it has been recognised that kinases control signal transduction from 
the cell surface. In 1998, Rogakou, et al. (Rogakou et al. 1998) showed that serine 139 
(128/129 in yeast) on H2AX is susceptible to phosphorylation following a double-strand 
break. Ser139ph is known as γH2AX. The phosphatidylinositol 3-kinase-related kinase 
(PIKK) family, including ATM, ATR and DNA-PK, are responsible for the phosphorylation 
of S139 of H2AX (Harrison & Haber 2006). In humans, H2AX is the only H2A variant that 
possesses an elongated C-terminal tail, which includes S139. 
 
Today, the presence of γH2AX is routinely used for DSB assays as it has become 
synonymous with DNA damage. Phosphorylation of γH2AX by the ATM kinase works as a 
signal for the DNA damage response (DDR) machinery. γH2AX is detected quickly (<5 min) 
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after DNA damage and can spread across a large distance from the DSB: 1Mb in 
mammalian cells and up to 100kb in yeast cells. γH2AX is responsible for recruitment of 
several DDR complexes to DSBs: Rhp9/53BP1 (Baldock et al. 2015); chromatin remodelers 
such as INO80; cohesin (Caron et al. 2012); and SMC5/6 (Nakamura et al. 2004). Without 
γH2AX/γH2A, it has been shown that in both yeast and mammalian cells, the DNA damage 
checkpoint will be compromised (Celeste, Fernandez-Capetillo, et al. 2003). Various 
proteins have been documented as being downstream effectors, and they typically 
possess 14-3-3 and BRCT domains which go on to recognise histones that have been 
phosphorylated (Taverna et al. 2007). 
 
Phosphorylation of histones is not exclusively reserved for the DDR but can also play a 
role in transcriptional regulation. When H3S10, H3T11, and H3S28 are phosphorylated, 
they coincide with adjacent or proximal lysine acetylation, PTMs that are synonymous 
with gene expression. H3 acetylation in a GCN5 dependent manner has been shown to 
associate with the aforementioned phosphorylations (Lo et al. 2000). H3S28ph also plays 
a role in combination with H3K27ac in transcription activation by perturbing any nearby 
PRC reactions with chromatin, resulting in demethylation of H3K27, and subsequently, its 
acetylation. This would occur on adjacent residues on cis tails (Gehani et al. 2010). H3T11 
and H3T6 have also been shown to displace methylation from H3K9 in a JMJDC2C-
dependent manner and encourage acetylation (Metzger et al. 2010). The same marks can 
also prevent H3K4 from being methylated, which would most likely result in 
transcriptional silencing in the local region. (Solier et al. 2009) 
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Several phosphorylation sites in the nucleosome have been connected to apoptosis. 
However, this section of the putative histone code remains unsolved as the exact 
combination required for inducing apoptosis has been contentious in recent years. H2AX 
on its most C-terminal residue, Tyrosine 142, can be phosphorylated, but this 
modification has been shown to decrease in the presence of DNA damage, is also 
putatively implicated in apoptosis (Xiao et al. 2008). Solier et al (2009) suggested three 
sites on two histones were crucial for the cell to undergo either repair of DNA, or to 
commit to apoptosis if the damage is too severe. The sites were H2AXS139, H2AXY142 
and H2BS14; in the presence of phosphorylation at all three sites, the cell will be fated 
for apoptosis (Solier et al. 2009). Lastly, it has been documented that upon DNA damage 
of the nicking sort, apoptotic cells can undergo increased phosphorylation in a PKCδ-
dependent manner at H3T45 (Hurd et al. 2009) 
1.4.5. Histone Ubiquitination 
Originally discovered by Goldstein et al. (Goldstein et al. 1975), ubiquitin has since been 
shown to be present in all eukaryotic cells, hence the name (it is ubiquitous). Unlike other 
PTMs, which involve a small adduct being added to a sidechain, ubiquitination involves 
the addition of one (or more) ubiquitin molecules, each with a molecular mass of 8.5 kDa 
(Figure 1.5c). A single ubiquitin can be added, or a chain of ubiquitin molecules. 
Ubiquitination can signal a protein for degradation but can also initiate or block 
interactions, change the location of a protein in a cell or alter the activity of a protein. 
Histones were the first proteins described to have been modified with a ubiquitin module 
(Goldknopf et al. 1975). Histone H2A and H2B are two of the most abundant proteins that 
carry ubiquitin sites: it is estimated that around 5-15% of H2A and 1-2% of H2B are 
ubiquitinated in the genome at any one time. There are three groups of catalysts, known 
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as ubiquitin ligases, that carry out ubiquitination on histone H2A: RN168; RING1B (RNF2), 
which is a subunit of the PRC1 complex; and BRCA1/BARD1. Histone H2A has been found 
to be ubiquitinated in response to DNA damage. H2A K13/K15 is ubiquitinated by RNF8 
and RNF168. ATM phosphorylates MDC1 which results in recruitment of RNF8, which 
then goes on to recruit RN168 to the site of damage and the E2 ligase UBC13, leading to 
the synthesis of lysine63-linked ubiquitin (K63-Ub) chains at the site of damage (Yan 
2012).  Ubiquitination of H2A at different sites can also act as a gatekeeper to dictate the 
DNA repair mechanism. For example, BRCA1/BARD1 ubiquitination of H2A in the context 
of DNA damage promotes the usage of HR to repair DSBs (Densham et al. 2016). On the 
other hand, phosphorylation of H2AX will recruit RNF168 which will result in a docking 
site for 53BP1 to be constructed at H2AK13/K15 (Panier & Boulton, 2014). 53BP1 cannot 
dock at the site of a double-strand break if H2AK13ub/K15ub is not present. In addition 
to K13/K15, H2A has also been observed to be ubiquitinated at sites K118/K119 in 
response to damage. RNF20/RNF40 and PRC1 are the ubiquitin ligases responsible in this 
case (Pan et al. 2011). H2A K118/119 ubiquitination was previously implicated in having 
a role in repressing transcription (Yan 2012). Nonetheless, the recruitment of E3 ubiquitin 
ligase in γH2AX dependent manner is necessary before HR-mediated or NHEJ-mediated 
repair of DNA damage can take place. Upon ATM phosphorylation of H2AX, MDC1 
recognises the newly phosphorylated site and is also phosphorylated in a CK2-ATM-
dependent manner. These ubiquitin chains allow for ubiquitin binding proteins to 
aggregate at the site of damage. One such protein is RAP80, which directly interacts with 
BRCA1, whose recruitment leads to HR-dependent repair. Alternatively, it is possible that 
53BP1 will be recruited in a H4K20me2 dependent manner to the same sites, leading to 
HR-independent repair (Kolas et al. 2007). 
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PRC1-dependent H2AK119 ubiquitination has been found to reduce transcription at 
global levels. In addition to the DDR and transcription, H2A ubiquitination has been seen 
in the silenced X chromosomes of mammalian cells (Barr bodies)(Fang et al. 2004). H2B 
ubiquitination was demonstrated to play a role in chromatin demarcation wherein its 
absence resulted in other histone modifications pervading to other regions of the 
genome (Fierz, et al., 2011). Cells that did not possess the H2BK120 ubiquitination were 
shown to have defects in HR-dependent repair as it was crucial for the activation of the 
damage checkpoint (Nakamura, et al., 2011). 
 
1.4.6. Lysine Propionylation 
It is chemically feasible to modify a peptide in-vitro to aid with quantification. Derivatising 
a residue involves covalently attaching a functional group at an acceptor site. In this case, 
derivatising unmodified or monomethylated lysines with a propionyl group on the amine 
of the R-group.  Derivatisation step pre-digestion has two main functions. The first is to 
ensure that there is uniformity and/or sufficient peptide length after digestion. For 
example, one can derivatise lysine residues so that regardless of whether there is a post-
translational modification on a given lysine, the peptide sizes will remain identical to that 
of a peptide sequence that has not been modified. Derivatisation involves covalently 
modifying the sidechains of the amino acid so that they exhibit preferred properties e.g. 
derivatising an unmodified lysine residue so that it will not be digested with trypsin. This 
is because trypsin digests at lysine with no modifications or monomethyl, but not when 
there are larger adducts attached to the lysine side chain. Ideally, peptides should be 
longer than four amino acids otherwise they may be below the threshold of detection. 
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The second effect of derivatising the peptide with propionic anhydride is that it may have 
the effect of elongating the peptide, sequence permitting, but it will definitely make the 
peptide more hydrophobic, thus simplifying quantitative analysis of peptides and their 
PTMs (Sidoli et al. 2015) (Figure 1.5i). The analysis is simplified because the peptides will 
all be uniform in length after trypsinisation. The uniformity simplifies the quantification 
of a PTM. The frequency of the different PTMs signals can be tallied instead of calculated 
against a control peptide. Since the different signals corresponding to the different 
permutations are tallied, a direct percentage can be obtained. If there are peptides of 
varying sizes, the peptides will need to be normalised against a control peptide, which is 
commonly either a spiked extrinsic peptide or an endogenous peptide. 
For a full summary of known HPTMs, their sites and putative function, please refer to 
Table 1.1. 
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Table 1.1: Chart of Characterised Histone Residues Susceptible to Acetylation, 
Methylation, Phosphorylation and, Ubiquitination and Histone Modifying Enzymes  
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1.5. Biological Mass Spectrometry 
Since the turn of the century, mass spectrometry has become a useful tool for analysing 
biological molecules such a proteins and lipids. Proteomics is the large scale study of the 
proteins produced by living organism, groups of organism or system. With constant 
development of new techniques and refinement of protocols, proteomics is capable of 
elucidating chromatin dynamics and quantifying HPTMs in a multiplexed manner. Prior 
to this, most of what is known about HPTMs was learnt through immuno-assays and the 
scope of the information was limited. To further understand the advantageous of mass 
spectrometry-based methods in the area of HPTMs, it is necessary to understand the 
basic principles of mass spectrometry. 
1.5.1. Introduction to mass spectrometry 
The mass spectrometer is an analytical apparatus that allows for measurements of the 
isotopic composition of an element or the mass of molecules. It is a technology that can 
trace its origins to the late 19th century where the first mass spectrograph was generated. 
By the 1920s, what is considered to be the prototype for a modern mass spectrometer 
was developed by  Arther Dempster and Francis Aston. Prior to the mass spectrometer 
being able to analyse particles, the particles have to be both charged and in a gaseous 
state. The mass spectrometer measures the mass-to-charge ratio (m/z) of the ionised 
gas-phase particles that accelerate through a chamber containing an electric or magnetic 
field. The m/z can then be used to infer the elemental composition of the molecule. Since 
it is not the molecular weight that is measured but the mass to charge ratio of individual 
ions, it is highly improbable that the m/z value measured would be an integer due to the 
relative abundance of isotopes in nature.  
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Figure 1.6: Stages of Events within an LC-MS Orbitrap Mass Spectrometer 
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Figure 1.6 Legend: Stages of Events within an LC-MS Orbitrap Mass Spectrometer 
 
LTQ Orbitrap Schematic Adapted from (Editors 2008). ESI and HPLC Adapted from 
(Greaves & Roboz 2013) 
a) Sample introduction: Analytes can be injected via direct infusion (not shown) or 
separating peptides based on their hydrophobicity. Hydrophilic peptides pass 
through the column the quickest due to the C18 coating. Eventually, hydrophobic 
peptides pass through as the organic gradient gradually increases over time 
 
b) Ionisation: Many forms of hard and soft ionisation are available. Electrospray 
Ionisation is suited for biological material with high polarity. Analyte in mobile 
phase is nebulised. Ions escape droplets and enter the mass analyser at an 
angle. At low flow rates, evaporation is enough for the gas to dry. 
 
c) Lateral view of quadrupole: Ions are trapped oscillating due to opposing electro-
magnetic rods encasing the ions. Ions can be ejected radially or axially. Linear 
ion traps have higher sensitivity compared to quadrupole ion traps as the ions 
do not cross paths as much. 
 
d) Orbitrap mass analyser: Spindle shaped electrode encased in an outer electrode. 
Ions enter at an angle for the purpose of creating momentum to orbit around 
the spindle while simultaneously oscillating laterally. The ion trajectory create 
unique paths which can be converted into spectra using Fourier Transformation 
 
e) Complete schematic of LTQ Orbitrap XL. From separation of analytes via HPLC to 
data analysis on an instrument attached computer 
 
f) Complete sequence of events of a mass spectrometer 
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Therefore, the m/z is almost always a non-integer and the number of significant figures 
given depends on the resolution of the instrument. The non-integer values highlights the 
precision to which the mass spectrometer can determine which element or molecule is 
present. 
There are three components of a mass spectrometer. Firstly, an ion source that ionises 
molecules, transferring produce gas-phase ions. The second component of a mass 
spectrometer is the mass analyser, that sorts the ions based on their m/z ratio. Finally, a 
detector records the charge induced by an ion flying by or colliding with the surface 
(Figure 1.6) (Glish & Vachet 2003). 
1.5.2. Ionization 
To get to the mass analyser, ionization is a prerequisite for the analyte so that it is able 
to accelerate through an evacuated chamber filled with magnetic or electric fields. There 
are two types of ionisation: hard and soft ionisation. Hard ionisation leads to large 
quantities of residual energies, resulting in increased levels of fragmentation of the 
analyte. Therefore, hard ionisation is not suitable for macromolecules prepared from 
biological systems. It is ideal for inorganic compounds that have a lower molecular weight 
and can remain intact in a harsh environment. Soft ionisation results in relatively less 
fragmentation (Glish & Vachet 2003). Soft ionisation is the preferred method when 
dealing with macromolecules such as peptides and oligonucleotides. The two main 
ionisation techniques in proteomics are Electrospray Ionization (ESI) and Matrix-assisted 
laser desorption/ionisation (MALDI), which are both soft ionisation methods. They both 
cater to thermodynamically labile organic compounds so that they can be converted into 
the gas phase as a whole unit. The development of the aforementioned soft ionization 
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methods led to the 2002 Nobel Prize in Chemistry being awarded to John Fenn and Koichi 
Tanaka for devising ESI and LDI, respectively. 
 
With ESI, the sample is introduced in solution. The solution flows through a capillary at 
atmospheric pressure and is then aerosolised when a high voltage is applied to the liquid 
sample, becoming a charged mixture of solvent and sample. Eventually, with enough 
energy, the droplet is desolvated (Figure 1.6b). Depending on the polarity of the voltage, 
the sample will either be protonated or deprotonated, resulting in a positively and 
negatively charged ion, respectively. As the size of the biomolecule increases, so does its 
susceptibility to receiving multiple protonations/deprotonation, which gives the ion a 
bigger charge and thus smaller m/z ratio. Multiple potential sites of de/protonation also 
result in different molecules of the same compound possessing different m/z 
measurements, which in the case of larger proteins, where isotopic resolution may not 
be achievable, can be deconvoluted to determine the charge-states. Higher charge states  
decrease the m/z ratio and increase the effective mass range of detection (Yamashita & 
Fenn 1983).  
MALDI differs from ESI in that the sample is in the solid phase. There are three steps to 
MALDI: the analyte crystallises concurrently with a matrix that acts as a media to absorb 
high energy radiation from the irradiating laser, resulting in ablation and desorption of 
the sample from the matrix and, ultimately, conversion of the sample into ions in the 
gaseous state. Upon ionisation, the sample can then be accelerated through the 
magnetic/electric field. However, MALDI generates predominantly  singly charged ions; 
this is in contrast to ESI, where the samples can be protonated and deprotonated at 
multiple sites (Karas & Hillenkamp 1988).  
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As mentioned, both ESI and MALDI are soft methods of ionising, making them suitable 
methods of ionisation for the analysis of biological material. They do differ in which 
applications they are suitable for. One example would be that ESI is better suited to 
analysing smaller molecules with lower m/z values, as the MALDI matrix results in low 
m/z background noise. For a more comprehensive comparison of the advantages and 
disadvantages of ESI and MALDI, and where they are both best deployed, refer to (Figure 
1.7). 
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Figure 1.7: Factors Determining Which Ionization Method To Use  
 
 
 
 
 
  
a) 
b) 
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Figure 1.7 Legend: Factors Determining Which Ionization Method To Use (Greaves & 
Roboz 2013)  
 
a) Polarity: Depending on the polarity of the analyte in question there are a range 
of ionisation techniques that together can cover the full spectrum of polarity 
from organic small molecules to biomolecular polymers 
 
b) Mass Range: EI is able to ionise masses in the low double digit Daltons. CI, APCI, 
and APPI possess a similar 100-1000 Da range in ionizing capability. ESI has the 
highest range and in conjunction with being the softest ionisation method is 
therefore the most utilised in biological mass spectrometry. MALDI cannot 
ionise as well at the low range compared to ESI but it has great ionization 
efficiencies of >500 Da 
 
APCI; Atmospheric Pressure Chemical Ionisation 
APPI; Atmosphereric Pressure Photo Ionisation 
CI; Chemical Ionisation 
EI; Electron Ionisation 
ESI; Electrospray Ionisation 
MALDI; Matrix Assisted Laser Desorption Ionisation 
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1.5.3. HPLC separation vs direct infusion 
Depending on the source of the sample and its complexity, it might be necessary to 
separate a complex mixture with a High Performance Liquid Chromatography (HPLC) step 
before applying the sample to the mass spectrometer. Reverse stationary phase uses a 
column packed with hydrophobic nano-particles and depending on the properties of the 
peptides, they will either pass through the column quickly or slowly, with the more 
hydrophobic peptides being retained for longer. Essentially, a gradient to analyse the 
peptides has been generated so that they do not arrive at the ESI all at once (Figure 1.6a). 
If a pure sample is being analysed, such as a sample obtained from peptide synthesis, 
then direct infusion without any further separation step would be a suitable method of 
analysis. The advantage would be that one could rapidly get confirmation of the mw of a 
substance. As the name suggests, direct infusion involves the loading of the analyte 
directly into the ESI through a capillary. However, for most other biological samples, it 
would be preferable to employ a miniaturised high-performance liquid chromatography 
(nanoLC). Standard-flow is an option. However, nano-flow enables one to work with 
much smaller concentrations of samples such as from immune-precipitation. In 
molecular and cell biology, seldom is a sample composed of only one type of molecule. 
Prior to some form of protein fractionation or enrichment, tens of thousands of different 
protein species will be present in the cell. After selection, for example via 
immunoprecipitation (IP), the vast majority of soluble proteins may have been excluded 
but non-specific artefacts will still be present in the sample. Moreover, the sample will 
have been digested with some form of protease (typically trypsin) during sample 
preparation, resulting in the generation of a variety of peptides with different 
biochemical properties. These peptides undergo further separation through the use of 
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HPLC (see above), ensuring that they do not all arrive at the ESI simultaneously. Reversed-
phase chromatography is a system for separating out peptides based on their 
hydrophobicity and is employed in both nanoLC and HPLC systems. The stationary phase 
consists of alkyl chains covalently attached to beads packed within the column; due to 
the nonpolar nature of the alkyl chains, the stationary phase is hydrophobic. On the other 
hand, the mobile phase is an aqueous solution. Hydrophobic peptides will be attracted 
to the environment created by the alkyl groups and will adsorb to the stationary phase, 
whereas hydrophilic peptides will remain in their preferred environment i.e., the aqueous 
mobile phase (Figure 1.8). As a consequence, hydrophilic peptides exit the column first 
in the form of an unbound flow-through fraction. The hydrophobic peptides are eluted 
from the column by applying a concentration gradient of organic solvent, i.e., non-polar 
solution. The least hydrophobic peptides, which adsorb most weakly to the alkyl groups, 
will be eluted at lower concentrations of organic solvent. Higher concentrations of 
organic solvent will be required to elute the more hydrophobic peptides from the 
column.  
 
In proteomics, separation of trypsinised peptides is crucial to generate high signal to 
noise data, which is essential for generating results that will have quantitative relevance. 
The nanoLC connected to the ESI method is provides a stable flow rate, ensuring that the 
droplet size is consistent and minimising any adverse effects on the ionization efficiency.  
For targeted MS, where m/z correlating to peptides of interest are picked (Figure 1.8), to 
ensure the highest degree of accuracy and precision, consistent retention times of 
peptides is a necessity. A modern and sophisticated nanoLC can provide this. Otherwise, 
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some scans of some targeted masses will be missed if they drift out of the window, 
thereby affecting results downstream (Rudnick et al. 2010) (Mason et al. 2005).  
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Figure 1.8: Targeted LC-MS-MS  
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Figure 1.8 Legend: Targeted LC-MS-MS: Data Dependent Acquisition 
 
Targeted LC-MS-MS can increase the levels of proteomic quantification. Samples are 
initially acquired a data independent acquisition (DIA) method. The prior run can be 
used to identify the presence of analytes of interest and when elution times for the 
analytes from the C18 column. 
 
The second run involves a Data Dependent Acquisition i.e. instructing the instrument 
with which masses to target and when. This method enables high resolution 
quantification which can be used to compare expression levels of a peptide or a PTM of 
a residue of interest. 
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1.5.4. Orbitrap 
The Orbitrap-XL utilized in this work is a hybrid instrument, incorporating a linear ion trap 
and an Orbitrap. The Orbitrap is composed of an inner electrode that is spindle-like in 
shape within a cylindrical electrode. Due to the geometry of the charge from the two 
electrodes, ions remain trapped orbiting the spindle-shaped electrode. The ions also 
oscillate around the spindle pole to pole. (Figure 1.9a). The oscillation generates an image 
current on the detector plate which the machine records. Using an algorithm derived 
from Fourier transformations of the recorded image, the m/z ratio can be deduced by 
the frequency of the image currents and a mass spectrum can be generated (Makarov 
2000).  
 
A quadrupole mass analyser is composed of four rods orientated in a parallel 
conformation. The quadrupole can use the m/z ratio of sample ions to sort them based 
on their flight path whilst oscillating around the electric fields applied to the rods. A linear 
ion trap will trap radially by utilising a quadrupole configuration. The second set of 
electrodes is then used to confine the ions axially. Linear ion traps are useful for confining 
the ions into a "well" which can then be used to filter the ions based on their m/z. This 
allows the machine to store a larger amount of ions and perform faster scans but with 
reduced resolution compared to the orbitrap (Soldi et al.  2014). An Orbitrap instrument 
possesses a high mass accuracy, is has high resolving power and can process samples over 
a large m/z ratio range. However, it does not provide the highest sensitivity or dynamic 
range compared to other mass analysers (Figure 1.9c) (L. Sun et al. 2012).  
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Figure 1.9: MS/MS Compatible Instruments: Orbitrap vs Q-IMS-TOF 
 
 
  
a) 
b) 
c) 
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Figure 1.9 Legend: MS/MS Compatible Instruments: Orbitrap vs Q-IMS-TOF 
 
Adapted from (Editors 2008) and (Waters Corporation 2016) 
 
a) Thermo Scientific Orbitrap LTQ XL: Orbitraps have the second highest resolution 
of mass spectrometers. Second only to Fourier Transform Ion Cyclotron 
Resonance. Both instruments use frequency and Fourier Transformation to give 
a higher mass accuracy than a Quadrupole-Time of Flight Instrument. The 
Orbitrap also has high mass resolution compared to Q-TOF based system. 
 
b) Waters Synapt G2 Si: While the resolution of this Q-TOF instrument is not as 
high as that of the Orbitrap, the Synapt G2 Si has an extra layer of resolving: the 
Ion Mobility Separator that differentiates ions not based on charge but on 
shape. Essentially three dimensions of resolution. It also trumps the Orbitrap in 
regards acquisition rates. The Synapt G2 Si also utilises a “W-Wave” in the TOF 
cell to increase the mass accuracy compared to a linear TOF cell. 
 
c) Table of Comparison of Manufacturers’ Specifications  
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1.5.5. Tandem Mass Spectrometry: pseudo-Selected Reaction Monitoring 
Even though mass spectrometry can in some cases obtain the elemental composition of 
a molecule from the m/z ratio, it is not possible to obtain the amino-acid sequence from 
a peptide without fragmentation. To obtain the amino-acid sequence of a particular 
peptide, it is necessary to isolate and fragment the corresponding peptide ion (precursor 
ion) with the aid of the linear ion trap. With a combination of different fragment ions 
being generated from a given precursor ion, one can infer the amino-acid sequence. This 
technique is known as tandem mass spectrometry and it allows for precise identification 
of peptides and localisation of PTMs to any given amino-acid residue (Glish & Goeringer 
1984) (Steen & Mann 2004). Using tandem MS allows for high levels of specificity to be 
attained. Two mass selectors are utilised by setting them to transmit targeted pairs of 
parent and fragment ions. A triple-quadrupole instrument enables increased sensitivity 
with the use of fragmentation. Two mass analysers are utilised; the first to gate the 
precursor ion and the second to gate fragment ions. In conjunction with high frequency 
cycles available on Q-TOFs, the two filtering steps lead to ultrahigh sensitive quantitative 
analysis (Figure 1.10). The precursor and fragment are together known as a ‘transition’. 
Tandem mass spectrometry has become a necessity for quantitative proteomics. 
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Figure 1.10: Tandem Mass Spectrometry (MS/MS) and Applications 
 
 
  
a) 
b) 
c) 
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Figure 1.10 Legend: Tandem Mass Spectrometry (MS/MS) and Applications 
 
a) (i) In tandem mass spectrometry, precursor ions are initially selected based on 
their m/z. The ions are fragmented in high energy collisions. The product ions 
can be further selected. (ii) There are high levels of specificity with increased 
sensitivity compared to Single Ion Monitoring alone. (i) Tandem mass 
spectrometry can also help distinguish overlapping peaks in a spectrum or 
reduce chemical background noise. 
  
b) Resolving Power of MS/MS. A tryptic histone H3 peptide with two lysine 
residues has four permutations when it can only be modified by propionylation 
and acetylation. Therefore two of the possible peptides possibilities are isobaric 
i.e. carrying one of each modification on either peptide (red dotted square). 
Without tandem mass spectrometry the isobaric peptides could not be 
distinguished. However, with MS/MS, CID results in the generation of b and y 
ions, where residues break off at the C and N terminal respectively. Product ions 
carrying only one of the modifications will help to distinguish which modification 
is carried. 
 
c) Table of Masses For All Product Ions of Tryptic H3 Peptide 
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In canonical selected reaction monitoring (SRM), the selected transitions are gated by 
quadrupoles, allowing 100% duty cycle for a given m/z. However, the Orbitrap is not 
capable of SRM, lacking quadrupoles for precursor and fragment ion selection, therefore 
the equivalent targeted experiment is referred to as pseudo-SRM (pSRM). The reduced 
duty cycle makes the Orbitrap pSRM less sensitive than SRM. In contrast to SRM on a 
triple quadrupole (QQQ), pSRM benefits from high resolution detection of precursors 
and/or fragment ions, helping to detect close to isobaric interference (Gallien et al. 2013) 
1.5.6. LC-MS/MS compared to Immunoassays 
Immunoassays have been well established for several decades (Yalow & Berson 2007). 
Rosalyn Yalow pioneered the use of antibodies and received the 1977 Nobel Prize in 
Physiology or Medicine for her work on developing radioimmunoassays. Immunoassays 
have been the standard for assessing protein expression and PTMs in 
biomedical/biochemical research for several reasons. Immunoassays give simple 
readouts of clinical assays or if a protein silencing has been successful. The antigen, which 
is the protein of interest, possesses epitopes that a specific antibody will recognise. The 
antibody specific for a protein of interest will have been raised in a known species, e.g. 
mouse, so a secondary antibody from a different species could be used, e.g. rabbit, that 
recognises IgG from the host species. The secondary antibody will be tagged with some 
form of reporter molecule. A common reporter tag is horseradish peroxidase (HRP), 
which fluoresces when it comes into contact with its substrate in the presence of an 
enhanced chemiluminescence (ECL) solution. Such a system can be utilised in western 
blotting, immunofluorescence, ChIP-on-chip, ChIP-seq and ChIP-qPCR. Immunoassays 
prove themselves useful in several ways: they are widely used around the scientific and 
medical community so libraries of extensive protocols and techniques are available. Also, 
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immunoassays do not have a steep learning curve so it is easier to train an individual on 
the rudimentary and common steps. They also provide decent sensitivity for analysis: 
modern microscopy techniques are able to detect single protein molecules (Etheridge et 
al. 2014). Antibodies are also able to cope with complex protein configurations e.g. a tried 
and tested antibody will be able to pull down a single species of protein from a clarified 
cell lysate. Financially, immunoassays have a low barrier of entry for a typical lab group. 
However, as proteomics has been improving its reputation as a formidable tool for 
analysing protein expression, immunoassays have had theirs tarnished in recent years 
due to antibody non-specificity. When raising antibodies, there will be inconsistencies 
from even the same individual animal if it is bled on different days. Batch-to-batch 
variation of the same antibody from the same manufacturer is a described issue. 
Moreover, a lack of rigorous antibody verification is a common problem with commercial 
antibodies. Traditionally, antibodies have been used to assess histone PTMs. However, in 
recent years, this approach has come under increasing scrutiny: numerous epigenetic 
antibodies that were used in immunoassays in previously published studies were found 
to be non-specific in their binding, which can obviously result in false positives (Egelhofer 
et al. 2010). There is no industry standard across manufacturers for the same protein of 
interest and so there is no consistent result for the same experiment across different labs 
(Tjeertes et al. 2009). In contrast,  once a standard technique is established in LC-MS/MS, 
it is more reproducible as there is substantially less variability between a mass 
spectrometer of the same model and make than there is for antibodies (Paulovich et al. 
2010). Some proteins, for example H2AX or 53BP1, are well characterised and therefore 
supply and demand states that there will be numerous antibodies available for that 
protein so there will be less chance of error. However, for the understudied proteins of 
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interest, the antibody availability would be scarce. The scarcity will require raising an 
antibody for the antigen which has greater potential for non-specificity. The non-specifity 
can result in misleading results downstream of the immunoassay. LC-MS/MS has no such 
inherent issues. Even though the use of mass spectrometry in molecular biology has 
become increasingly popular in recent years, compared to immunoassays, there are not 
as many established protocols. However, there is an increasing library of mass 
spectrometry-based protocols. The advantage is that the proteomic protocols are more 
reproducible across lab groups compared to immunoassay protocols (Tabb et al. 2010) 
(Eyers & Gaskell 2014) (Sechi 2007) 
 
Not only do antibodies have specificity issues, they are also limited in the questions that 
they can answer. With mass spectrometry, it is possible to quantify protein isoforms 
amongst other isoforms which are not possible with immuno-based methods. In addition, 
mass spectrometry gives a high-throughput of HPTM quantification. With antibody-based 
systems, one would need to know which particular proteins and modifications they would 
be interested in prior to starting the immunoassay as the relevant antibodies would need 
to be purchased beforehand. However, mass spectrometry detection is not limited to 
what is available in the lab stock or manufacturers catalogue. LC-MS/MS allows for data-
independent methods so that a whole data stream of what is and is not present in the 
sample can be generated. Due to the high throughput analysis that mass spectrometry 
affords, which particular HPTMs change in response to damage on a temporal scale can 
be determined. With the addition of SILAC (Stable isotope labeling by amino acids in cell 
culture) based systems, whether the modification changes are new modifications or old 
modifications are determinable. Which histone variants are present at the site of damage 
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can be checked simultaneously, rather than one or two (depending on a number of 
channels available with microscopy). We can see what the temporal chromatin dynamics 
are at the site of damage, which yields answers to questions such as whether more 
repressed chromatin exists later in the DNA repair process (Goodarzi et al. 2008). If an 
increase in repressive PTMs are found at later time points, we can then ask if those PTMs 
are old modifications or new modifications with heavy labelled methionine and arginine. 
As outlined, mass spectrometry is a high resolution, unbiased technique that can 
generate large amounts of data rapidly. It makes sense that the next step in epigenetics 
research would be to utilise state of the art proteomic techniques. A comparison of 
immune-assay against LC-MS is laid out in Table 1.2. 
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Table 1.2: Comparison of the capabilities and feasibility immuno-assays and LC-MS 
 
 
  
Immuno-assay Liquid Chromatography-Mass 
Spectrometry
Cost Depending on the assay, relative cheap to set 
up e.g. western blotting. However can also be 
expensive to set e.g. cost of a sophisticated 
fluorescent microscope 
Relatively expensive to set up. An instrument from any 
manufacturer can be prohibitively expensive for most 
groups. Reagents, maintenance and space required can 
be expensive
Ease-of-use Very easy to train new members on most 
techniques
Steep learning curve compared to most immuno-assay 
techniques
Live Cell Work Possible Not possible
Design of Experiment Bias: requires prior knowledge and 
hypotheses to utilise a given antibody
Non-bias: can discover new interacting partners or 
PTMs with data-independent acquisition method
Feasibility of scaling up 
experiment
Does not scale well for most assays and costs 
increase substantially
With the use of HPLC, tens if not hundreds of peptides 
can be targeted and analysed directly
Differentiate PTMs 
spatially
Can be an issue if raised antibody recognises 
modified residues proximal to epitope site
Use of b and y ions can determine which specific amino 
acid residues carry a PTM
Differentiate PTMs 
temporally
Pulse chase experiment can determine loss or 
gain of PTM but not determine new or old
SILAC can determine whether proteins or PTM are new 
or old
Less-characterised 
proteins
Pool of commercial antibodies may be 
smaller. May even require raising antibodies. 
Potential for trial and error and less 
reproducibility between batches
As long as peptides can ionize efficiently, there is no 
difference results in regards to well studied or less 
studied peptides.
 67 
1.6. HPTMs in the DDR; An LC-MS/MS Challenge (preface to results) 
To summarise this introduction, three components of biochemistry have been explored 
in detail, with the aim of marrying them together: DNA damage response, histone post-
translational modifications and mass spectrometry. Understanding the DDR can 
eventually pave the way for leading to better treatments for cancer, infertility and 
neurodegenerative diseases. The Histone Code, as coined by David Allis, has given the 
genome a whole new dimension of complexity when comparing to the transcriptome 
alone (Strahl & Allis 2000). It plays a role in a long list of biological functions, including the 
DNA damage response. However, with the different permutations that are possible with 
the histone code, new systems are required to answer more complicated questions. The 
aim of this thesis is to develop a mass spectrometry method that can be utilised to answer 
questions of the DDR HPTM changes that can occur on a spatiotemporal scale. Histones 
that have been prepared from the nucleosome indiscriminately can answer questions at 
a global level. However, if we were to select for histones specifically from damaged 
chromatin, then the HPTM changes identified would reflect what is taking place at a local 
level. Several protein tagging options are explored to develop such a technique, which 
will be outlined in later chapters. In conjunction with a pulse-chase experiment, questions 
can be asked on a time scale of when a particular HPTM is introduced and whether its 
presence overlaps or does not coincide with another protein or HPTM. Determining what 
is present or absent alongside a given HPTM would help to identify potential interaction 
partners, thus providing mechanistic insights into the relationship between HPTMs and 
DDR proteins. Here, we aim to analyse as many HPTMs that were reported in previous 
studies to change as a result of the DDR (Table 1.1) and ask whether we would see similar 
results with the developed proteomics method.  
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Chapter 2: Methods and Materials  
2.1. Culturing of Cells and cell lines used 
Mouse Embryonic Fibroblasts (MEF), Human U2-OS and HeLa cells were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% foetal calf serum, 
2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin. Epstein-Barr virus-
transformed wild-type (i.e. from an unaffected sibling of a patient; generous gift from the 
O’Driscoll lab) lymphoblastoid cells (LCLs were cultured in Roswell Park Memorial 
Institute (RPMI) 1640 medium supplemented with 15% foetal calf serum, 2mM L-
glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin.  
 
Table of cell lines used in experiments 
Cell Line Origin Immortalised 
LCL Wild Type Lymphoblastoid EBV 
U2-OS Bone Osteosarcoma Cancer 
53BP1:3xFLAG U2-OS Bone Osteosarcoma Cancer 
HeLa Cervical Cancer Cancer 
MEF Wild Type Mouse Embryo TERT 
MEF H2AX -/- Mouse Embryo TERT 
 
2.2. DNA Damage: Ionising Radiation 
Irradiating U2-OS Cells: DMEM media was aspirated and replaced with 5 ml Trypsin 
(0.05% EDTA) (GIBCO#25300) and the cells were incubated at 37 °C until they detached 
from the flask. Cells were spun down at 1500 rpm for five minutes and resuspended in 
50 mL of DMEM media in a 50 mL conical centrifuge tube. U2-OS cells were irradiated 
with a dosage of 20 Gy using a 137Cs source. Cells were immediately placed in a 37°C 
incubator and were left to recover for either 5 minutes, 30 minutes, or 60 minutes. Upon 
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recovery, cells were spun down and were immediately flash frozen in liquid nitrogen and 
stored at -80°C before sample preparation. 
Irradiating LCLs: Cells from different flasks were collated together into suspension. Cells 
were then spun down at 1500 rpm for five minutes and suspended in new RPMI in a 15 
mL conical centrifuge tube.  LCLs were irradiated with a dosage of 20 Gy using a 137Cs 
source. Cells were immediately placed in a 37°C incubator and were left to recover for 
either 5 minutes, 15 minutes, 30 minutes, 60 minutes or 24 hours. Upon recovery, cells 
were spun down and were immediately flash frozen and stored at -80°C before sample 
preparation. 
2.3. Nuclear Extract 
Modified from Lin et al. (Lin et al, 2012). Nuclei Isolation Buffer 250 (NIB-250) was 
prepared: 15 mM Tris-HCl (pH 7.5), 60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 1 mM CaCl2, 
and 250 mM Sucrose. NIB-250 was supplemented with the following phosphatase and 
protease inhibitors:  
For acid extractions in chapter 3: 
• 10 mM Na-butyrate 
• 0.5 mM AEBSF (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) 
• 2 μM leupeptin 
• 1 μM Pepstatin A 
• 1 μM aprotinin 
• 2 mM PMSF (phenylmethane sulfonyl fluoride) 
• 5 mM NaF 
• 5 mM NEM (N-Ethylmaleimide) 
• 2 mM Na-orthovanadate 
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• 60 mM β-glycerophosphate,  
 
For Micrococcal nuclease digestions preceding immunoprecipitations in Chapter 4:  
• 10 mM Na-butyrate 
• 0.5 mM AEBSF  
• 2 μM leupeptin 
• 1 μM Pepstatin A 
• 5 mM NaF 
• 5 mM NEM 
NIB-250 with 0.3% NP-40 was added to the cells at a ratio of 10:1, by volume of cell pellet. 
Cells were incubated on ice for 5 min and then subsequently spun down at 600 rcf for 
five min at 4°C. The supernatant was discarded and then NIB-250 without NP-40 was 
added to the cell pellet and spun down again, twice. The remaining pellet consisted of 
isolated nuclei. The isolated nuclei were vortexed slowly and 0.4N sulphuric acid was 
added to the cells at a final ratio of 5:1. The nuclei-H2SO4 suspension was left to incubate 
on ice for 60 minutes and then spun down at the centrifuge's maximum speed for 5 
minutes at 4°C. The supernatant was transferred to a microcentrifuge tube. To the 
supernatant, 100% trichloroacetic acid (TCA) was added to give a final concentration of 
20% TCA. The mixture was left to precipitate overnight at 4°C. The precipitate was then 
spun down at the microcentrifuge's maximum speed. The pellet was resuspended in 
chilled acetone with 0.1% hydrochloric acid. The sample was then spun down, washed 
twice with acetone, left to air dry, and finally dissolved in water.   
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2.4. Acid Extraction of Histones 
Modified from Lin et al. (Lin et al, 2012). The isolated nuclei were vortexed slowly and 
0.4N sulphuric acid was added to the cells at a final ratio of 5:1. The nuclei-H2SO4 
suspension was left to incubate on ice for 60 minutes and then spun down at the 
centrifuge’s maximum speed (5,000 rpm; Eppendorf Centrifuge 5810) for 5 minutes at 
4°C. The supernatant was transferred to a microcentrifuge tube. To the supernatant, 
100% trichloroacetic acid (TCA) was added to give a final concentration of 20% TCA. The 
mixture was left to precipitate overnight at 4°C. The precipitate was then spun down at 
the microcentrifuge’s maximum speed (13,500 rpm; Eppendorf Microcentrifuge 5424). 
The pellet was resuspended in chilled acetone with 0.1% hydrochloric acid. The sample 
was then spun down, washed twice with acetone, left to air dry, and finally dissolved in 
water.  
2.5. Micrococcal nuclease treatment 
Upon completion of nuclei isolation, the DNA concentration was measured: 10 μL of 
nuclei isolation was diluted in 89 μL ddH2O, 1 μl 10% SDS was also added to give a final 
concentration of 0.1% SDS. The sonicator (diagenode Bioruptor® Pico) was switched on 
prior to use, to allow cooling of the device. The sample was sonicated for 10-15 cycles 30 
seconds on, with 30 seconds off between each sonication. The number of cycles 
depended on the viscosity of the isolated nuclei dissolved in 0.1% SDS solution. A 
NanoDrop Microvolume spectrophotometer was used to measure the ratio of 
absorbance at 260 nm and 280 nm (A260/280) to determine the DNA concentration of 
the sonicated isolated nuclei. 
From the original unsonicated mixture, 500 – 2000 μg of chromatin was aliquoted into a 
new tube. The sample was spun down at 400 rcf and resuspended in digestion buffer:  
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• 0.25 M sucrose 
• 50 mM Tris-HCl pH 7.9 
• 5 mM CaCl2 
The following inhibitors were also added:  
• 1 mM NaF 
• 5 mM Na-Butyrate 
• 20 μM NEM 
• 0.2 mM AEBSF 
• 10 μM Leupeptin 
• 1 μM Pepstatin A.  
Freeze dried micrococcal nuclease (Mnase) was resuspended in 0.25 M sucrose and 50 
mM Tris-HCl. 1 U (Worthington Unit) was used to digest 150 μg of chromatin-bound DNA 
into mono- and dinucleosomes. The samples were placed in a micro-shaker-dry bath set 
at 37 °C for 50-60 minutes at 1500 rpm. EDTA was added to each reaction for a final 
concentration to each sample to quench the Mnase digestion. The samples were spun 
down (11,000g x 10 min) and the supernatant was collected (S1).  
To release nucleosomes from more compact regions of the genome, the pellet was 
resuspended in 500 μL lysis buffer:  
• 0.5 M NaCl 
• 1 mM Tris-HCl pH 7.4 
• 0.2 mM AEBSF 
• 5 mM Na-Butyrate 
• 20 μM NEM 
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• 1 mM NaF. 
The samples were then shaken vigorously on a vortex for 30 minutes. The samples were 
then spun down at the tabletop microcentrifuge’s maximum speed, ~ 14,000 RPM. The 
supernatant was then collected: S2.  
 
The DNA concentration of both supernatants was measured using the NanoDrop, 
measuring the A260/280: the supernatants were diluted into 1% SDS and 1X New England 
Biolabs loading buffer, shaken vigorously for 15 minutes and then heated in a dry bath at 
85°C for 15 minutes. 
2.5.1. Agarose gel electrophoresis  
To check the efficiency of the Mnase digestion, approximately 1.5 μg of DNA was loaded 
onto a 1% agarose gel with no ethidium bromide in 0.5 M TAE (Tris base, acetic acid and 
EDTA). The gel was run at 50 Volts for 45 minutes, or longer if required for better 
separation. The gel was then shaken in 1 in 20,000 Ethidium Bromide solution. DNA 
released from S1 should be in the size range of 200-400 base pair: denoting mainly mono- 
and dinucleosomes. S2 will have a larger range of DNA size as the Mnase would not have 
digested the DNA completely. A Mupid mini-gel electrophoretic unit was used to run the 
gels. 
2.6. Immunoprecipitation of γH2AX 
Upon digesting chromatin with Mnase, the supernatants S1 and S2 were pooled together 
for a ratio corresponding to approximately 1:2 respectively in protein content. The 
additional buffer was added to S1 and S2 mixture to ensure total salt concentration 
remained around 200 mM. An antibody concentration of 0.25 μg of γH2AX antibody 
(Abcam ab81299) was incubated overnight at 4°C with for every 1 mg of nucleosomes. A 
 74 
total of 1.5 mg of protein was used to pull down γH2AX. 10-20% percent of the starting 
material was retained as input. The next day, 10 μl magnetic IgG beads (Dynabeads® 
Protein G for Immunoprecipitation) were washed twice in PBS, and once in incubation 
buffer. The beads were then left to incubate with the Mnase-digestion and γH2AX 
antibody for 60 minutes. After incubation, a magnetic stand was used to collect the flow 
through which was to be kept for analysis with western blot, to determine depletion of 
γH2AX. The beads were washed for five minutes for a total of five minutes in wash buffer:  
• 500 mM NaCl 
• 50 mM Tris 
• 1% NP40 
• 1% Tween 
The beads were agitated fifteen minutes in Laemmli buffer. The beads were then boiled 
beads in the Laemmli buffer. The Laemmli buffer supernatant was collected using the 
magnetic stand. 2-Mercaptoethanol (βME) was then added to the Laemmli buffer to give 
a final concentration of 5% βME. The beads were boiled once more and then loaded onto 
an SDS-PAGE gel. 
2.7. SDS-PAGE and Western Blot 
BIO-RAD Mini-PROTEAN® Tetra Vertical Electrophoresis Cell was used for running SDS-
PAGE electrophoresis gels and for transferring proteins onto membranes. 15% 
polyacrylamide gels were used to run and separate proteins: 
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Running Gel (1x) Stacking Gel 
1.8 ml ddH2O  2.5 ml ddH2O  
4 ml 30% Bis-Acrylamide 1 ml 30% Bis-Acrylamide 
2 ml 1.5M Tris pH 8.8 1.25 ml 0.5M Tris pH 6.8 
80 μl 10% SDS 50 μl 10% SDS 
80 μl 10% APS (Ammonium 
persulphate) 
50 μl 10% APS 
8 μl TEMED 
(Tetramethylethylenediamine) 
4 μl TEMED 
 
Gels were run at fixed voltage, 200 V for 60 minutes. Once the proteins were separated, 
the proteins were then transferred onto nitrocellulose membrane  (0.45 μm, Bio-Rad, 
Catalogue number: 1620115) at fixed current 400 mA for 60 minutes. The membranes 
were subsequently stained with Ponceau S (Sigma-Aldrich) to check for complete transfer 
of proteins. 
 
After imaging the Ponceau S stained membranes, the membranes were incubated 
overnight on a roller for agitation at 4 C̊ in 0.2% Tween-TBS (TBST) with 5% milk powder 
for blocking. The next day, the TBST-milk solution was discarded and replaced with TBST-
milk solution containing the primary antibody for probing a protein of interest. The 
primary antibody solution was left to incubate for an hour at room temperature. The 
membranes were then washed for 5 minutes in TBST, three times. Afterwards, the 
membranes were incubated with a secondary antibody that is specific for the species that 
the primary antibody was raised in. Secondary antibody incubation was at room 
temperature for 60 minutes. This incubation was followed by the second round of three 
5 minutes TBST washes. Pierce™ ECL Western Blotting Substrate was then used for 
detection via chemiluminescence reaction with the horseradish peroxidase-conjugated 
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to the secondary antibody. Membranes were exposed onto x-ray film (GE Healthcare 
Amersham Hyperfilm ECL) for a short period of time ranging from 10 seconds to 5 
minutes. The x-ray film was then developed using a Photon Ecomax Automatic X-ray 
Developer  
2.8. Derivatization and digestion of peptides 
2.8.1. In-solution derivatisation 
Modified from Garcia et al. (Garcia et al. 2007). 5 μg of chromatin obtained from either 
acid extraction or Mnase digestion was resuspended in a volume of 9 μL, 1 μl of 1M 
tetraethylammonium bromide (TEAB) was added to the sample to buffer the subsequent 
reaction. 1 μl of 1%  propionic anhydride (in acetonitrile) was added to the histones. The 
samples were vortexed for 2 minutes at room temperature. To quench the derivatization 
reaction, 1 μl of 80 mM hydroxylamine was added and the samples were incubated for 
20 minutes at room temperature. The pH of the samples was measured to ensure optimal 
trypsin digestion, ~pH 8.5. 250 ng of trypsin was added to each sample and left to digest 
at 37°C for 4 hours or overnight. Upon digestion, the second round of derivatization was 
carried out by adding 3 μl of 1:100 diluted propionic anhydride dissolved in acetonitrile. 
The samples were then vortexed for 2 minutes at room temperature. 3 μl of 80 mM 
hydroxylamine was then added to quench the second round of derivatisation. 
 
2.8.2. In-gel derivatisation 
Modified from Bonaldi et al (2004) (Bonaldi et al. 2004). SDS-PAGE gel was prepared as 
previously stated. However, the protein was only allowed to migrate from the stacking 
into the running gel. Once all of the desired proteins had migrated, by checking the 
corresponding band on the protein ladder, the electrophoresis was stopped and the gel 
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was stained with coomassie (InstantBlue Protein Stain) for at least an hour. The gel was 
then washed with ddH2O. The stained section was cut out from the gel with a scalpel. The 
gel piece was cut into three pieces: not so small as to get aspirated by a pipette but small 
enough to allow for a larger exposed surface area. The gel slices were then shaken for 
three 5 minutes washes in destaining/dehydrating solution: 50% acetonitrile, 100 mM 
TEAB. Any residual liquid was then removed. The gel pieces were dehydrated, and so 
were rehydrated with 100 mM TEAB. The gel pieces were submerged with a 75:25 
acetonitrile to propionic anhydride mixture that was prepared immediately before being 
added to the gel pieces. The gel pieces were left to shake at room temperature for 30 
minutes. The liquid was then discarded, and the gel pieces were washed twice in 100 mM 
TEAB with 5-minute vigorous shaking. 
 
The gel pieces were then dehydrated as before, two changes of destaining/dehydrating 
solution, with 5 minutes shaking between each change. The liquid was removed. The gel 
pieces were then spun in a vacuum centrifuge (Savant™ SPD131DDA SpeedVac™ 
Concentrator) without heating. Dilute trypsin solution was prepared: 25 ng/μl, in 100 mM 
TEAB. The gel pieces were rehydrated in trypsin solution so that the gel pieces are full 
size. The gel pieces were left on ice for 5 minutes to swell up. Excess trypsin solution was 
removed. The gel pieces were submerged in 100 mM TEAB. They were incubated for at 
37 °C for four hours or overnight. An hour after incubation, the gels were monitored to 
assess if more 100 mM TEAB solution was required. 
 
The next day, the gel pieces were vortexed, spun down and the supernatant that contains 
digested peptides were collected. Acetonitrile equivalent to the volume of gel pieces was 
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added to the tubes. They were then shaken for 5 minutes on the vortex. The supernatant 
was then removed and added to the other peptide containing supernatant. This 
acetonitrile dehydration was repeated twice more to dehydrate the gel pieces. The 
supernatant was then spun in the vacuum centrifuge to concentrate the solution to 10 
μL. The peptides were derivatized again following the in-solution derivatization protocol. 
 
2.8.3. In solution trypsin digestion of peptides 
5 μg of prepared histone solution (either with acid extraction or Mnase digestion) were 
made up to 10 μL with 100 mM TEAB. 250 ng of trypsin (Sequencing Grade Modified 
Trypsin Promega Cat: V5111). Samples were incubated at 37 °C for four hours or 
overnight. Upon digestion, the samples were acidified by adding trifluoroacetic acid (TFA) 
to give a final concentration 0.1% TFA. 
 
2.8.4. On-bead Trypsinisation 
Upon completion of IP washes, the magnetic beads were washed twice with 1 mL of cold 
100 mM TEAB solution, which was freshly made and kept at 4 °C. After the second TEAB 
wash, the magnetic beads were transferred to new tubes. 
 
10 μl (10 ng/μl) of trypsin in 100 mM TEAB, was added directly to the washed beads, to 
digest the bead-bound protein. An enzyme-to-protein ratio of 1:100 (wt/wt) was used. 
The samples were vortexed for 15 seconds every 3 minutes for the first 15 minutes to 
ensure that the beads were evenly suspended in the trypsin solution. The mixture was 
then left to digest overnight at 37 °C in an oven incubator without further agitation of the 
beads. 
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After the overnight digest, 10 μl of trypsin, at the same previous enzyme-to-protein ratio, 
to each sample was added and left to digest for 4 hours at 37 °C.  The tubes were placed 
back on the magnetic rack. The supernatant, which now contains the digested peptides 
was removed and retained. The samples were acidified by adding TFA to the solution to 
give a final concentration of 0.5% TFA. 
2.9. Peptide Desalting and Detergent Removal 
2.9.1. Stage-Spin column desalting 
Modified version from Rappsilber et al. (2007). Desalting tips were prepared by punching 
out a circle of Empore C18 membrane with a blunt-ended 250 μL syringe. Fused-silica 
was used in place of the plunger to push out the C18 membrane into a 20 μL pipette tip. 
Three circles were pushed into the pipette tip as far as they can fit. Used miniprep 
columns from QIAGEN QIAprep Spin Miniprep Kit were used as a bracket for the tips 
containing the C18 membranes. The silica from miniprep was hollowed out and 
discarded. When the column was placed into a 1.5 mL microcentrifuge and the C18 
membrane tip was placed into the column, the bottom of the tip would not come into 
contact with the bottom of the microcentrifuge tube. In 1.5 mL microcentrifuge tube, 
two solutions were prepared: 
• Solution A: 80% acetonitrile, 0.1% TFA.  
• Solution B: 0.1% TFA.  
The C18 membrane was wetted by adding 20 μL Solution A to the top of the tip. They 
were spun for 1 minute at 2000 rcf on table-top microcentrifuge. Once confirmation that 
all of Solution A had passed through the C18 membrane, the solution in the 
microcentrifuge tube was discarded. If the whole solution had not passed through the 
membrane, then another spin session on the microcentrifuge was applied. The check was 
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applied after every microcentrifuge spin. 20 μL Solution B was added to the C18 
membrane to equilibrate the membrane and then spun at 2000 rcf for 1 minute. 
 
The sample was acidified (0.1% TFA) and then loaded onto the tip. The samples were 
spun through the membrane for five minutes at 2,000 rcf. 40 μL Solution B was loaded 
on to the C18 membrane tip to wash and spun at 3.5 minutes at 200 rcf. The tips were 
then transferred to newly labelled microcentrifuge tubes. 20 μL solution A was loaded, 
spun for 3 minutes at 2000 rcf. A final check to ensure all of the liquid has passed through 
the C18 membrane. The samples were spun on the vacuum concentrator with no heat to 
evaporate the acetonitrile. After acetonitrile evaporation, 4 μL of the sample remained. 
The volume was increased to 20 μL by adding 0.1% TFA. 
 
2.9.2. Sera-Mag CM clean up of peptides 
A stock solution of the Sera-Mag beads was prepared (DSMG-CM 1 μM 5% solids: Fisher 
part #11819912). Beads were taken out of the fridge for 10 minutes. 20 μl of Sera-Mag 
beads A were added to 20 μL of Sera-Mag beads B. 160 μL of water was added to the 
mixture. The mixture was placed on a magnetic rack and the supernatant was discarded. 
The tubes were taken off the magnetic stand and the beads were then rinsed with 200 
μL of ddH2O and mixed by pipetting up and down repeatedly. Two more identical washes 
were carried out. The beads were stored in 100 μL of water in the fridge.  
 
The stock beads were vortexed for a minute, and 2 μL (20 μg) of beads were added to 
each sample of prepared histones (20-100 ul volume). 5 μL of neat formic acid was added 
to 995 μL acetonitrile (FA/MeCN). An equivalent volume of FA/MeCN were added to the 
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prepared histone sample to give a 50% FA/MeCN concentration. The samples were 
incubated upright at room temperature for 8 minutes. The tubes were then placed on a 
magnetic rack for 2 minutes. The supernatant was carefully removed and discarded. The 
beads were rinsed with 200 μL 70% ethanol. They were left to incubate for 30 seconds 
and then placed on the magnetic rack for 2 minutes. The supernatant was then removed 
and discarded. Care was taken to ensure no Sera-Mag beads were aspirated. The protein 
was eluted in 20 μL of 100 mM TEAB, the beads were mixed by pipetting up and down, 
and then left to incubate for 5 minutes.  
 
2 μl of 1% (v/v) propionic acid (Fisher Scientific: A258-500) in acetonitrile was added to 
the solution and then vortexed for 2 minutes at room temperature. 2 μL of 80 mM 
hydroxylamine was then added to quench the propionylation reaction. The pH was 
measured to ensure it was in the range of pH 7.5-8.5. Trypsin was added to the solution 
at a 1:20 protein ratio (wt/wt). The samples were left to digest overnight. Upon digestion, 
acetonitrile was added to reach 87-97% final concentration. The sample was left to 
incubate for 8 minutes and then the supernatant was removed and discarded. The 
peptides were eluted for the second round of derivatization by adding 20 μL of 100 mM 
TEAB and left to incubate with slight agitation by vortexing and pipette mixing for 5 
minutes at room temperature.  2 μL of freshly prepared 1% propionic anhydride in 
acetonitrile was added to the solution and then vortexed for 2 minutes at room 
temperature. 2 μL of 80 mM hydroxylamine was then added to quench the reaction. The 
samples were incubated upright for 20 minutes at room temperature.  
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Formic acid was added to the samples for a final concentration of 5% so that the pH was 
acidic. Acetonitrile was then added to reach 87.5-95% final concentration. The samples 
were incubated for 8 minutes at room temperature and then the supernatant was 
discarded using the magnetic stand. The peptides were eluted in 2% DMSO and then 
sonicated for 1 minute using the diagenode Biorupter Pico. The tubes were then spun 
down at maximum speed for 1 minute and then placed on the magnetic stand. The 
peptide-containing supernatant was transferred to a fresh microcentrifuge tube. TFA was 
added to a final concentration of 0.1%. 
2.10. Phosphoenrichment 
 
Peptide samples were resuspended in Loading Buffer (80% acetonitrile, 6% trifluoroacetic Acid). 
A constricted GELoader tip was prepared as previously described using Empore C8 filter 
membrane material by punching out a small C8 disk using the tapered end of a 1000 μL pipette 
tip. Circular movements were applied to rotate the tip to ensure complete excision of the disk. 
The 1000 μL tip was placed into a 200 μL tip and fused-silica tubing was used as a plunger to fix 
the disk into the tapering of the GELoader tip. The GELoader tip was cut at the tapered end, 
approximately 0.2 cm away from the C8 plug. TiO2 beads (Titansphere; 5 μm; GL Sciences, Japan) 
were resuspended at 10 mg/mL in 30% ACN and 0.1% TFA. The C8 constricted tip was washed 
with 20 μL of methanol by centrifugation (100 g, 1 minute, RT). 50 μL of the TiO2 slurry was 
packed into the prepared GELoader Tip-Column by centrifugation (100 g for 5 minutes at RT). The 
TiO2-C8 microcolumn was conditioned with 50 μL Loading Buffer (150 g for 5 minutes at RT). The 
samples were then loaded onto the microcolumns by centrifugation (50 g for 30 minutes at RT). 
The microcolumns were washed with: 50 μL Wash 1 Buffer (50% ACN, 0.5% TFA, 0.2 M NaCl) at 
150 g for 20 minutes at RT. A second wash was carried out with 50 μL Wash 2 Buffer (50% ACN, 
0.5% TFA): at 150 g for 20 minutes at RT. The outside tip was wiped using ethanol-
wetted Kimtech wipes. The microcolumn was transferred to a new pipette tube. 35 μL of 10% 
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(v/v) formic acid (FA)was pipetted in to a new tube. The sample was eluted into the same tube 
with two elutions: 20 μL Elution Buffer 1 (10% NH4OH): 100 g for 20 minutes at RT and then with 
3 μL Elution Buffer 2 (80% ACN, 2% FA): 100 g for 20 minutes at RT.  3μL of 100% FA was added 
to further acidify the samples. The samples were vortexed and briefly spun down. Samples were 
dried down using a Thermo SpeedVac and resuspended in 0.1% FA. 
 
2.11. Nano-LC/MS 
ThermoFisher U3000 nanoLC and Orbitrap XL mass spectrometer were used to analyse 
peptide samples. The nanoLC was equipped with a Pepmap100 C18 trapping cartridge. 
Peptide samples were loaded in 0.1% TFA loading buffer at a flow-rate of 5 μL/min for 
five minutes. Peptides separation was conducted with a PepMap100 analytical column in 
0.1% FA at a flow rate of 0.3 μL/min; a 1-35% gradient with increasing acetonitrile is 
applied, over 28 minutes. 
Time (min) 0 15 25 28 28 35 35 
Acetonitrile % 1 12 35 60 90 90 1 
 
Electrospray Ionisation was performed using a New Objective nanospray emitter with a 
10 μm tip (FS360-20-10-N-20). The linear ion trap of Orbitrap XL was used to conduct 
Pseudo-SRM with the following settings: 
• Precurson Isolation Window: 2 m/z 
• Ion-trap fill time: maximum of 50 ms 
• Target Ion Count: 1x104 
Orbitrap was used to carryout high resolution precursor scan with a total cycle of <30 s 
which provided enough points across peptide peaks for quantification. A data-dependent 
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event was performed concurrently with targeted LTQ events on TiO2-enriched eluates to 
identify untargeted enrichment. 
2.12. Data Analysis  
Skyline v3.5 (MacCoss Lab, University of Washington) (MacLean et al. 2010) was used for 
the development of pseudo-SRM methods and for analyzing data generated from LC-
MS/MS. Sequences for peptides corresponding to targeted proteins were downloaded 
from Uniprot (Uniprot Consortium, 2017) and imported into Skyline. The peptides were 
modified in-silico with reported and speculative post-translational modifications. Possible 
permutations of m/z were generated after in-silico digestion with trypsin and chemical 
derivatisation. To ensure we were detecting different peptides that were isobaric, we 
monitored for b and y ions that would differentiate between the isobaric peptides. 
 
LC-MS/MS data was imported into Skyline and exported as CSV file into Microsoft Excel. 
Precursor ion signal was deducted from total ion signal to obtain fragment ion signal for 
the peptides. Fragment ion signal corresponding to the same peptide together (i.e. 
different modifications on the same sequence) were combined to get total fragment 
signal. Peptide of interests were quantified by normalising their signal intensity against a 
series of internal control peptides (listed below) that did not carry any known 
modifications and were available in all known isoforms of Histone H3 and Histone H4. 
Therefore, the control peptides would have similar levels of abundance across the 
different samples. Error bars were generated using standard deviation across different 
biological replicates. Triplicate data was generated from three different biological 
samples. For γH2AX-IP-MS, two-tailed T-tests were carried out on all time points eluates 
against undamaged global values and corresponding global time point. 
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Table 2.1 H2AX Control Peptides Used for Quantifications 
 
Histone Sites Sequence Monoisotopic 
Mass (Da) 
Derivatised  
Histone 
H2AX 
39 to 43 GHYAER 731.324 No 
Histone 
H2AX 
135 to 
142 
ATQASQEY 896.377 No 
Histone 
H2AX 
135 to 
142 
ATQASQEY 976.343 No 
Histone 
H2AX 
135 to 
142 
ATQASQEY 976.343 No 
Table 2.2 Control Peptides Used for Quantifications of pSRM 
 
Histone Sites Sequence Monoisotopic 
Mass (Da) 
Derivatised  
Histone 
H3 
41 to 49 Y[+56]RPGTVALR 1,089.628 Yes 
Histone 
H3 
57 to 63 S[+56]TELLIR 888.527 Yes 
Histone 
H4 
68 to 78 D[+56]AVTYTEHAK[+56]R 1,403.703 Yes 
Histone 
H4 
46 to 55 ISGLIYEETR 1,181.628 No 
Histone 
H3 
41 to 49 YRPGTVALR 1,033.602 No 
Histone 
H4 
24 to 35 DNIQGITKPAIR 1,326.761 No 
 
 
Table 2.3 Synthetic peptides and recombinant histones 
Peptides listed below were synthesised by JPT (Germany) 
Synthetic Peptide Sequence 
GHYAERATQASQEY 
GHYAERATQA-S[p]-QEY 
GHYAERATQASQE-Y[p] 
KGHYAERGKTGGKAR 
KGNYAERGKTGGKAR 
GKTGGKARAKAKSR 
GKQGGKARAKAKSR 
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Synthetic peptide sequence locations are in bold below: 
 
H2AX: 
MSGRGKTGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGHYAERVGAGAPVYLAAVLEYLTAE
ILELAGNAARDNKKTRIIPRHLQLAIRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTSATVGPKAP
SGGKKATQASQEY 
 
H2A1B: 
MSGRGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLRKGNYSERVGAGAPVYLAAVLEYLTAEIL
ELAGNAARDNK KTRIIPRHLQLAIRNDEELNKLLGRVTIAQGGVLPNIQAVLLPKKTESHHKAKGK 
Heavy labelled recombinant H2AX and H2A1B were synthesised in collaboration with 
Andrew Flaus group, National University of Ireland, Galway (Hatimy, et al 2015). 
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Chapter 3: Global H2AX Analysis 
3.1. Introduction 
3.1.1. H2AX 
In regards to variants, the H2A family of histones is the most diverse and numerous. 
Structurally, the C-terminus of H2A variants are located at the point where the DNA 
double helix enters and exits the nucleosomes (Bonisch & Hake 2012). By possessing such 
a large diversity of amino-acid sequence at the C-terminus, there is an increased 
assortment of intra-chromatin interactions. Compared to the other histone H2A variants, 
H2AX is unique in that it possesses a distinctive 22 amino acid C-terminal (Pinto and Flaus 
2010). While the sequence can vary slightly between closely related species, H2AX 
possesses a conserved characteristic motif, SQ[E/D]* (* being a hydrophobic residue) 
that differentiates it from other H2A variants (Bonisch & Hake 2012). Upon DNA damage, 
Serine 139 of H2AX is phosphorylated by one of the PIKK kinases. Essentially, H2AX is 
crucial for maintaining genome stability and integrity, and not just in the context of DNA 
damage. 
  
There are few “universal” H2A variants, that can be found in almost all organisms. H2AX 
and H2AZ are two examples of that can be found in almost all higher eukaryotes including 
plants (Talbert & Henikoff 2010). Even if the variant is not present in a given species, the 
phosphorylation of H2A at the C-terminal end at the onset of DNA damage is a conserved 
phenomenon. Both S. pombe (Nakamura et al. 2004) and S. cerevisiae (Downs et al. 2000) 
possess the SQ[E/D]* motif in their H2A variants, the consensus site for PIKK kinases. 
When DNA damage takes place, S129 of yeast is phosphorylated similarly to S139 of 
H2AX. Mec1 (ATR) and Tel1 (ATM) are the kinases responsible for phosphorylating H2A 
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S129 in the presence of DNA damage. Once S129 is phosphorylated, Rhp9(Chk1) is 
recruited showing that it is a conserved process. 
 
It has also been observed that when the C-terminus of H2AX is phosphorylated, the weak 
affinity between histone H1 and H2AX is weakened further (A. Li et al. 2010); the 
phosphorylation modification makes H2AX even more negatively charged resulting in 
DNA having reduced binding with the nucleosome, making the chromatin more 
accessible for DDR machinery.  
Even though H2AX and it is phosphorylated form, γH2AX, is seen to facilitate the DDR it 
is not essential for DSB repair. Cells are still viable. However, H2AX-/- mice are much more 
sensitive to ionising radiation compared to their H2AX+/+ counterparts. H2AX-/- mice also 
possess increased chromatid breaks and dicentric chromosomes. (Celeste, Petersen et al. 
2002). 
 
Another function of H2AX not thought to be related to the DNA damage response directly 
is during oocyte development. Upon fertilisation in mammals, the protamines from the 
sperm are rapidly replaced by histones. Histones H3.3 and H2AX were deposited into the 
paternal chromatin. The particular conformation is thought to be required as a marker 
for maternal cell machinery to identify which parental chromatin to strip DNA 
methylation from. Interestingly, it was not the phosphorylated S139 that was important 
in this case but the C-terminal end of H2AX (Nashun et al. 2015).  
 
The modifications of H2AX that we shall focus on in this section are S139phos and 
Y142phos. Even though phosphorylation of Threonine 136 has been reported to occur in 
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mammalian systems (A. Li et al. 2010), the precise function of T136phos has yet to be 
elucidated. It is theorised that upon DNA damage, S139phos along with T136phos can 
modify chromatin structure (A. Li et al. 2010). 
 
 
3.1.2. S139 phosphorylation 
 
In quick response to DNA damage, the C-terminal domain of H2AX at S139 is 
phosphorylated (Rogakou et al. 1998). When a double strand break has occurred, MRE11, 
RAD50 and NBS1 bind to the double-strand break and in turn recruit one of ATM, ATR 
and DNA-PK, which are the kinases responsible for phosphorylating S139 (Podhorecka et 
al. 2010).  All three kinases are phosphatidylinositol 3-kinase-related kinases. Due to its 
rapid response to DNA damage and ease of detectability, the presence of γH2AX is used 
as a diagnostic marker of DSB (Heylmann & Kaina 2016). Phosphorylation of H2AX S139 
can take place within 1 minute of DNA damage taking place. The spread of the 
phosphorylation can spread megabases away from the site of damage in a bi-directional 
manner. Rokagou et al. saw that for every Gy of ionising radiation, you get an increase of 
1% of total H2AX becoming γH2AX. Rokagou et al. also deduced that one double strand 
break would result in γH2AX spreading so that its coverage across the genome 
encompasses 2 million base pairs (Rogakou, Pilch et al. 1998). To say there is only one 
exact biological function of megabase-wide amplification of γH2AX would be contentious 
with the overwhelming body of evidence that has specified different functions of γH2AX 
in the context of DDR alone. 
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Perturbed recruitment of 53BP1, NBS11, and BRCA1 to IRIFs was demonstrated in cells 
that had H2AX knocked out (Celeste et al. 2002). There were increased chromosomal 
aberrations in mouse thymocytes that had the genotypes H2AX+/− and H2AX−/− (Celeste, 
Difilippantonio, et al. 2003), (Petersen et al. 2001) and (Bassing et al. 2002). It was also 
observed that mouse embryonic stem cells lacking phosphorylated H2AX had an 
increased sensitivity to DNA damage as both the NHEJ and HR pathways were 
demonstrated to be sluggish in its efficacy in repairing breaks (Bassing et al. 2002). Also, 
H2AX knockout mice were both sterile and possessed compromised in class switch 
recombination as there was a reduction in secondary immunoglobulin isotypes levels. At 
the immunoglobulin locus, chromosomal abnormalities were observed; as the cell 
induces DSBs during CSR, the cell was then not able to repair the breaks in an efficient 
manner (Petersen et al. 2001). 
 
The culmination of these studies indicate that γH2AX is a docking site for DDR proteins 
and facilitates the DDR: phosphorylation of H2AX at the C-terminal tail, especially 
S139phos, acts an epigenetic signal that acts as a signal for a handful of proteins that 
possess inherent binding sites specific for the phosphorylated H2AX C-terminal tail. 
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3.1.3. H2AX Kinase 
ATM is in an inactive state when there is no DNA damage. It forms a homodimer with 
another ATM molecule. At the onset of DNA damage, ATM phosphorylates itself at serine 
1981, and the ATM pair disassociate from each other (Rogakou, Pilch et al. 1998) (Helt et 
al. 2005). Upon chromatin remodelling, NBS1 recruits ATM to the site of damage. ATM 
proceeds to phosphorylate both checkpoint proteins and downstream DDR proteins (Lou 
et al. 2006). It was demonstrated that ATM recruitment to DSB is hindered in the absence 
of γH2AX. Any DDR pathway downstream that takes place as a result of ATM activation 
via ATM recruitment to the site of damage would be affected as a result. (Kobayashi et 
al. 2004). 
3.1.4. MDC1 
Knocking out MDC1 (Mediator of DNA damage checkpoint protein 1) in mice exhibited a 
phenotype similar to that of H2AX being knocked out: Male mice are infertile, and mice 
exhibit slowed growth. H2AX S139 phosphorylation is regulated by MDC1. MDC1 also 
mediates the interaction between ATM and γH2AX. MDC1 interacts with H2AX through 
its BRCT domain. Also, ATM interacts with MDC1 with the FHA domain on MDC1; 
speeding up ATM-dependent recruitment to the site of damage (Lou et al. 2006). Stewart 
et al. used human cell extract to demonstrate that MDC1 interacted with 
phosphopeptides during phosphor-enrichment (Stewart et al. 2003). MRN was also 
shown to interact with MDC1. Shortly after, it was determined that MDC1 BRCT domain 
recognises the H2AX C-terminal domain uniquely (Goldberg et al. 2003). In vivo 
experiments showed that there is a significant reduction in recruitment of MDC1 to IRIFs 
when the conserved residues in the BRCT domain are mutated. MDC1 also had reduced 
recruitment to IRIFs when either Serine 139 or Tyrosine 142 of H2AX were mutated. As a 
result, cells were much more sensitive to irradiation (Stucki et al. 2005). 
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3.1.5. 53BP1 
In the presence of a DSB, chromatin-bound ATM will phosphorylate MDC1. In turn, MDC1 
will recruit RNF8 and RNF168. RNF168 will ubiquitinate histone H2AK13/K15, including 
H2AX (B. Wang & Elledge 2007; Mattiroli et al. 2012). 53BP1 will be recruited to the site 
of damage by interacting with H2AK13ub/K15ub with its ubiquitination-dependent 
recruitment (UDR) motif. The Tudor domain of 53BP1 will then interact with 
H4K20me1/me2. 53BP1 cannot dock in the absence of either one of H2AK13/15ub and 
H4K20me1/me2. Even though 53BP1 possesses a BRCT domain, it is dispensable for 
recruitment to damage sites. 53BP1 activates ATM by interacting with MRN through 
RAD50 and its BRCT domain. In turn, more ATM is recruited to the site of damage (Lee & 
Paull 2007).   
Ward et al., demonstrated that when cells are deficient in H2AX, there is reduced 53BP1 
foci formation implying H2AX plays a role in 53BP1 recruitment (Ward et al. 2003). More 
recently, 53BP1 has been shown to bind to γH2AX S139 in both in-vitro and in-vivo. 
(Kleiner et al. 2015) (Baldock et al. 2015) 53BP1 binding to γH2AX with its BRCT is required 
for ATM foci formation at the site of damage. Baldock et al. also showed that a version of 
the 53BP1 void of BRCT2 domains was not able to recruit NBS1 or phosphorylated ATM. 
If 53BP1 has a mutated BRCT domain perturbing the binding to γH2AX, NBS1 could still 
be recruited (and without the MRN complex) to the site of damage but could not recruit 
pATM (Baldock et al. 2015). Lastly, they demonstrate if pATM could not be recruited as a 
consequence of the cells lacking functional 53BP1, the number of γH2AX foci in the late 
time point would be significantly higher than that of cells that were mock treated. 
Consistent with previous work showing that in the absence of ATM, breaks in 
heterochromatic regions persist at later time points (Goodarzi et al. 2008). 
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3.1.6. Y142 phosphorylation 
 
The Williams Syndrome Transcription Factor (WSTF) remodelling factor kinase is the only 
known kinase in somatic cells responsible for phosphorylating tyrosine 142 on the H2AX 
C-terminal (Cook, Ju et al. 2009; Krishnan, Jeong et al. 2009; Xiao, Li et al. 2009). In the 
presence of DNA damage, H2AX Y142 within the vicinity of the damage is 
dephosphorylated so as to avoid an unnecessary apoptotic cell fate (Cook, Ju et al. 2009). 
Cook et al. demonstrate binding of proteins involved in apoptosis with doubly-
phosphorylated H2AX S139 Y142 synthetic peptides. Compared to S139 phosphorylation, 
Y142 phosphorylation is not as well documented. However, the kinases and 
phosphatases responsible for modifying the residue have been characterised, but 
accurate basal levels of Y142 phosphorylation have yet to be attained. Previous estimates 
suggest that the modification cannot possess a basal level higher than 10% (Tran, 
Zamdborg et al. 2011). Xie et al.  transfected HA-tagged H2AX into H2AX deficient mouse 
cell line. They irradiated their cells with 50 Gy of IR, and they were able to detect six post-
translational modifications of H2AX, but Y142 phosphorylation was not amongst the 
modifications detected using the LC-MS screen. However, as they did not specify the 
recovery time allotted to the cells after irradiating them with 50 Gy of ionising radiation, 
it is difficult to say whether Y142 phosphorylation corresponding to apoptotic signals as 
a response to damage would have been activated (Xie, Odate et al. 2010). Another role  
 
The part that Y142 phosphorylated plays in the DDR is of great importance. It would also 
be interesting if interacting partners could be identified of the doubly phosphorylated 
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isoform. (Singh, Basnet et al. 2012). Brown et al., identified that by mutating Y142A 
mutation alone exhibited sensitivity to DNA damage. However, when both S139A and 
Y142A mutation were present then the IR sensitivity was rescued (Brown, Eykelenboom 
et al. 2012); implicating Y142 in both apoptosis and DDR depending on if the residue is 
phosphorylated or not, respectively.  
 
3.1.7. H2AX levels across cell lines and in the genome 
 
γH2AX plays a vital role in the DDR; it is then paramount to see whether different cell 
lines express the gene for H2AX in varying amounts or at a more homogenous level. If the 
levels vary between different cell lines, would the discrepancy have leading effects on the 
response time or intensity to damage? Previous studies have shown that H2AX levels can 
vary in different cell lines from as low as 2% to as high as 25% of the total H2A (Rogakou, 
Pilch et al. 1998).  
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3.2. Results 
3.2.1. S139 phosphorylation  
Synthetic peptides corresponding to the C-terminal of H2AX were designed for H2AX 
phosphopeptides SRM assay (Methods and Materials). Three different synthetic peptides 
were developed; the phosphorylated S139 residue, phosphorylated Y142 residue or no 
phosphorylated residues. To determine how the three different synthetic peptides would 
ionise compared to each other, all three peptides were concatenated with an identical 
quantification peptide. A simple trypsin digest would allow for both the control peptides 
to separate from the peptides of interest. Using the linear ion trap of an Orbitrap XL, the 
C-terminal synthetic peptides were fragmented (Figure 3.1a) and their ionisation 
efficiencies were quantified with pseudo-SRM assays. Singly and doubly-charged ions 
were detected for the H2AX C-terminal peptides. The m/z region corresponding to the 
singly charged peptide exhibited low background. In the presence of abundant canonical 
H2A peptides, the C-terminal peptide may be harder to detect in double-charged form. 
The common quantification peptide released upon trypsin digestion acts an internal 
control because the ionisation efficiency of GHYAER (Figure 3.1b LHS) should not be 
affected by the phosphorylated or lack of connection to the other peptide. Since the 
ionisation efficiency should be equal for the internal common quantification peptide, it 
can be used as a standard for the C-terminal peptide to be measured against. In Figure 
3.1b RHS we see that the phosphorylated peptides were detected less compared to the 
unphosphorylated form. Phosphorylated S139 and phosphorylated Y142 peptides were 
detected 2.6x less and 8.3x less than the unphosphorylated peptide, respectively. The 
new values could be applied to correct data corresponding to percentages of H2AX that 
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possess phosphorylated S139 or Y142 in cells that have been treated with ionising 
radiation. 
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Figure 3.1. MS/MS Fragmentation of ATQASQEY S139 orY142 phosphorylated 
precursors 
 
 
 
 
 
  
a) 
b) 
c) 
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3.1 MS/MS Fragmentation and ionization efficiency of ATQASQEY S139 and Y142 singly 
phosphorylated precursors 
 
a) MS/MS fragmentation of singly charged precursors for residues corresponding to 
phosphorylated S139 or Y142 from the synthetic peptide sequence ATQASQEY. Fragment 
ions detected are highlighted on the left hand side. Fragment ions used for quantitation 
are underlined.    
 
b) Ionization efficiency of differently modified C-terminal peptides. LHS: Synthetic 
peptides were designed concatenated to a common quantitation peptide, to be released 
by trypsin digestion. RHS: quantification of ionization efficiency after trypsin digestion, 
nanoLC separation and pseudo-SRM peptide fragmentation. Error bars correspond to 
standard deviation, n = 3 separate digestions. 
 
c) Table of synthetic peptide sequence used in this assay. Peptides listed in the table were 
synthesized by JPT (Germany). 
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Applying the correction factor results in an inflated values of γH2AX levels compared to 
regular H2AX. In Figure 3.2 we see that γH2AX levels peaked at around 30 minutes for 
both U2-OS cells and LCLs. This implies that the response of DDR is consistent between 
the two cell lines in that γH2AX reaches its maximum level at the same time in both cell 
lines.  If applied to γH2AX levels obtained from irradiated LCL and the U2-OS cells we 
observe levels reaching 5-10 times higher than undamaged cells after being subjected to 
20 Gy of ionising radiation. 
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Figure 3.2.  Quantification of global γH2AX S139 phosphorylation after DNA damage 
 
 
  
a) 
b) 
c) 
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3.2.  Quantification of global γH2AX S139 phosphorylation after DNA damage  
 
a) Time course after 20 Gy IR treatment in U2-OS. Fragment ions for singly charged 
ATQASQEY and ATQAS[p]QEY precursors were quantified against internal control 
peptides. Error bars correspond to standard deviation; n = 2 biological replicates. 
Technical triplicate were used to analyse each of the two biological replicates. 
 
b) Time course after 20 Gy IR treatment in LCLs. Fragment ions for singly charged 
ATQASQEY and ATQAS[p]QEY precursors were quantified against internal control 
peptides. Error bars correspond to standard deviation. Technical triplicate were 
used to analyse each of the three biological replicates.  
 
c) Western blot of α-γH2AX after 20 Gy IR treatment in U2-OS. Immunoblot Histone 
H3 and Ponceau staining of the membrane post-transfer were used to control for 
loading. 
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3.2.2. Y142 phosphorylation 
While quantifying S139 phosphorylation in U2-OS cells, Y142 phosphorylation was also 
targeted. Y142 phosphorylation could not be detected in the undamaged U2-OS cells nor 
in the post-IR recovery time points shown in Figure 3.2a. As the literature states that Y142 
phosphorylation is most prominent in the absence of DNA damage, a TiO2 metal oxide 
affinity phosphoenrichment was carried out on histones prepared from acid extracts 
corresponding to U2-OS cells that were not subjected to IR.  Post-enrichment, these cells 
were shown to have a low percentage of S139 phosphorylation, approximately 4%, as 
seen in Figure 3.2. Alongside, the phosphoenrichment from U2-OS acid extracted 
prepared histones a control sample was also used that was a cocktail of 50 pmol BSA, 0.5 
pmol α-casein, phosphorylated S139 synthetic peptide, and phosphorylated synthetic 
Y142 peptide. In the U2-OS post-enriched samples, levels of γH2AX were elevated similar 
to that of damaged cells (Figure 3.3a). Also, other phosphorylated peptides were 
detected in the post-enriched samples, but no phosphorylated Y142 peptide was 
detected from the U2-OS post-enriched sample. In the control sample, we detect 
increased enrichment of both phosphorylated S139 phosphorylated Y142 peptides, 
which demonstrated that there was no technical fault with the enrichment process. 
Another control to ensure that there was no fault with the technique was applied: 2 pmol 
of the phosphorylated Y142 synthetic peptide was spiked into a 50 μg sample of 
undamaged of U2-OS acid extract. Enrichment was carried out in parallel with an 
unspiked equivalent sample. As shown in Figure 3.3a, γH2AX was enriched in both the 
spiked and unspiked sample (Figure 3.3d). In Figure 3.3d, we see that phosphorylated 
Y142 was enriched in the spiked sample and compared to pre-enrichment the signal was 
much more pronounced. Even in the presence of a histone rich environment, the TiO2 
 103 
enrichment allowed for the enrichment of 232 other distinct phosphopeptides from non-
histone proteins such as CDK3 Y15 phosphorylation, see Appendix 1. Histone 
phosphopeptides included H3 S10, H3 S57, H4 S47 and nine phosphorylated peptides 
from histone H1.   
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Figure 3.3. Y142 Phosphorylation 
 
    
  
a) b) 
c) d) 
e) 
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3.3 H2AX Y142 Phosphorylation is a low abundance modification 
 
a) Endogenous S139 phosphopeptide was enriched from undamaged U2-OS, 
relative to the unmodified peptide. Ions fragmented from singly charged 
precursors were used for quantification.  
 
b) ATQASQEY and ATQAS[p]QEY synthetic peptides were successfully enriched from 
100x excess BSA peptides. 
 
c) H2AX C-terminal peptides 
 
d) Precursor ions from b) shown with relative intensity pre- and post-enrichment. 
 
e) ATQASQEY[p] synthetic peptide enriched successfully after being spiked into U2-
OS acid extract. 50 μg acid extract sample prepared and 0.1% of it was analysed 
pre-enrichment. (LHS) Using pseudo-SRM both ATQAS[p]QEY and ATQASQEY[p] 
were detectable pre-enrichment. Precursor ions were not detectable (Data not 
shown). (RHS) Both ATQAS[p]QEY and ATQASQEY[p]synthetic peptides are 
identified with much improved signal-to-noise ratio post-enrichment.  
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3.2.3. H2AX abundance  
The relative abundance of two peptides unique to H2AX (GKTGGKAR and KGHYAER) were 
compared with those of similar peptides in other H2A isoforms. Three cell lines were used 
for the assay: U2-OS, HeLa, and LCLs. The peptides were propionylated before and after 
trypsinization, so as to prevent trypsin digesting at lysine resides. A known amount of 
heavy labelled 15N recombinant H2AX and H2A1B (Methods and Materials) were spiked 
into the samples to account for variation in sample preparation and analysed in technical 
triplicate. Figure 3.4a shows that across the cell lines, U2-OS contains the larger of relative 
abundance of H2AX: Threefold and twofold more compared to HeLa and LCLs 
respectively. The endogenous unique H2AX peptides were normalised to the spiked-in 
15N recombinant H2AX across all the cell line. The relative abundance was consistent 
with the two H2AX unique peptides across the cell lines. 
The two H2AX unique peptides (KGHYAER/GKTGGKAR) were then used to quantify the 
levels of H2AX in the proteome compared to other H2A variants. Three peptide 
sequences were used for this analysis: GKTGGKAR/KGHYAER (H2AX), 
GKQGGKAR/KGNYAER (canonical), and GKGGVKRKGNYSER (one/three variants). The 
peptides were concatenated to correct for ionisation efficiencies. Figure 3.4b and Table 
3.1 show that U2-OS possess the largest percentages of H2AX, then LCLs and HeLa cells 
having the least amount of the cell lines analysed. Even though the percentages  were 
not the same for both peptides, they are consistent in demonstrating H2AX levels across 
the three cell lines. Four H2A variants were not analysed as they did not possess a specific 
sequence to compare against.   
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Figure 3.4. H2AX Abundance 
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3.4 H2AX Abundance 
 
a) H2AX relative amounts were measured across three cell lines. U2-OS, HeLa and 
LCL extracts were spiked with 15N recombinant H2AX and H2A1B. Diagnostic 
peptide ratios were quantified. To control for discrepancies in prepared histone 
starting material, H2A1B GKQGGKAR was used to normalise the diagnostic 
peptides across samples. 
 
b) Percentage of H2AX variants compared to other H2A isoforms. U2-OS, HeLa and 
LCLs H2AX levels were measured relative to other H2A variants. The levels were 
corrected for ionization efficiency. Fragments from doubly charged precursors 
were used for quantification. N = 2. Technical triplicate were used to analyse each 
of the two biological replicates. 
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Table 3.1. H2AX Abundance 
 
  
Measured peptide Protein(s) U2OS HeLa Lymphoblast 
GKTGGKAR H2AX 3.1 1.0 1.9 
GKQGGKAR 
11 H2A (1A, 1B, 1C, 1H, 1J, 1D, 1, 2A, 2C, 
3, 2B) 96.3 97.7 97.6 
GKQGGKVR H2AJ 0.6 1.3 0.5 
Not measured H2AB1, H2AB2, H2AV, H2AZ n.m. n.m. n.m. 
Total 17    
KGHYAER H2AX 6.4 2.6 5.1 
KGNYAER 9 H2A (1A, 1C, 1H, 1J, 1, 2A, 2C, 2B, J) 91.1 88.4 82.9 
KGNYSER H2A 1B, 1D, 3 2.4 9.0 11.9 
Not measured H2AB1, H2AB2, H2AV, H2AZ n.m. n.m. n.m. 
Total 17    
 H2AX average 4.7 1.8 3.5 
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Table 3.1. H2AX Abundance (Legend) 
 
Table of relative amounts of various H2A isoforms. Detection of GKTGGKAR was 1.1x 
better than GKQGGKAR the canonical H2A sequence. KGHYAER, peptide sequence 
unique to H2AX, was detected with 1.7x stronger signal, compared to the canonical 
KGNYAER. The relative percentages have been corrected to take into account different 
ionization efficiencies.   N = 2. Technical triplicates were used to analyse each of the two 
biological replicates. Values for standard deviation are in brackets. 
 
n.m. = not measured 
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3.3. Discussion 
H2AX C-terminal phosphorylation levels were able to be quantified using in-house 
developed pseudo-SRM assays. Due to two structural reasons, phosphorylation of both 
S139 and Y142 are challenging modifications to analyse. Normally, the last amino acid 
after a tryptic digestion is basic in nature: arginine or lysine. The basic residues would 
assist in balancing the charges brought on by modifications to the peptide -OH side chain. 
Each additional phosphorylation to the peptide will increases the negativity by -1. 
Together, the lack of a basic molecule and receiving phosphorylation has an additive 
effect of decreasing the ionisation efficiency in positive mode mass spectrometric 
quantification assays, resulting in the peptide signal more difficult to detect. 
Nevertheless, both phosphorylated Serine 139 and Tyrosine 142 were able to be 
detected in both singly and doubly charged species, which can be fragmented into 
fragment ions that make it easier for quantification. Even though the two phosphorylated 
peptides are isobaric in nature, they do not co-elute from the nano-LC, therefore, there 
is no overlap in the diagnostic fragment ions from both species which would make 
quantification of both modifications more nebulous. 
 
We see discrepancies between both U2-OS and LCL in γH2AX levels after being irradiated 
with 20 Gy of ionising radiation. The large differences between the two cell lines in γH2AX 
levels has two possible explanations: sample prep differences and biological differences. 
The histones from LCLs were obtained with a Micrococcal nuclease digestion of isolated 
nuclei, and the histones from U2-OS were obtained with an acid extract of the two nuclei. 
Points that would need to be taken into consideration before making a judgment in 
stating that there are biological differences between LCLs and U2-OS in regards to 
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phosphorylation S139 levels: the samples were prepared at different times, and two 
different methods of histone preparation were used. While an acid extract, in theory, 
should extract all the histones from the chromatin as it is a crude method of extraction, 
it is difficult to say where the histones would be coming from in a Mnase digestion. Cowell 
et al. demonstrated previously that H2AX S139 is more likely to be phosphorylated in 
much more open euchromatic regions of the genome (Cowell et al. 2007). Using MCF7 
cells, they observed that at the 30-minute time point two-thirds of γH2AX foci do not 
overlap with HP1α. However, more recent studies suggest that HP1α is recruited to sites 
of damage (Baldeyron et al. 2011). Nonetheless, Mnase does not digest and release 
nucleosomes uniformly across the genome, especially when compared to acid extraction 
that is not so discriminating  in where nucleosomes are obtained from.  What is consistent 
in both γH2AX assays with LCLs and U2-OS is that there is a peak of γH2AX signal around 
30-minutes after damage. In both irradiated cells, there is a ten-fold increase in γH2AX 
compared to cells that were not subjected to IR.  In U2-OS cells, phosphorylated Y142 
H2AX was not detected in undamaged or damaged cells, even after enriching for 
phosphorylated peptides from a copious amount of starting material, 50 μg. We were 
able to use the same method to enrich for synthetic phosphorylated Y142 peptides with 
good signal. It is possible that global Y142 phosphorylation levels are below 1% and below 
the levels of detectability with the instrument used in the analysis. Phosphorylated S139 
was enriched with a signal to noise ratio of 100:(1e6/9000). Furthermore, we identified 
phosphorylated S139 has 20-40x lower abundance natively in the genome (in relation to 
damaged chromatin), indicating that the lowest threshold for detection of γH2AX is 
between 0.125-0.25%. When taking ionisation efficiencies correction into account; 
phosphorylated Y142 peptide is detected 3.2x less than the phosphorylated S139 
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peptide, then that leaves an upper ceiling detectability of 0.8% phosphorylation Y142 at 
a genome level. Other proteomic studies that looked into phosphorylated Y142 also had 
difficulty with detecting the modification. Both in the presence of damage where S139 
phosphorylation was also detected and in the absence of DNA damage (Olsen, Vermeulen 
et al. 2010; Rigbolt, Prokhorova et al. 2011). Therefore, it is not farfetched to say that the 
presence of phosphorylated Y142 is so low that it is below the threshold of detectability 
with mass spectrometry. An estimate that takes into account ionisation efficiencies of the 
phosphorylated species would suggest that phosphorylated Y142 was at least below 1% 
of H2AX in undamaged U2-OS. Even though U2-OS cells were used in this case, other cell 
lines were used, and it is possible that those cell lines, such as HEK 293T, mouse 3T3 and 
mouse embryonic fibroblasts, express the WSTF kinase more efficiently or the WSTF 
kinase is more potent in those cell lines. However, with Y142 phosphorylation being 
implicated in both apoptosis and the DDR, it is not likely there would be large variance 
across different cell lines or within highly conserved mammalian systems. 
Of course, the implication of this finding is that it questions the findings of studies that 
used immunoblotting systems to quantify or detect new functions of Y142 
phosphorylation. Xiao et al. raised an antibody that binds to Y142 phosphorylation as an 
epitope site. However with there being a ratio of >100:1 mod:pY142, a small margin of 
error could result in potentially erroneous results with a likelihood of false positives being 
given in data outputs (Xiao, Li et al. 2009). The low abundance of phosphorylated Y142 
also affects the paradigm in which Y142 was previously thought to be involved with both 
the DDR and apoptosis. With phosphorylated Y142 being present at the genome at below 
1%, means that for both S139 and Y142 to be phosphorylated simultaneously on the 
same H2AX molecule would be an even lower percentage (Cook, Ju et al. 2009; Singh, 
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Basnet et al. 2012). The only time it would seem to be conceivable for both Y142 and 
S139 to be phosphorylated would be in an environment that possesses large amounts of 
DNA damage, when γH2AX is to be the majority (Brown, Eykelenboom et al. 2012). Using 
site-directed mutagenesis to elucidate further functions of Y142 is complicated by the 
fact that when Y142 is mutated, Binding of MDC1 to γH2AX is perturbed (Xie, Hartlerode 
et al. 2007). Even though WSTF is dispensable during meiosis and is not required for male 
fertility (Broering et al. 2015), removal of WSTF reduces γH2AX formation and hinders 
the DDR. It remains to be determined if the DDR depends on phosphorylated Y142 in 
some form or another or whether the chromatin remodelling role of WSTF is required for 
the DDR (Xiao, Li et al. 2009). The findings here indicate that WSTF has an indirect effect 
on the DDR. 
H2AX was also found to be present at around 2-5% in three different cell lines. Out of 24 
H2A variants, only 17 were analysed, which comprises the vast majority of H2A variants, 
the percentage of H2AX will be slightly inflated as a result. However, it is not orders of 
magnitudes different to the real number and the level calculated here was close to the 
correct figure. U2-OS was found to possess the most amount of H2AX compared to LCL 
and HeLa. To suggest that the increased response to 20 Gy of IR is due to an increasing 
number of H2AX would be premature as consistent controls are required to be carried 
out first. 
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1.1. Chapter 4: The Development and 
Optimisation of γH2AX-IP-MS Method  
 
4.1. Introduction 
 
In Chapter 3, the only changes in HPTM levels that could be detected via LC-MS upon 
treatment of cells with ionizing radiation was γH2AX. As a result, it became apparent that 
a new method of enriching histones from damaged chromatin would be required. The 
hypothesis was that the main issue with using a method solely based on an acid extraction 
for a DNA damage proteomic screen was that the acid extraction does not filter out non-
DNA damaged chromatin, resulting in excessive background noise from histones that 
were not near the site of damage (Figure 4.1a). Apart from HPTM changes in γH2AX, 
other HPTMs did not show any changes as a result of damage (Chapter 3). It was further 
hypothesised that histones from the rest of the genome were masking the actual signal 
of DDR epigenetic changes. Therefore, a system that would only target DDR histones was 
required. Several approaches were considered, but a two-pronged strategy was settled 
to reach this goal. The first approach wass to pull-down different DDR proteins that are 
known to bind to damaged chromatin, such as RAD51 and 53BP1, and examine the PTMs 
of associated histones (Figure 4.1b). The second approach was to pull-down histones 
associated with damaged chromatin using damage-specific antibodies (Figure 4.1c). To 
identify the best pulldown method prior to LC-MS,  both native pull-down and tagging a 
protein were investigated.  
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The abundance of histones within the genome was always going to be a double-edged 
sword: they would be relatively more straightforward to enrich compared to other 
proteins, but their copious amounts would also result in increased susceptibility in 
obtaining misleading and/or undetectable data. Therefore, it was imperative for a high 
quality proteomic screen to develop a method that had the right balance of enrichment 
combined with a good signal-to-noise ratio. Other factors would also come into play and 
how they were negotiated will be elaborated further on. The motivation to develop a 
method that would give a better proteomic read out of the DDR-related HPTMs was 
because the crude method of preparing samples for mass spectrometry with just an acid 
extraction from isolated nuclei resulted in a reduced signal-to-noise ratio for detecting 
changes in HPTMs apart from γH2AX. 
 
4.1.1. Rationale of Choice of DDR Proteins 
 
There were two approaches to consider when enriching for damaged chromatin. Either 
a protein that is known to associate with chromatin upon DNA damage could be targeted, 
or the other option would be to enrich for damaged chromatin directly (Figure 4.1b and 
4.1c). The initial intention was to develop both in tandem to hedge our bets in case one 
approach was not successful. 
 
Only two DDR proteins came to mind when considering which one to use for enriching: 
53BP1 and RAD51. Initially one would think to use one of the kinases responsible for 
phosphorylating γH2AX. However, ATM, ATR and DNA PKcs have approximate molecular 
weights of 350 kDa, 317 kDa, and 469 kDa, respectively (The UniProt Consortium 2017).  
Even though the kinases of γH2AX would be at the site of damage immediately, their 
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relatively large protein sizes would also make them more challenging to enrich with a 
decent yield for a proteomic screen.  
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Figure 4.1. Amplifying DDR-HPTM For Proteomic Screen 
 
 
 
 
 
 
 
 
 
 
  
a) 
i) 
ii) 
Histone Acid Extraction (genome wide)  
 
Cell nucleus after DNA Damage and nuclei 
isolation 
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Figure 4.1 Legend Introduction 
 
a) (i) Preparing histones via acid extraction does not allow to for the distinction of 
nucleosomes that are close to the site of damage and those that are far from the 
site of damage. Quantifying HPTM’s close to the site of the damage becomes a 
problem as a result. The indiscriminate histone extraction is not a hindrance when 
a genome wide assay is desired.  
 
(ii) Due to the chemical nature of acid extractions, all of the histones within the 
genome of a cell will be pulled down together regardless of where they are 
located in the nucleus. H2AX occupies approximately 5% of H2A variants, and the 
percentage of these containing the phosphoS139 modification would be even 
fewer. Therefore, the MS/MS signal obtained from nucleosomes in a DNA damage 
environment will be overwhelmed by the >90% of nucleosomes not containing 
γH2AX, making quantification of HPTM close to or at the site of DNA damage 
unfeasible. DSB, double strand break. 
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4.1.  Introduction (continued) 
 
 
 
 
 
 
 
 
 
 
  
b) 
c) 
i) 
ii) 
Immunuprecipitation of γH2AX (local to region of damage) 
 
Only γH2AX nucleosomes loaded onto MS after γH2AX-IP 
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Figure 4.1 Legend Introduction (continued) 
 
 
b) (i) Using an α-γH2AX antibody, you can enrich for nucleosomes that are close to 
the site of damage, or at the site of damage exclusively. The DNA bound 
nucleosomes together can be digested using micrococcal nuclease, thus releasing 
the nucleosomes. 
 
(ii) The MS/MS signal obtained from running histones enriched from sites of 
damage exclusively will give better quantification in regards to HPTMs that are 
damage related. 
 
c) 53BP1 is known for binding to ubiquitinated histone H2AK13/K15 and histone 
H4K20me1/2. 53BP1 foci are synonymous with double strand breaks. Thus, it 
should be possible to enrich for nucleosomes containing DSB-associated histones 
by isolating 53BP1 after damage has occurred with either native 
immunoprecipitation or with the aid of crosslinking agents. By enriching damaged 
associated nucleosomes, the signal for damaged related HPTMs should be 
enhanced compared to MS/MS signal with no enrichment. 
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The other two DDR proteins that could be used are RAD51 and 53BP1 which have a 
molecular weight of 37 kDa and 214 kDa, respectively (The UniProt Consortium 2017). If 
it were a just a matter of protein size, RAD51 would have been chosen, but there are also 
time-sensitive molecular biological logistics that need to be taken into account. The 
chromatin modification that takes place as a response to DNA damage is an ever-
changing series of events, so determining what is taking place at a temporal scale was 
preferred (Cao et al. 2016).  
 
For this reason, RAD51 is ruled out as a protein of choice for pulling down damaged 
chromatin, as RAD51 comes into play later in the DDR compared to 53BP1 and time-
sensitive events would be missed as a result (Goodarzi et al. 2008). Not only would early 
events be missed but RAD51 efficacy as a pull-down candidate starts once homologous 
recombination has been chosen as the repair pathway, which mainly occurs in S-phase 
and G2-phase. Most of the vegetative cells remain in G1, about 80%. Even if a double 
strand break takes place in G2, 80% of the time, the repair pathway is chosen is still NHEJ 
(Kakarougkas & Jeggo 2014). Therefore, 53BP1 is the most suitable choice to pull down 
damaged chromatin that is both nascent and proximal. 53BP1 is an early response 
protein, and its response is quick with many molecules recruited to the site of damage 
that it used as a readout for double-strand breaks in immunofluorescence (Panier & 
Boulton, 2014). There is also the added advantage that 53BP1 binds to several histone 
PTMs: H2AK13ub/K15ub, H4K20me2, H3K79me2, and γH2AX (Panier & Boulton, 2014) 
(Baldock et al. 2015) (Wakeman et al. 2012). Also from a technical point of view, the 
three isoforms of 53BP1 are all similar in size with only a difference of 0.5 kDa between 
them. In contrast to RAD51, which has four different isoforms ranging between 25 kDa 
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and 37 kDa in size (The UniProt Consortium 2017). The issue would be that it would make 
interpreting western blots and Coomassie stained SDS-PAGE gels more difficult if multiple 
bands are corresponding to the same protein.   Unlike γH2AX, which is present at both 
single-strand breaks and double strand breaks, 53BP1 only binds to double-strand breaks. 
A potential issue with 53BP1 is that it does not persist long enough for late repairing 
breaks so it might not be sufficient for studying HPTM changes in late repairing breaks. 
 
The other approach was to directly enrich for nucleosomes from damaged DNA with the 
use of an antibody that has a specific PTM as its epitope. Compared to pulling down a 
DDR associated protein, this method should be less of an arduous task as there would be 
no need to modify the native histones. Three HPTMs are indicative of DNA damage: 
H2AK13ubi/K15ubi, H4K20me2 and γH2AX (Cao et al. 2016). The three modifications are 
covered much more in-depth ex-supra but in-brief: γH2AX is much more characterised, 
and its formation after the damage is so rapid compared to ubiquitination of H2AK13/K15 
and dimethylation of H4K20. Therefore an IP of γH2AX would yield a higher enrichment 
resulting in better signal to noise ratio. Another factor is what biochemical reagent to 
use. Due to γH2AX being used an identifier of damaged chromatin in many different 
assays there is a plethora of antibodies from many different manufacturers to choose 
from which will increase the chances of using an antibody suited for the task. Antibodies 
for ubiquitinated H2AK13/K15 are less common among the available assortment of 
commercial antibodies. Antibodies specific for ubiquitin are used to determine if the 
protein of interest has been ubiquitinated compared to an antibody for γH2AX which is 
specific for the PTM and the protein of interest. A single antibody is available from 
Merckmillipore (catalogue number: EDL H2AK15-4) that can apparently recognise 
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ubiquitination at H2AK15 (no mention of H2AK13) at the time of writing. However, it has 
not been tested for immunoprecipatation applications. Another consideration is that 
there are so many variants of histone H2A. It is not certaint whether an antibody would 
be recognising all of the ubiquitinated H2AK13/K15 as an amino acid difference or two 
between two or more variants could result in the antibody only recognising some variants 
of histone H2A while others would be ubiquitinated but also missed. 
 
Histone H4 only has one variant which is advantageous. Also, a large number of 
antibodies exist for H4K20me2. However, the problem with using H4K20me2 to enrich 
for damaged chromatin is that the vast majority of H4K20 is dimethylated outside of 
damage (Pesavento et al. 2007). Despite several studies showing that H4K20 
dimethylation increases following damage, there is high proportion of background 
H4K20me2 not originating from damage sites, and avoiding the enrichment of 
background non-damaged nucleosomes is the purpose of this exercise.   
When taking into account the size of a mammalian genome and the number of 
nucleosomes it encompasses and that only a few of those nucleosomes would exhibit 
changes as a result of DNA damage, the more apparent option would be to pull down 
γH2AX. It also cannot be understated the usefulness of γH2AX possessing a unique tail 
(Chapter 3) that no other variant of H2A has in their amino acid sequence; this rapidly 
decreases the chances of having a false positive from a α-γH2AX antibody. Therefore, the 
decision left was to use γH2AX for: its quick response following damage; its persistence 
at the late-repairing break; the fact that it is a highly specific and unique PTM; and the 
vast abundance of readily available commercial antibodies to choose from for developing 
the method. 
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4.1.2. Potential Technical Issues  
 
It should be mentioned that by introducing a biochemical affinity enrichment step to the 
proteomic method, not only was another potential point of weakness being added 
whereby things could go wrong, but the mechanical precision of the mass spectrometer 
was being sullied with the mercurial temperament of biological reagents such as 
antibodies.  Essentially the purification step is the most vulnerable part as that is where 
most non-specific contamination can take place. Antibodies are notorious for their issues 
which can be classified into one of three categories: non-specificity, batch-to-batch 
inconsistencies and incorrect application (Figure 4.2). Antibodies could recognise 
unintended epitope sites that are similar in either both sequence and modification 
relative to the target protein/site. Immuno-assays of histone post-translational 
modifications could be problematic, especially with the issue of cross-reactivity as similar 
PTMs are dotted around across various histones. For example, an antibody for H3K9me3 
or H3K9ac could potentially recognise H3K4me3 and H3K14ac respectively, which are 
lysine residues that very close to each other. Resulting in false positives leading to 
erroneous findings (Figure 4.2d).  
 
Tjeertes et al. acknowledge different results from their lab group compared to another 
separate lab group concerning whether or not H3K56ac increases after DNA damage 
(Tjeertes et al. 2009). They explain that the discrepancy is due to the antibodies targeting 
the same epitope used by the different labs coming from two different manufacturers.  
Numerous other studies have questions the results from antibodies. Egelhofer et al. 
(2010) (Egelhofer et al. 2010) tested nearly 250 epigenetic antibodies that had been 
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utilised in previous studies and found that approximately a quarter were not specific and 
would bind to multiple sites. Historically, antibodies have also been undependable in 
immunohistochemistry. Buchalow et al. (2011), demonstrated that excessive blocking did 
not prevent the antibodies from binding to non-specific sites (Buchwalow et al. 2011). In 
a separate study, over 20,000 commercial antibodies were analysed, fewer than half 
were found to have a minimum threshold of reliability to observe the distribution of 
proteins in slices of tissue (Berglund et al. 2008).  
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Figure 4.2 Common problems with antibodies 
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Figure 4.2 Legend: Common problems with antibodies 
 
a) Non-specifity: an antibody is deployed that was intended for a protein of interest 
but a non-desired protein is also recognised by the antibody because it shares 
sequence homology with the original protein that corresponds to the epitope site 
of the antibody. To avoid such issues, you would test the antibody with stringent 
controls such as knockout cell lines to ensure the antibody only has one antigen. 
 
b) Manufacturing Inconsistencies: Different lot numbers for the same product 
(identical catalogue numbers) from a single manufacturer could provide 
inconsistent results from one experiment to the next: the antibody worked 
optimally in recognising an antibody (i). When the lab stock was depleted and new 
stock was procured, it results in a different result for the assay (ii). To 
circumnavigate this potential pitiful, you could keep to using only monoclonal 
antibodies if possible for your protein of interest. Otherwise conduct an audit with 
the supplier for their quality assurance if such discrepancy is noticed. 
 
c) Incorrect assay: Depending on the antibody, they could recognise the same 
peptide in its denatured form exclusively because the epitope site is buried with 
in the core of the folded protein (i) but when the peptide is denatured it exposed 
for the antibody to recognise (ii). You would use an antibody that functions in this 
manner in applications where the protein ends up being denatured such as in 
Western Blotting. An antibody could also recognise a given protein in its native 
form where the epitope site is formed by two domains being brought closer due 
to the proteins 3D conformation resulting in a folded-only epitope (iii). However, 
when the peptide is denatured, the antibody no longer recognises the protein 
because the epitope is no longer present (iv). Antibodies could be useful in this 
scenario for applications that use native proteins such as immunohistochemistry.  
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Figure 4.2 Common problems with antibodies (continued) 
 
 
 
  
 
 
 
 
 
 
 
 
  
d) 
Scenario of antibody not functioning as intended resulting false data 
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Figure 4.2 Legend Common problems with antibodies (Continued) 
 
d) Antibody non-specificity. (LHS) An antibody raised against H3K9me3 will detect 
the correct epitope site when the trimethylation modification is present on the 
residue. (RHS) Potentially, an antibody can bind to a similar epitope site that 
possesses the same residue at a different site with the identical modification. In 
this case, the α-H3K9me3 antibody gives a false positive by recognising the 
trimethylation on the nearby H3K4 residue. Antibodies could also recognise 
methylation at a specific site without distinguishing how many methyl groups 
were deposited on the amino acid reside. For example, an antibody binding to 
both H3K9me2 and H3K9me3. 
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In another case of non-specificity of antibodies giving inconclusive results, Michel et al. 
found that the majority of signalling receptor antibodies they tested recognised multiple 
proteins thus they did not give any confidence in being able to differentiate one receptor 
from another (Michel et al. 2009). It is one thing to cause hindrance to a scientific study, 
but when there is a translational application intended, it can be disheartening to find out 
that close to 90% of separate cancer studies were not reproducible as a result of 
antibodies (Begley & Ellis 2012). 
 
What needs to be taken into consideration as well is that the most common uses of 
antibodies, i.e. western blotting and immunofluorescence, do not give direct readouts: it 
is assumed that the secondary antibody has bound to a primary which itself has bound 
to a given protein of interest. An issue more so for polyclonal antibodies but still possible 
with monoclonal antibodies are discrepancies in efficacies from one batch to the next 
could be introduced at the manufacturing stage, when a given antibody is raised within a 
new stock of animals or even bled on a different day. The problem arises when different 
batches of an antibody are advertised as suitable for specific applications on the 
manufacturer's website and given the same catalogue numbers. 
 
Antibodies are not standard chemical reagents manufactured on an assembly line. They 
are biological reagents that are more susceptible to variance due to their nature. One 
needs to maintain an air of scepticism when procuring antibodies from any given 
manufacturer. Prassas et al. lost nearly $500,000 and two years chasing a phantom result 
due to a mischaracterisation of a commercial antibody-based protein detection kit for 
CUZD1, a protein found to be overexpressed ovarian cancer. They found that the kit was 
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detecting the wrong protein altogether: CA125 (Prassas & Diamandis 2014). To ensure 
that this experiment did not fall into the same trap, it was decided to implement a 
stringent design of experiment (DOE) where a series of quality control tests were carried 
on multiple antibodies from different manufacturers (Bordeaux et al. 2010).   
  
Another potential problem to consider is whether the antibody is suitable for the 
application that is being used. As mentioned, antibodies are utilised in assays that are as 
varied as immuno-precipitation to immunofluorescence. For example, just because the 
manufacturer states the antibody is specific for immunoprecipitating γH2AX, it does not 
mean the antibody would be suitable for detecting γH2AX in an immunofluorescence 
application. Some antibodies have been designed to identify epitope sites when the 
protein is in its native structure which would make the antibody suitable for 
immunofluorescence. The epitope, in this case, could be two sequences that are within 
proximal distance when the protein is folded. However, for applications that require the 
antibody to be denatured such as for western blotting, the antibody as mentioned above 
would not be suitable as the sequences would be too far apart to be recognised as an 
antigen. Therefore, an antibody that is more suitable for unfolded polypeptides would be 
more suitable (Figure 4.2a). 
 
The frequency of antibody validation has increased in recent years. Antibody validation 
is the process of reporting on which applications the antibody is suitable for and whether 
there is cross-reactivity, state whether the antibody has been recalled, etc. There is 
increased collaboration from academia, industry and the biotech manufacturers in 
ensuring that antibodies function as described. However, the onus of assessing the 
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suitability of the antibody remains on the investigator to ensure that the antibody is 
applicable. In this project, the most vulnerable part would be the immunoprecipitation 
step of the IP-MS γH2AX/53BP1-3xFLAG. Even though trypsin and Mnase are also 
biological reagents, their function is relatively more binary: they either cut or do not cut 
at specific sites of protein and DNA, respectively. Therefore, to determine if they are 
functioning or not would require an assay with a rudimentary readout, i.e. running an 
agarose or SDS-PAGE gel. 
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4.2. Results 
 
4.2.1. 53BP1-3xFLAG Pull Down 
Transient 53BP1-3xFLAG and 53BP1: SNAP cell lines were established. Stable cell lines of 
53BP1-3xFLAG were also established, but stable 53BP1:SNAP cell lines could not be 
established as the cells failed to survive the neomycin selection. Expression of 53BP1-
3xFLAG was confirmed by western blot and immunofluorescence experiments (Figure 
4.3a, 4.3b). Immunofluorescence indicated that the native function of 53BP1 was not 
compromised when tagged with FLAG as α-FLAG and α-γH2AX exhibited overlapping foci 
(Figure 4.3b). 53BP1-3xFLAG was successfully able to be enriched with an IP using an α-
FLAG antibody (Figure 4.3d). However, putative 53BP1 bands were barely visible after 
Coomassie staining, suggesting that the quantity of IP’d protein was quite low. 
Nevertheless, bands at approximately 190-245 kDa were excised and prepared for mass 
spectrometry analysis (Figure 4.3e). Bands from the 53BP1-3xFLAG cell line showed 1-2% 
peptide coverage of 53BP1. In the untransfected cell line, 53BP1 was not detected at all 
via mass spectrometry (Figure 4.3f). 
 
The streamlined option to enriching for 53BP1 would be to procure an antibody specific 
for 53BP1. If an unmodified protein was purified, it would save time in setting up stable 
cell lines. It would also add more confidence in the protein being pulled down. Another 
potential advantage of using antibodies for the protein themselves is that polyclonal 
antibodies could be used, which would have multiple epitope sites so instead of having 
one antibody per protein molecule one could have multiple antibodies per protein 
molecule, which would make it easier to pull down larger proteins such 53BP1. The caveat 
of using polyclonal antibodies would be that they could lead to non-specific binding. 
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However, good quality monoclonal antibodies specific for 53BP1 can cost 3-4 times as 
much, if not more, as an antibody raised for a common tag.  At the time of writing, Abcam 
sells α-FLAG (catalogue number: ab49763) which costs £285 for 100 μL at a concentration 
of 1 mg/mL, while the highest rated α-53BP1 antibody from Abcam (catalogue number: 
ab175933) costs £289 for 100μL 0.286 mg/mL. Sigma Aldrich sells an α-FLAG antibody 
with quantities of 0.2 mg for £332 or even 1 mg for £752, which substantially reduces the 
costs when purchased in bulk. The α-FLAG antibody had already been well characterised 
for ChIP, by both our lab and others in previous studies. Testing a suitable α-53BP1 for IP, 
would not only be much costlier as multiple α-53BP1 antibodies from multiple 
manufacturers would require assessing, a lot of time would be spent trying to optimise 
the condition for the untested antibody. Therefore, it was neither economically feasible 
or productive use of time to use an antibody specific for 53BP1. Even though it may seem 
both gauche and meta to discuss the costs of antibodies in a scientific study, one still 
needs to consider that when developing a novel method the consequences of excluding 
others from attempting to reproduce the method for their application solely based on 
financial ceilings. 
However, there are also some potential issues with tagging a protein: the original 
function of the protein being altered or even the tag itself being inaccessible due to how 
the protein folds. If the wrong tag was also selected, e.g. HIS tag, it could result in non-
specific proteins being pulled down alongside the tagged-protein due to some cellular 
proteins containing multiple histidines adjacent to each other in their amino-acid 
sequence (Bornhorst & Falke, 2000). The lab already possessed a recombinant plasmid 
containing 53BP1. Attaching two different tags to 53BP1 via cloning was chosen and to 
transfect the tagged version into U2-OS cells, with the intention of creating a stable cell 
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line. The cloning was successful and was confirmed by sequencing. The plasmid maps 
detail where the tags were cloned in (Figure 4.2c). When the U2-OS cell lines were 
transfected, both tags could be expressed transiently (Figure 4.2a). For whatever reason, 
the SNAP-tagged version of the cell line could not survive long term neomycin selection. 
The lack of a SNAP-tagged cell line was not such an issue as by using two different tags, 
the chances of using a compatible tag with 53BP1 were increased. From then on the focus 
was on the FLAG tag version of 53BP1. The initial concern of having the tag alter the 
original function of 53BP1 was ablated as the FLAG tag was observed to have overlapping 
foci with γH2AX in etoposide challenged U2-OS cells that had been transiently transfected 
with the 53BP1-3xFLAG plasmid (Figure 4.3b).    
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Figure 4.3. 53BP1: 3xFLAG Pull Down 
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Figure 4.3: 53BP1: 3xFLAG Pull Down  
 
a) Western blot of transient cells expressing 53BP1:SNAP (top) and 53BP1:3xFLAG 
(bottom). SNAP and FLAG tag were both probed to determine whether cells could 
express the tagged version of 53BP1. Ponceau staining used as a loading control. 
Multiple SNAP due to degredation. U2-OS wild type were not transfected. 
 
b) Stably selected mixed population of U2-OS cells expressing 53BP1:3xFLAG (left). 
Confirmation of FLAG DSB foci formation, suggesting that the DNA damage-
induced chromosomal localisation of 53BP1 to DSBs was not compromised. Cells 
were treated with 20 μM etoposide for 1 hour. Microscopy was performed on the 
ScanR microscope.  
 
c) (Left) 53BP1:3xFLAG plasmid used to transfect U2-OS cells. 3xFLAG tag placed at 
the C-terminus of 53BP1. (Right) 53BP1:fSNAP plasmid used to transfect U2-OS 
cells. SNAP tag placed at the C-terminus of 53BP1.  
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Figure 4.3: 53BP1: 3xFLAG Pull Down (continued)  
 
 
 
 
 
 
 
  
d) 
e) 
f) 
Ponceau 
245 
190 
135 
100 
80 
1 
2 
3 
4 
 140 
Figure 4.3 Legend: 53BP1: 3xFLAG Pull Down (continued) 
 
d)  Western blot of FLAG tag IP. Untransfected U2-OS and stably-transfected 
53BP1:3xFLAG U2-OS monoclonal cells were irradiated with 20 Gy ionizing 
radiation. The FLAG tag was probed to confirm transfection and to verify that the 
signal in the eluate was exclusive to the tagged version of 53BP1 as opposed to 
the endogenous 53BP1. 53BP1 was also blotted as a control for the correct 
protein being pulled down. Ponceau staining used as a loading control. 
 
e) Coomassie stained gel of the eluates. 90% of the eluate from the 53BP1:3xFLAG 
IP was run on a 7.5% SDS-PAGE to determine if 53BP1:3xFLAG would be 
detectable by MS. Gel Band 1 corresponds to proteins larger than 245 kDa and 
Gel Band 2 corresponds to proteins larger than 190 kDa and less than 245 kDa, as 
determined by the size marker. 
 
f) Running a data dependent method on the LTQ Orbitrap, we were only able to 
detect a combined 3% coverage of 53BP1 from both gel bands. We did not detect 
any 53BP1 from the FLAG IP used in the untransfected cell lines as a negative 
control. 
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At first, 53BP1-3xFLAG was IP’d from 2.0 x 107 cells that were irradiated with 20 Gy γ-
radiation. FLAG could not be detected via western blot in the eluate. Subsequently, the 
number of cells were increased ten-fold and the 53BP1-3xFLAG IP was repeated using an 
α-FLAG antibody. Consequently, both 53BP1 and FLAG were detected in the stable cell 
line with western blot: 53BP1-3xFLAG was successfully enriched(Figure 4.2d). Bands with 
a molecular weight that corresponded to 53BP1 were detected when 90% of the eluates 
were loaded onto Coomassie stained SDS-PAGE gels. However, the bands were barely 
visible (Figure 4.2e). It was encouraging to see that there was no 53BP1 detected with 
mass spectrometry from the untransfected U2-OS cell line. Even though 53BP1 was 
detected via mass spectrometry in the stable cell line, it was only at 1-2% coverage of the 
peptide, which would not be sufficient for a proteomics screen.  
 
The low peptide coverage of 53BP1 could be due to various reasons. It was not a mass 
spectrometry technical issue as other proteins could be detected with good signal and 
decent coverage as outlined in other sections. Therefore, it was hypothesised that the 
low peptide coverage could be due to biological reasons. The two factors that could be 
responsible were the promoter that was chosen, i.e. the cytomegalovirus (CMV), and the 
endogenous 53BP1 outcompeting the FLAG-tagged version of 53BP1. The CMV promoter 
has been documented as being susceptible to DNA methylation (Grassi 2003). Cytosine-
179 from the transcription start site has been shown to be a common methylation site. 
Moritz et al. (2015) carried out numerous cytosine to guanine point mutations across the 
promoter in a plasmid containing the CMV promoter. They transfected the plasmids into 
Chinese hamster ovary cells. They demonstrated that C-41G and C-179G point mutations 
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had led to both increased protein production and extended maintenance of protein 
expression in stably transfected cell lines (Moritz et al. 2015).   
 
Grassi et al. (2003) chose another route to reactivate the CMV promoter. 5’-Aza 2’-
deoxycytidine (5’-Aza) has shown to be an inhibitor of DNA methylation. Its use has been 
shown to reactivate gene expression and potentially alter cellular differentiation. 
(Jüttermann et al. 1994). Trichostatin-A (TSA) has also been shown to activate gene 
expression by inhibiting HDACs (Mogal & Abdulkadir 2006). Grassi et al. had transfected 
cells with a hygromycin resistance gene that was regulated by the CMV promoter and 
also had GFP as a marker of expression that would be detectable by microscopy and flow 
cytometry. They used both of these inhibitors individually and in combination to 
demonstrate that they could prolong the expression of the hygromycin gene that had its 
expression regulated by the CMV promoter. 5'-Aza had more of an effect compared to 
TSA alone, but when used in conjunction, it resulted in an additive effect of increased 
CMV expression (Grassi 2003). The issue with these different approaches to reactivating 
a putatively silenced CMV promoter is that the former would require more weeks if not 
months for fine-tuning, and it is another point of failure in a molecular biological sense. 
The use of inhibitors for chromatin modifiers has an experimental caveat; the intention 
is to study the effects of DNA damage on HPTMs. There is not going to be any accuracy 
in the proteomic screen if the DOE results in manipulation of the chromatin outside of 
the scope of DNA damage. Also, where exactly the inhibitors would affect gene 
expression could not be controlled. The effect of TSA and 5’-Aza would be at a global level 
and not local because the inhibitor cannot be controlled from pervading throughout the 
nucleus. 
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Another hindrance to the 53BP1-3xFLAG IP system would be that 53BP1 would have to 
compete with endogenous 53BP1. Western blot from Figure 4.2a shows that there might 
be a small increase of 53BP1 expression in FLAG-tagged compared to untransfected U2-
OS cell line, as the same amount of protein was loaded onto the gel. The minute increase 
could be a result of the total sum of FLAG-tagged 53BP1 in addition to native 53BP1 in 
the transfected cell line. If the difference were to be subtracted, it would show that 
53BP1-3xFLAG's expression is a small fraction compared to the native 53BP1 regarding 
total 53BP1 expression. An option one could consider to potentially increase the yield of 
53BP1-3xFLAG during IP is to completely replace the endogenous version of 53BP1 with 
the FLAG-tagged version.  In human cells, 53BP1 is located on chromosome 15 
(The UniProt Consortium 2017). Canonically, somatic cells possess only two copies of 
chromosome 15. However, some osteosarcoma cell lines have been shown to possess 
multiple copies of chromosome 15; aneuploidy and polyploidy are not uncommon in 
cancerous cells (Ozaki et al. 2003). Another issue with using cancerous cell lines is that 
their expression levels of a given gene have deviated from the "wild type" and can be 
stochastic. Therefore, it becomes imperative that if one wishes to use 53BP1-3xFLAG to 
pull down DNA damaged chromatin one should mitigate against the intracellular 
competition of what one is trying to achieve by completely replacing the endogenous 
version of 53BP1 with 53BP1-3xFLAG. However, the best use of carrying out gene editing 
would be with the use of CRISPR-Cas9 editing system as compared to TALEN based 
systems, CRISPR-Cas9 requires less effort to tailor the system to new desired DNA 
sequences and that cleavage takes place at a more specific site rather (between the 17th 
and 18th of the target sequence) have the cleavage takes place in a non-specific manner, 
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where it ranges from 12-24 bp as seen in a TALEN system (Ran et al. 2013). An 
improvement to this approach in the future, would be to implement a modified CMV 
promoter so that it does not become methylated in the future as demonstrated by Moritz 
et al. (Moritz et al. 2015), which would take several weeks with an optimistic timescale. 
Also, the implementation of knocking-out the endogenous 53BP1 and replacing with the 
tagged version would also take several weeks if not months. So, even though the 53BP1-
3xFLAG showed glimpses of working, it would require a significant overhaul of the cell 
line to get working with possible efficiency. From here on, it was decided to focus solely 
on γH2AX IP as it was showing to be more promising. 
 
4.2.2. Lymphoblastoid for DNA Damage Proteomic Screen 
 
Pulling down γH2AX directly with a specific antibody was the other option for enriching 
DNA damaged-related chromatin. Three antibodies for γH2AX were selected: Millipore 
clone JBW301 05-636, Millipore clone JBW301 16-193, and Abcam (ab2893). The three 
antibodies were used to immunoprecipitate γH2AX from the same lymphoblastoid cell 
line (LCL) sample that was irradiated with 20 Gy of IR. The Abcam antibody had enriched 
the most γH2AX from the LCL sample (Figure 4.4a). A technical replicate was carried out 
with a new biological sample to ensure the result was accurate. The JBW301 16-193 
antibody has a biotin conjugate, therefore γH2AX enrichment with streptavidin was also 
attempted to determine if it was better able to enrich compared to Dyna IgG beads. 
Again, the Abcam antibody was the most efficient at pulling down γH2AX (Figure 4.4b). 
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Figure 4.4: Antibody Selection for γH2AX IP 
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Figure 4.4 Legend: Antibody Selection for γH2AX IP 
 
a) Western blot of γH2AX IP after the use of various antibodies to 
immunoprecipitate γH2AX. Lymphoblastoid cell line (LCL) were irradiated with 
20 Gy ionizing radiation. 200 μg of digested nucleosomes from the same 
biological sample were used for each IP. Three different antibodies were used 
for the IP to assess which antibody gives the best yield of γH2AX: Millipore 
(JBW301), Abcam (ab2893 Chip grade), and Biotin (JBW301-biotin conjugate). α-
γH2AX was blotted to determine yield of γH2AX. Ponceau staining and α-H3 
loading controls failed but Ponceau indicated similar loading of protein. 
 
b) Western blot of biological replicate γH2AX IP with various antibodies to 
immunoprecipatate γH2AX. LCLs were irradiated with 20 Gy ionizing radiation. 
200 μg of digested nucleosomes from the same biological sample were used for 
each IP. Three different antibodies were used for the assay to assess which 
antibody gives the best yield of γH2AX: Millipore (JBW301), Millipore (JBW301-
biotin conjugate) and Abcam (ab2893 Chip grade). α-γH2AX was blotted to 
determine yield of γH2AX. α-H3 was blotted as a loading control. 
 
A: Millipore, clone JBW301 05-636, with strep beads 
B: Millipore, clone JBW301 16-193, biotin with dyna (IgG) beads 
C: Millipore, clone JBW301 16-193, biotin with with strep beads 
D: Abcam (ab2893) with dyna (IgG) beads 
 
E: Elution 
FT: Flow Through 
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It was decided to use LCLs as opposed to U2-OS cells for the γH2AX-IP-MS. U2-OS cells 
are more suited for engineering stable cell lines. However, with the γH2AX-IP-MS, there 
would be no need to introduce any tags since the different tail of H2AX acts as an intrinsic 
tag; mainly when an antibody that only recognises the phosphorylated form of H2AX is 
used. LCLs have more practical advantages compared to U2-OS cells: they are non-
adherent, so they grow in suspension. Thus more cells can be grown within a given space 
compared to U2-OS that are adherent. Their lack of adsorptive nature makes them easier 
to handle when inducing DNA damage via IR. Standard flasks that are used for growing 
cells cannot fit inside the IR-source, so the cells require being transferred to a 50 mL 
conical centrifuge tube. This is not such an issue for LCLs as they can be decanted in sterile 
conditions. However, U2-OS cells require treatment with trypsin to loosen them from the 
surface of cell culture flask. The concern is that unintended cell responses are being 
introduced when they are not in their natural state, e.g. hypoxia could introduce a DNA 
damage response (Olcina & Hammond 2013). Another issue would be how the cells cope 
with recovery: U2-OS cells would have to simultaneously be dealing with adhering to the 
surface while also responding to the DNA damage. LCLs would only be concerned with 
repairing their IR-induced DNA breaks. Another molecular advantage of using LCLs 
compared to U2-OS is that as long as LCLs have not undergone many rounds of passages 
then the IR induced DNA damage response should have a better representation of what 
takes place in regards to DDR-induced HPTM in mammalian physiology as compared to 
U2-OS cells (Sie et al. 2009). LCLs have been used in other labs in regards to the 
transcriptional response of DNA damage, where 3 Gy to 10 Gy of IR were used to 
challenge the cells (Jen & Cheung 2003). They have also been used in proteomic studies 
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to determine the responsiveness of DNA damage response proteins after treatment with 
bleomycin (Dirksen et al. 2006).  
4.2.3. Native or Crosslinking for γH2AX IP 
Another question that arose is whether to use a crosslinking agent for the 
immunoprecipitation (IP) of proteins. While crosslinking-chromatin immunoprecipitation 
(xChIP) has its advantages over native ChIP (nChIP), those advantages would not apply to 
immunoprecipitating nucleosomes (Turner 2001). xChIP is useful when one wants to 
assess the interactive partners of a protein complex which would involve proteins that 
possess weak affinity to DNA or do not interact with DNA directly. Fixing the proteins in 
place would lead to a snapshot of the proteins present at a specific site at a given moment 
of time, which is useful for determining how a particular reagent or gene deletion affects 
the molecular machinery involved in a given biological process. Another advantage to this 
would be that the chromatin remained fixed during the preparation and 
immunoprecipitation stages. However, the benefit of keeping chromatin fixed in place 
does not apply to γH2AX-IP-MS. This is because the interaction of DNA and histones is so 
strong that they form nucleosomes in vitro. This interaction was characterised in the 
1970s (Axel et al. 1974), (Oudet et al. 1975), (Laskey et al. 1978), and (Nelson et al. 1979). 
Also, pulling down extra nascent protein could increase the background noise and reduce 
the efficacy of detecting HPTM changes. Another issue with crosslinking is that it requires 
an incubation step which can affect time sensitive data collection; time points were 
collected mere minutes after the induction of DNA damage, and most crosslinking 
protocols require an incubation step that is even longer than the shortest recovery in the 
DOE (Pchelintsev et al. 2016). However, it would be less of an issue when assessing 
HPTMs at late repairing breaks. The other disadvantage with cross-linking is that it 
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requires a sonication step to shear the fixed chromatin. The issue with this is that 
sonication can be imprecise and lead to lower yields of both DNA and protein. It has been 
shown with the use of electron microscopy that sonication can alter the structure of the 
protein. Their structure exhibits properties similar to that of amyloids (Stathopulos et al. 
2008) Alternative methods have been developed that make light use of sonication 
(Pchelintsev et al. 2016). However, it would be most efficient to abstain from it in this 
case. Tseng et al. (2014) developed an H2AX purification protocol that enables the 
mapping of where particular histone variants were located in the genome of embryonic 
stem cells; in this case, they had avoided the use of crosslinking and used native ChIP-seq 
(Tseng et al. 2014). They were then able to demonstrate that H2AX deposition in 
embryonic stem cells works as a signal for identifying the developmental potential of 
pluripotent stem cells and H2AX downregulates the expression of extraembryonic genes 
in pluripotent stem cells (Wu et al. 2014).  David et al. (2017) cross-compared the same 
sample of chicken pectoral tissue that was either crosslinked and not crosslinked. They 
found that after sequencing, the sample that had been processed with nChIP had given 
a much higher hit rate of identifying H3K27me3 regions compared to the tissue sample 
that had undergone xChIP: 11,008 regions vs 611 regions for nChIP-seq and xChIP-seq, 
respectively. They were then able to confirm the discrepancies between native and 
crosslinking with n/x-ChIP-qPCR. (David et al. 2017). Therefore, to ensure the highest 
possible yield of pulling down chromatin, native ChIP would be the best approach for 
γH2AX-IP-MS.   
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4.2.4. Antibody Selection for γH2AX IP 
There is a vast library of γH2AX antibodies available from over a dozen manufacturers. 
Therefore, with the plethora of antibodies raised for γH2AX, it was paramount to not only 
choose the right antibody for the application, but the antibody’s specificity for the chosen 
antigen would need to be tested and its use in immunoprecipitating γH2AX was 
reproducible. Linscott’s Directory is a search engine for antibodies that trawls the 
catalogues of various biotech manufacturers. If one were to search for γH2AX, it would 
return a result of 175 antibodies from twelve suppliers. The result can be filtered down 
to a desired specification: monoclonal or polyclonal; host species; reactive species; 
conjugated or not; and if available the known applications where the antibody is useful 
in. Linscott’s Directory does not even include results from Abcam and Sigma Aldrich, 
which would push the results potentially north of 200 results. Manually characterising 
200 antibodies is neither feasible or practical. Therefore, a select few antibodies were 
shortlisted: some were available in the lab stock that were used for other applications 
and others were procured for testing for the assay.  
 
The three antibodies tested here were: Millipore clone JBW301 05-636, Millipore clone 
JBW301 16-193, and Abcam (ab2893). To validate the shortlisted antibodies, the Rimm 
Lab Algorithm for antibody validation was adapted and modified. The algorithm works by 
employing sequential selective control tests to ensure that a given antibody is reliable, 
specific, and suitable for a given assay (Bordeaux et al. 2010).  Rimm’s algorithm was 
initially designed for immunohistochemistry and quantitative immunofluorescence. In 
this case, the methodology was tailored for proteomics (Figure 4.5). As mentioned, the 
vast numbers of antibodies available for γH2AX would have unintended consequences of 
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potentially choosing the wrong antibody for immunoprecipitating. The procedure 
requires identification of several suitable γH2AX antibodies candidates from several 
manufacturers, which had been already carried out. LCLs were irradiated to induce 
damage and carry out a western blot to determine that the antibodies can recognise the 
S139phos epitope. The bands were checked to ensure that they correspond to the 
molecular weight of the protein of interest; in this case, it would be around 15 kDa for 
the unubiquitinated version. If the size of the bands does not correspond to the expected 
size, the original algorithm suggests the next step would be to follow through with IP, but 
γH2AX is such a powerful signal that if there are no bands or multiple bands for a protein, 
then the antibody would be discarded. If the molecular weight is what was expected, 
then an IP for γH2AX with a single time point would be the next step. A positive and 
negative control cell line were included as well to give further credence to the antibody. 
Once the negative and positive results illustrated that the antibody was functional for the 
task, the next step was to titrate the antibody for optimal salt concentrations and 
determining what is the least amount of antibody that can be used that results in 
depletion of γH2AX from the lysate. The cells were irradiated with 20 Gy of IR. Even 
though such a large dosage of radiation is not physiologically relevant, as 2-8 Gy is lethal, 
it would ensure that the cells give a tremendous DNA damage response, resulting in more 
histones undergoing post-translational modifications and in turn potentially producing 
large yields of nucleosomes from damaged chromatin during the immunoprecipitating. 
One needs to take into consideration, that even though H2AX accounts for approximately 
5% of all H2A variants (Chapter 3), not all of the H2AX will be phosphorylated: the number 
of nucleosomes that are pulled down could be minuscule when compared to all the 
chromatin. The Abcam antibody resulted in the most enrichment of γH2AX: it was almost 
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entirely depleted from the flow-through. Comparitively, both the biotinylated and 
unbiotinylated Millipore antibodies had negligible differences in their efficiency of pulling 
down γH2AX. However, compared to Abcam there was a significant reduction in γH2AX 
in the eluate (Figure 4.4a). A technical replicate was repeated to ensure the result was 
not an anomaly, and an affinity purification was attempted with the biotin-conjugated 
Millipore antibody by using streptavidin beads instead of IgG beads. Just in case there 
was a chance the affinity purification resulted in a higher yield of enriched γH2AX. 
However, a repeat result was observed: the Abcam antibody was much more suited to 
this application compared to the other antibodies, regardless of using IgG or step beads. 
(Figure 4.4b). Now that the candidate antibody had been filtered to one, the method of 
getting the γH2AX-IP-MS to work was only beginning, as there were further quality 
control checks that needed to be satisfied before being fully deployed. 
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Figure 4.5: DOE Algorithm for antibody validation for the use of γH2AX IP-MS  
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Figure 4.5 Legend DOE Algorithm for antibody validation for the use of γH2AX IP-MS 
 
(above the dotted line) Step 1 of antibody validation involves selecting the best candidate 
with a sequential gauntlet which involves a direct multivariate IP, followed by using 
several negative controls: (λ-phosphatase and MEF H2AX-/-) 
 
(below the dotted line) Further validation; optimisation and reproducibility of γH2AX 
antibody on isolated nuclei for protein of interest localization. Finalised with 
reproducibility between biological repeats and different antibody lots.  
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4.2.5 γH2AX IP optimisation: λ-Phosphatase Treatment 
 
To validate the antibody further, some negative controls were employed that challenged 
the fidelity of the chosen γH2AX antibody’s ability to bind to its epitope. It was 
hypothesised that if the antibody were only binding to phosphorylated S139 of H2AX, the 
antibody would not enrich for any proteins after treatment with a phosphatase. Even in 
the presence of large amounts of damage. Lambda protein phosphatase ( λ-phosphatase) 
was originally discovered in bacteriophage λ by Cohen & Cohen (1989) (Cohen & Cohen 
1989) where at the time it was putatively characterised to be a phosphatase that was 
dependent on Mn2+ ions. Further studies of λ-phosphatase by Zhuo et al. (1993) (Zhuo et 
al. 1993) confirmed its ability to remove the phosphate modification from serine, 
threonine and tyrosine.  
 
The rate of dephosphorylation varied with different proteins. They also characterise the 
biochemical activation and inhibition by metal and non-metal ions, respectively. To 
minimise any discrepancy between any samples, the same biological material was used 
throughout: a harvest of LCL was divided in two with a ratio of 1:2. The larger portion was 
treated with 20 Gy of ionising radiation, and the smaller portion was mock irradiated. 
After recovery, the IR treated cells were split in two again but this time equally. One 
subset of the IR treated cells were incubated with λ-phosphatase with the intention of 
removing the phosphorylation from γH2AX. Thus ending up with three samples of LCL: 
mock treated, IR-treated and λ-treated, and only IR-treated sample. The antibody of 
choice was further certified as suitable for the task when another γH2AX-IP was carried 
out with the three samples (Figure 4.6a). The IR treated sample had enriched γH2AX as 
expected. However, encouraging results came from no γH2AX being enriched in the λ-
 156 
phosphatase treated sample, despite those same cells being treated with the same 
gamma-source simultaneously as the IR-only treated sample. The levels of γH2AX signal 
in the λ-phosphatase treated cells were at similar levels to that of mock-treated cells. The 
lack of detectable signals was further corroborated by the fact that barely any histones 
were visible when the eluates were run on an SDS-PAGE (Figure 4.6a). From this exercise, 
two results were obtained: the choice of antibody was highly specific and thus more 
validated, and that λ-phosphatase treatment is both a thorough and contextual control 
step to γH2AX and should be employed for future γH2AX-MS-IP assays.   
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Figure 4.6: γH2AX IP optimisation: λ-Phosphatase Treatment 
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Figure 4.6 Legend: γH2AX IP optimisation: λ-Phosphatase Treatment 
a)  Western blot of γH2AX IP with three different conditions for measuring 
specificity of the γH2AX IP using the antibody from Abcam. LCLs were irradiated 
with 20 Gy ionizing radiation and a mock sample that was not treated to ionizing 
radiation were digested with micrococcal nuclease. 1 mg of digest histone 
sample was used for each IP sample. Prior to incubating the antibody with the 
sample, 1 mg of 20 Gy LCL irradiated digested histones was treated with  λ-
phosphatase to remove the phosphorylation modification from S139. λ-
phosphatase used: New England BioLabs P0753.  
 
b) Coomassie stained 15% SDS-PAGE gel of the eluates. 30% of the eluate from the 
γH2AX IP was run to determine yield of nucleosomes enrichment. 
 
S; Start 
FT; Flow-Through 
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4.3.8 MEFS as control for antibody specificity 
 
To further verify that the antibody was only pulling down H2AX phosphorylated at S139 
and not another protein that was also phosphorylated with a coincidentally similar 
migration, the Abcam antibody was used for another immunoprecipatation in a mouse 
embryonic fibroblast cell line that did not express H2AX (MEF H2AX -/-). . The argument 
could be made that the λ-phosphatase treatment just shows that the antibody binds to a 
phosphorylation site, but it does not specify which one. It is still possible that the antibody 
could be pulling down proteins that possess phosphorylation sites that act as undesired 
epitope sites and happen to be similar in size to a histone in kDa. As the Rimm Lab 
Algorithm was adapted for antibody validation, the next step would be to try the same 
experiment in a negative control cell line. In this case, the negative control would be 
γH2AX knockouts. Mouse and human H2AX possess very strong homology (Figure 4.7b). 
Also, mouse genome having undergone extensive genomic rearrangement 
(Graphodatsky et al. 2011).  Despite this, and the cells not having human origins, it would 
not be problematic; the DNA sequences of the genes of humans and mice remain very 
homologous. In the case of H2AX, which is the protein of interest, mice isoforms of H2AX 
possesses a difference of only four amino acids when contrasted against human H2AX 
sequence In spite of the strong homology, a MEF cell line that did express H2AX was used 
as a positive control for the negative control, to illustrate that if the antibody did not 
pulldown any histones from the MEF H2AX-/- cell lines, it is not because it derived from a 
different species. LCLs, MEF H2AX+/+ and MEF H2AX-/- were challenged with 20 Gy IR. In 
addition, LCLs were also mock-treated. The Abcam antibody was able to enrich γH2AX 
from both the irradiated LCLs and the H2AX+/+ MEFs. However, no γH2AX was enriched 
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with either the mock-treated LCLs or H2AX-/- MEFs, suggesting that the antibody was 
highly specific for γH2AX and suitable for the IP of damaged chromatin. 
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Figure 4.7: MEFS as control for antibody specificity 
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Figure 4.7 Legend: MEFS as control for antibody specificity 
 
a) Western blot of γH2AX IP with three different cell lines for measuring specificity 
of the γH2AX antibody from Abcam. LCLs, MEFs and MEFS H2AX -/- were 
irradiated with 20 Gy ionizing radiation. 1 mg of Mnase-digested histone sample 
was used for each IP sample. MEF H2AX-/- were used as a negative control for 
the γH2AX antibody. Wild type MEFs were used as positive control for the 
γH2AX antibody binding to the mouse version of H2AX. 
 
b) Sequence homology of human H2AX and mouse H2AX. The two mammalian 
H2AX isoforms have a four amino acid residue difference to each other. 
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Not only are the function of HPTMs conserved amongst mammals but in which cell they 
take place is also conserved (Woo & W. H. Li 2012). Therefore, in this scenario, it would 
be optimal to include a wildtype MEF that expressed H2AX in acting as a control for the 
negative control, i.e. the MEF H2AX -/-. At this stage, it would not cause the antibody to 
fail to recognise H2AX just because the cells are from a different mammalian species. 
Subsequently, LCLs, MEF H2AX+/+ and MEF H2AX-/- were irradiated with 20 Gy of ionising 
radiation. There was also a batch of LCLs that were mocked-treated. When the γH2AX-IP 
was carried out, enrichment of γH2AX was detected in the IR treated LCLs and the MEF 
H2AX+/+ cells (Figure 4.4b).  The fact that the antibody was able to recognise γH2AX across 
species, and not recognise a false positive when H2AX was either not phosphorylated or 
not present, i.e. mock treated or λ-phosphatase treated and  MEF H2AX -/-, respectively, 
made the antibody suited for the task of enriching chromatin that is proximal to DNA 
damage. However, in the negative samples, it happened to be that histone H3 was being 
pulled down, which was visible in all of the eluates (Figure 4.7a). The abundance of H3 
signal suggested that there was non-specific binding, which could affect proteomic 
results, so that would also require further optimisation. However, at this point, the 
antibody could not be validated any further in a practical manner and thus completed 
the adapted algorithm for validating the antibody and for its practical purpose. 
  
 164 
 
4.2.6 IP of γH2AX with stringent conditions 
 
Even though γH2AX was not detected in the eluates of the negative controls, histone H3 
was still detected in the eluates. It was reasoned that increasing the washing and 
including detergents could address this issue. The number of washes was increased from 
three to five; two different detergents were added, NP40 and Tween-20, at 
concentrations of 0.1%; and finally, the wash buffer volume was increased from 400 μL 
to 800 μL. The issue of non-specific histone H3 being pulled down in the negative control 
was resolved (Figure 4.8a), but the addition of detergent did not make a difference to the 
non-specific histone H3 that was enriched with γH2AX.  
 
Detecting histone-H3 in the eluates of the negative controls but not γH2AX itself heavily 
implied that there was a non-specific binding problem (Figure 4.7a). The concern with 
the wash step is that there is a balance betweeen retaining as much of the protein as 
possible and excluding as much background noise as possible. For example, if the salt 
concentration is too high, then it might lead to premature elution of the protein. 
However, if the salt concentration is too low, unwanted non-specific protein will not be 
ejected which could hinder both the signal-noise ratio and interpreting results. Since 
there was non-specific binding, an increase in the harshness of the wash step was 
required; to avoid manipulating the different salt concentrations as that would require 
more elaborate optimisations (Chapter 2) for the whole IP step, compared to tinkering 
with the frequency of washes. The first alteration was to increase the number of washes 
from three to five. The volume of the wash buffer was increased from 400 μL to 800 μL. 
The rationale for both of these alterations was simple: the larger the volume of wash 
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buffer the beads are exposed to the more likelihood of washing away weak non-specific 
bound proteins. The other alteration was to use detergent (0.1% NP40 and 0.1% Tween-
20) which should decrease non-specific binding. The γH2AX-IP was repeated with the 
prescribed wash conditions, and when comparing detergent based washing vs non-
detergent based washes, no difference in non-specific binding was observed (Figure 
4.8a). However, it was decided the detergent in the wash step was kept in the protocol 
as it has the serendipitous effect of making the solution less viscous, which resulted in 
decreased surface tension and so there were less magnetic beads lost with each 
subsequent wash cycle. There was, however, an immediate and significant difference in 
the reduction of histone H3 in negative control eluate. This result concurred with the 
hypothesis that both free histones and octomers would bind non-specifically as they have 
a strong affinity for DNA, especially double-stranded blunt-ended DNA (Almouzni et al. 
1990). Therefore, it was imperative to eliminate any non-specific chromatin as it could 
affect the results of the proteomic screen. With the wash step optimised, the samples 
were ran on a SDS-PAGE gel, which was stained with Coomassie. There were no visible 
signs of histones in the negative control (Figure 4.8b). This was a very positive result as 
histones are available in abundance in the genome, and their cluster which spans from 9 
kDa to 17 kDa can be detected quite easily with Coomassie staining of an SDS-PAGE gel. 
The fact the lanes on the gel that correspond to the negative control were almost clear 
indicates that the modification in the wash step resulted in high efficacy in eliminating 
non-specific bound protein. 
 
The detergent was still retained in the wash step as it reduced the surface tension which 
had the positive consequence of losing fewer beads with each wash step. The Coomassie 
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stain showed an abundant enrichment of histones in the eluate of LCLs and MEF H2AX+/+  
compared to MEF H2AX-/-, where there was virtually none (Figure 4.8b). The input and 
eluate of the LCL sample was prepared for mass spectrometry. A ten-fold increase in the 
enrichment of γH2AX as a proportion of all H2AX was observed. Another technical 
replicate was carried out to ensure the wash steps were efficient in removing non-specific 
nucleosomes from the eluate (Figure 4.8c).  
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Figure 4.8 IP of γH2AX with stringent conditions 
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Figure 4.8 Legend: IP of γH2AX with stringent conditions 
 
 
a) Western blot of γH2AX IP with three different cell lines for measuring specificity 
of the γH2AX antibody from Abcam. LCLs, MEFs and MEFS H2AX -/- were 
irradiated with 20 Gy ionizing radiation. 1 mg of Mnase-digested histone sample 
was used for each IP sample. MEF H2AX-/- were used as a negative control for 
the γH2AX antibody. Wild type MEFs were used as positive control for the 
γH2AX antibody binding to the mouse version of H2AX. Each sample was 
incubated with the γH2AX antibody and with and without the presence 
detergent (0.1% NP40 and 0.1% Tween-20). Number of washes were increased 
from three to five. Volume of wash buffer was increased from 400 μL to 800 μL 
 
b) Coomassie stained SDS-PAGE gel of the eluates. 30% of the eluate from the 
γH2AX IP was run to determine yield of nucleosomes enrichment. 15% SDS-
PAGE gel  
 
c) MS quantification of the γH2AX enrichment. Phosphorylated peptide increased 
from 5% in the start to approximately 60% in the eluate. Singly charged 
fragment ions from ATQASQEY and ATQAS[p]QEY precursor ions were used for 
quantification. 
 
d) western blot of γH2AX IP with three different cell lines for measuring specificity 
of the γH2AX antibody from Abcam. LCLs, MEFs and MEFS H2AX -/- were 
irradiated with 20 Gy ionizing radiation. IP without incubation with detergent. 
200 μg of digested nucleosomes were used for each IP sample. 
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4.2.7 Antibody Titration 
 
The last step in the antibody optimisation was a titration to determine the minimal 
amount of antibody required to deplete sufficient quantities of γH2AX from the extracted 
nuclei. The crass option would be to use as much antibody as possible, but again, to 
ensure that the project remained as economically feasible as possible various 
concentrations were tested: 0.5 μg/mg of protein to 10 μg/mg which was the 
manufacturers recommended concentration. The optimal concentration was found to be 
around 2.5-5 μg of antibody per mg of protein and any concentration above that would 
result in diminishing returns (Figure 4.9). Histone H3 was not depleted with the highest 
concentration of antibody due to the nature of H2AX only occupying a small proportion 
of nucleosomes compared to the rest of the genome.  
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Figure 4.9: Antibody Titration 
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Figure 4.9 Legend: Antibody Titration 
 
Western blot of γH2AX antibody titration with two different cell lines to determine 
optimal concentration of γH2AX antibody for IP. LCLs and MEFS H2AX -/- were irradiated 
with 20 Gy ionizing radiation. 200 μg of histone sample was used for each IP sample. 
MEF H2AX-/- were used as a negative control for the γH2AX antibody. Different 
concentrations of antibody for IP tested were 0.5 μg/mg, 1 μg/mg, 2.5 μg/mg, 5 μg/mg, 
and 10 μg/mg. 1 μg/mg antibody concentration was used for MEF H2AX-/-.  
μg/mg = antibody/lysate protein 
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4.2.8 Mnase optimisation 
 
To determine the efficiency with which Micrococcal Nuclease (Mnase) was digesting the 
chromatin, assays were conducted under different conditions to test DNA digestion. The 
protease inhibitors that were used during the nuclei isolation step were inhibiting the 
enzymatic activity of the Mnase in both the agarose gel and Coomassie stained SDS-PAGE 
gel (Figure 4.10a and 4.10b). Subsequently, a titration of the protease inhibitors was 
carried out with four conditions with one no Mnase condition acting as a negative control. 
It was also observed that the inhibitors that were used to keep proteases and intrinsic 
chromatin modifiers from functioning after the nucleosomes were extracted were also 
inhibiting the Mnase digestion of the chromatin (Figure 4.10a and 4.10b). Titrations were 
carried out that assayed the maximum concentration of inhibitor that the Mnase will 
tolerate before its activity is quenched. It was found that the optimal amount of inhibitor 
was that much lower of what is used during the nucleosome preparation (Figure 4.10d). 
As a result, the protocol was altered so that the concentration of inhibitors were 
decreased to below the maximum tolerance threshold that Mnase during the digestion 
step. Upon carrying out a titration of inhibitors and time-course to determine optimal 
incubation, it was determined that 50-60 minutes of treatment would result in a great 
yield of nucleosome chains spanning 1-2 nucleosomes in size in the S1 and approximately 
5-8 nucleosomes in the S2. When there is no Mnase in the sample, there is a visible band 
observable at the top of the gel, highlighting that the DNA has not been digested at all. 
There is a correlation of longer incubation of Mnase with less smears being present and 
more of the DNA being found towards the bottom of the gel. The smears on the agarose 
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gel represent varying lengths of DNA corresponding to the bands with which they align in 
the DNA size ladder. 
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Figure 4.10 Mnase Optimisation 
  
 
 
 
 
 
 
 
 
a) 
b) 
c) 
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Figure 4.10 Legend: Mnase Optimisation 
 
a)  Protease Inhibitors inhibit activity of Micrococcal nuclease. Agarose gel of Mnase 
treatment of LCLs. 1.5 μg of DNA was loaded onto a 1% agarose gel and ran at 50 
V for 45 minutes. The same biological replicate of isolated nuclei aliquoted and 
were treated with two different conditions:  
1. NEB Buffer for Mnase: 50mM Tris and 5mM CaCl2 .  
2. NEB + sucrose + inhibitors.  
S1: First supernatant after spin down post-Mnase treatment 
S2: Second supernatant after spin down post-Mnase treatment 
 
b)  Protease Inhibitors prevent activity of Micrococcal nuclease. Coomassie stain gel 
Mnase treatment of LCLs. 1.5 mg of histone was loaded onto a 15% SDS-. The 
same biological replicate of isolated nuclei were treated with two conditions: 1. 
NEB Buffer for Mnase: 50mM Tris and 5mM CaCl2 .  2. NEB + 250mM Sucrose. 3. 
NEB + sucrose + inhibitors 
 
 
c) Titration of inhibitors with Micrococcal Nuclease. Agarose gel of Mnase treatment 
of LCLs. 1.5 μg of DNA was loaded onto a 1% agarose gel and ran at 50 V for 45 
minutes. The same biological replicate of isolated nuclei were treated with four 
conditions (all had NEB Buffer for Mnase: 50mM Tris and 5mM CaCl2):  
 
i) 10 mM Na-butyrate, 0.5 mM AEBSF, 2 μM leupeptin, 1 μM Pepstatin A, 50 mM 
NaF, and 5 mM NEM 
ii) 10 mM Na-butyrate, 0.5 mM AEBSF, 2 μM leupeptin, 1 μM Pepstatin A, 5 mM 
NaF, and 1 mM NEM 
iii) 5 mM Na-butyrate, 0.2 mM AEBSF, 2 μM leupeptin, 1 μM Pepstatin A, 5 mM 
NaF, and 0.5 mM NEM 
iv) 5 mM Na-butyrate, 0.2 mM AEBSF, 10 μM leupeptin, 1 μM Pepstatin A, 1 mM 
NaF, and 20 μM NEM 
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Figure 4.10: Mnase Optimisation (continued) 
 
 
 
 
 
  
d) 
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Figure 4.10 Legend: Mnase Optimisation (continued) 
 
d) Time course of Micrococccal Nuclease: 150 Worthing Units of Micrococcal 
nuclease was used per 150 μg DNA. The same nuclear isolation sample was 
distributed equally into seven parts. Then equal amounts of Micrococcal nuclease 
were added to each part and the reaction was quenched every ten minutes for 
up to 60 minutes. This assay was intended to see how long is required for optimal 
digestion of chromatin.  
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Upon completion of the optimisation steps, a pulse-chase experiment was carried out to 
ensure that each of the chosen time points would return efficient γH2AX enrichment. 
LCLs were irradiated with 20 Gy of IR and they were allowed to recover for a maximum 
of 24 hours, while taking time points at prescribed times: 5 minutes, 15 minutes, 30 
minutes, and 60 minutes. The protein amounts from each sample were normalised and 
then proceeded to carry out a γH2AX-IP from the isolated nuclei. Except for T0 which 
corresponds to mock irradiation, all the time points gave sufficient enrichment of γH2AX 
(Figure 4.11).  The samples were subsequently prepared for analysis via LC-MS. The 
results for these assays are analysed in Chapter 5. 
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Figure 4.11 Western blot of γH2AX IP timecourse. 
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Figure 4.11 Legend: Western blot of γH2AX IP timecourse. 
 
Western blot of γH2AX IP timecourse. Pulse chase experiment: LCLs were irradiated with 
20 Gy ionizing radiation and were allowed to recover for 5 minutes, 15 minutes, 30 
minutes, 60 minutes and 24 hours. 1.5 mg of histone sample was used for each IP sample. 
Blotted for γH2AX to measure efficiency   of pull down.  Histone H3 blotted as a loading 
control.  
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Chapter 5: LC-MS Quantification of HPTMs after 
IR-Induced DNA Damage  
 
5.1 Introduction 
 
As mentioned before, certain HPTMs have been shown to change in response to DSBs, as 
detected by antibody-based techniques. In Chapter 4, we develop and optimise a novel 
method for quantifying these changes. A system that should be impervious to load 
capacity in regards to the number of samples collected and number of different HPTMS 
assayed simultaneously. It is important to note that even though the readout of the 
screen for our in-house developed technique is mass spectrometry based, there is still an 
enrichment step that is dependent on antibodies. The results here will give an indication 
of whether the method would be viable. Before examining the results, it is crucial to give 
an outline of what has been reported before in the literature in regards to HPTM changes 
that occur as a result of the DNA damage response. 
5.1.1. H2AX Modifications  
γH2AX is an established indicator of DNA damage and it would be disconcerting if it was 
not detectable in our system. Any issues in detecting γH2AX would stem more from a 
technical issue rather than biological or sample preparation. Unlike typical peptides, the 
C-terminal tryptic peptide of H2AX has no positively-charged C-terminal residue. 
Furthermore, phosphorylation makes the peptide more negative. Potential technical 
issues could arise from analysis in the positive mode. Nevertheless, the interesting point 
about γH2AX is not if it is present but how much of it is present. Elucidating the 
relationship between S139 phosphorylation and Y142 phosphorylation in regards to their 
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concomitant relationship with apoptosis would also bring much-needed clarity as to what 
is happening prior to cell death. Since the Allis group reported the phosphorylation of 
H2AX-Y142 as being ubiquitous and decreasing in the presence of damage (Xiao et al. 
2008).  
5.1.2. Ubiquitination of H2A(X) 
Ubiquitination of H2AX-K13/K15 is synonymous with DNA damage, much like γH2AX. 
However, the signal of this ubiquitination is not as intense or quick in formation as the 
phosphorylation. H2AX-K13/K15 is one of the docking sites for 53BP1, which promotes 
NHEJ, and since NHEJ is responsible for the repair of most DSBs (Kakarougkas & Jeggo 
2014), detecting the ubiquitination should be possible if we pull-down nucleosomes 
closer to the site of damage. We expect this HPTM to increase and persist at earlier time 
points but fade away in a pulse-chase experiment. However, detection of this 
ubiquitination event at a global level may prove too challenging due to the high 
background associated with equivalent histones distal to sites of DNA damage (i.e., signal 
from unmodified H2AX-K13/K15 may drown out the modified signal). There have also 
been reports of ubiquitination at the C-terminal end of the histone tail in response to 
damage. Classically, Polycomb Repressive Complex 1 is known to ubiquitinate K118/K119 
for transcriptional repression. However, Pan et al (Pan et al. 2011) report that a 
monoubiquitination of H2AX at K120 is required to prime the DDR. If this is the case, we 
would expect to detect a positive correlation between S139 phosphorylation and K120 
ubiquitination.  
 
5.1.3. H3K9 PTMs 
H3K9 di- and trimethylation has a role in maintaining the structural integrity of chromatin, 
as seen in constitutive heterochromatin. That role could serve one of two purposes at 
 183 
sites of DNA damage: the presence of methylation could stabilise the chromatin so that 
collateral damage to adjacent chromatin does not take place, or the modification could 
be removed to allow the repair machinery access to the chromatin. Studies have shown 
that both can take place: Suv39 and HP1 (human homologues of Swi6 and Clr4, 
respectively) which are involved in methylating H3K9 and spreading H3K9 methylation, 
respectively, have both been shown to increase at the site of damage at both 
euchromatin and heterochromatin (Baldeyron et al. 2011). Ayrapetov et al (2014) suggest 
that there is a small increase of methylation at the site of damage (Ayrapetov et al. 2014). 
H3K9Ac was also shown to decrease in response to damage (Tjeertes et al. 2009). We 
expect that with a pulse-chase experiment, it should be possible to detect if the 
methylation is decreasing at those points and eventually being restored. 
5.1.4. Histone Docking Sites of 53BP1 
5.1.4.1. H3K4me2 
 
It has been reported with immune-assays that in response to damage, LSD1 is recruited 
to the site of DNA damage, resulting in a reduction of H3Kme2 at those sites 
(Mosammaparast et al. 2013). LSD1 was also shown to be required for recruitment of 
53BP1 but not for γH2AX formation. A link to RNF168 was suggested, which implies that 
H3K4me2 may be required for repair pathway choice in S and G2 phase. Demethylation 
of H3K4me2 has been seen to occur during late S and G2. Therefore, when LSD1 is 
recruited, it may promote HR-mediated DSB repair. H3K4me2 is indicative of 
transcription and so it could also be that its removal is required to ensure that 
transcription does not take place until the DNA damage is repaired. We would expect to 
see an initial decrease in H3K4me2 levels at the site of damage but not at a global level. 
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5.1.4.2. H4K20me2 
 
Along with H2AK13/K15 ubiquitination, H4K20me1/me2 has also been reported as being 
required for loading of 53BP1 onto sites of damage (Pellegrino et al. 2017). H4K20me2 is 
already the most abundant form of H4K20, however docking of 53BP1 onto H4K20me2 
is only activated in the presence of DNA damage. If we get enough resolution to 
distinguish between global H4K20 methylation and local levels, we should see an 
immediate increase of methylation at local levels. SILAC could also reveal whether any 
new modifications are taking place or whether a monomethyl is being promoted to 
dimethylation. 
 
5.1.4.3. H3K79 methylation 
 
H3K79 methylation is present in undamaged cells (Sweet et al. 2010). Nevertheless, it is 
also required for the recruitment of 53BP1. H3K79 is unique in that it is the only known 
histone residue that is methylated by a non-SET domain HMT, DOT1. 53BP1 possesses a 
Tudor domain that will recognise and bind to the H3K79 methylation. 53BP1 is a fast 
response DNA damage protein, so we expect to see a slight increase compared to global 
levels soon after the induction of damage. 
5.1.5. H3K14ac 
H3K14ac had conflicting results in the past in that H3K14ac level has been reported to 
both increase globally as a result of damage (Kim et al. 2008) but also to exhibit no change 
in response to damage (Tjeertes et al. 2009). If Kim et al. (2008) are correct, then we 
should see global increases but decreases at local levels. On the contrary, if Tjeertes et 
al. (2009) are correct, we should not detect any changes. 
 185 
5.1.6. H3K36 
H3K36me3 is associated with HR-mediated repair of DSBs (Pfister et al. 2014). When the 
KMT responsible for trimethylating H3K36 was knocked down, there was a significant 
reduction in the cells undergoing HR. However, if the same residue is demethylated, the 
DDR’s repair pathway choice can be steered towards NHEJ in a Metnase-dependent 
manner (Fnu et al. 2011). Therefore, what we would anticipate is an increase in both 
dimethylation and trimethylation of H3K36. However, as mentioned, most of the repair 
is conducted by NHEJ so we expect to only notice a negligible difference of H3K36me3, 
whereas the rest of the histone will be disproportionately demethylated.  
5.1.7. H3K56ac 
In response to damage, H3K56 acetylation has been reported to be required in both yeast 
and mammalian systems. Tjeertes et al. (2009) detected an immediate decrease of the 
modification before its levels increased again. The early response of reducing the 
modification level could be explained as the DDR system requiring to stabilise the 
chromatin that has been impacted by damage, as H3K56 is known for interacting with 
the minor groove of DNA (Brehove et al. 2015) and is dependent on H3T45 
phosphorylation. Therefore, if there is a sufficient amount of the modification to begin 
with and if it has good ionization efficiency, we should be able to detect fluctuations in 
its level by LC-MS/MS after DNA damage. 
5.1.8. H4K16Ac 
The consensus from previous studies is that H4K16Ac levels will increase at the onset of 
DNA damage. Deletion of MOF2, the HAT responsible for acetylating H4K16, indicates 
that it is responsible for ATM recruitment at the site of damage (G. G. Sharma et al. 2010); 
there were reduced γH2AX foci, which are a readout for ATM activity, in MOF knock out 
cells. H4K16ac is also required for dephosphorylation of γH2AX after DNA damage repair 
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(Neumayer & Nguyen 2014), so it is feasible that acetylation of H4K16 works as a marker 
to indicate the progress of the repair to the DDR machinery. Hence, we expect to see 
increased H4K16ac that persists into the later time points. 
5.1.9. H2AZ 
While histone H2AZ is not a PTM, it is a variant that has been shown to be involved in the 
DDR and implicated in several other biological processes: chromatin compaction (Fan et 
al. 2002), DDR (Y. Xu et al. 2012), meiosis (Yamada et al. 2017), and defining 
transcriptional start sites and gene bodies (Gervais & Gaudreau 2009) (Coleman-Derr & 
Zilberman 2012). H2AZ is recruited to sites of DNA damage within mere seconds and it is 
deposited at such sites. However, within five minutes, it appears to be removed from the 
site of damage (Gursoy-Yuzugullu et al. 2015) (Alatwi & Downs 2015). If H2AZ is not 
removed, HR-mediated repair is impeded. H2AZ will be more challenging to quantify as 
when its DDR-induced chromatin deposit takes place, it would need to be close to a 
phosphorylated H2AX to be pulled down alongside it. 
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5.2. Results 
 
5.2.1. Increase in H2AX S139 phosphorylation but not growth in enrichment of other 
variants of H2A 
γH2AX 
Whenever a single or double strand break takes place, H2AX will be phosphorylated. The 
process is described in much further detail in this thesis in Introduction and Chapter 3. 
The levels of phosphorylated S139 were measured based on the proportion of ATQASQEY 
vs. ATQAS[p]QEY normalised to internal control peptides. (Figure 5.1). The difference 
between the acid extract and Mnase extraction is that the acid extract has the capability 
to pull down histones from most of the genome indiscriminate of different regions. 
However, Mnase like any other nuclease will be limited to where it can digest in the 
genome. Mnase is used in assays to determine if chromatin is more accessible after a 
given treatment (Mieczkowski et al. 2016).  
 
It is not surprising that enriching for nucleosomes with a α-γH2AX antibody would result 
in an increased yield of the γH2AX signal in the eluate (Figure 5.1a). This control allows 
us to determine whether the nucleosomes that we enrich for with immuno-based 
techniques are actually from DNA damaged area. The T0 sample, before induction of 
damage, still shows increased γH2AX after IP, consistent with enrichment of background 
endogenous damage present in the cell. The cells were not synchronised, and γH2AX 
occurs at high levels in S-phase (Figure 5.1b).   
 
Another explanation can be attributed to the method development decision of 
combining the S1 and S2 supernatants after digesting with Mnase (Figure 4.8). S1 would 
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normally be composed of mono-/di-nucleosomes bound together by the undigested DNA 
wrapped around their histones and would be more uniform in composition. However, S2 
supernatant contains a range in size of digested chromatin from tetranucleosomes to 
octanucleosomes for example. As seen in Figure 3.4, the acid extraction data suggests 
that approximately 1 in 20 H2A variants are H2AX. Mnase does not digest across the 
genome uniformly: mainly cutting at euchromatin and we know this is the same region 
of the genome that H2AX occupies (Hamilton et al. 2014). So there might be a higher 
proportion of H2AX to start with compared to a crude method of extraction such as acid 
extraction. However, when we have fragments of chromatin containing upwards of six to 
ten nucleosomes each and assuming there is a random distribution of H2AX, we would 
be potentially deflating the H2AX numbers despite enriching for γH2AX when mixing the 
S1 and S2 together. 
 
By immunoprecipitating from S1 supernatant solely, the vast majority of the chromatin 
would have been composed of mono- or-dinucleosomes. The levels of H2AX that we 
would expect to see would be somewhere approximately of 25-50% depending on the 
equal distribution of H2AX in the genome and whether H2AX is deposited into the 
nucleosome symmetrically or asymmetrically i.e. occupies a nucleosome with a different 
H2A variant. 
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Figure 5.1. Increase in H2AX S139 phosphorylation but not increase in enrichment of 
other variants of H2A 
 
 
 
 
 
 
  
a) 
b) 
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Figure 5.1 Legend: Increase in H2AX S139 phosphorylation but not growth in 
enrichment of other variants of H2A 
 
a) Time-course analysis of H2AXS139 post-translational modification changes. LCLs 
irradiated with 20 Gy ionizing radiation. H2AXS139 modification percentages 
were quantified by measuring fragment ions for singly charged precursors:  
ATQASQEY and ATQA[p]SQEY. Error bars correspond to standard deviation. N = 
3 biological replicates.  
 
(LHS) There is a steady increase of γH2AX at a global level that peaks between 
30 min and 60 min time point. At 24 hours, γH2AX levels decrease to that similar 
of no damage.   
 
(RHS) Enrichment of γH2AX relative to H2AX. With every time point, there is 
increased γH2AX levels especially when compared to the reciprocal global time  
 
b) Pulse chase analysis of H2AX enrichment post-translational modification 
changes. LCLs irradiated with 20 Gy ionizing radiation. Percentage of H2AX 
variants compared to other H2A isoforms. Fragments from doubly charged 
precursors were used for quantification. Peptides used for quantification: 
KGHYAER (H2AX), KGNYSER (three variants), and KGNAYER (canonical). Error 
bars correspond to standard deviation. N = 3 biological replicates. Error bars 
correspond to standard deviation. N = 3 biological replicates.  
 
(LHS) There is no increase in H2AX at a global level throughout the time points: 
all ratios remain level. 
 
(RHS) Enrichment of H2AX relative to other H2A isoforms. With larger error bars, 
there is a trend showing increased H2AX relative to other H2A isoforms. 
However, even if the increase is taken into consideration, which shows a two-
fold enrichment of H2AX relative to the global level, it is not as much as increase 
as we would expect as we were only pulling out γH2AX-containing mono-
nucleosomes.   
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5.2.2. Increase in Histone H3K9 Dimethylation 
The role that histone H3K9 methylation plays in compacting chromatin has been 
documented (Introduction &(Saksouk et al. 2015)). In recent years, studies have shown 
that H3K9 methylation is not only involved in constitutive compaction of areas of the 
genome void of genes but also has a role to play in the DDR.  Baldeyron et al. (2011) show 
that Heterochromatin Protein 1α, which co-recruits with the primary HKMT responsible 
for methylating H3K9 (Suv39) is recruited to the site of damage regardless of if the 
environment is euchromatic or heterochromatic, in a CAF-1 dependent manner.  
 
The recruitment of HP1α to the DSBs can take place at both early and late stages of the 
repair. HP1α requires KAP1 to be recruited. In a follow-up study from the same group, 
Soria et al. (2013) find that HP1α and HP1β are both involved in DNA end resection which 
is a prerequisite for homology searching in the homologous recombination repair 
mediated pathway (Soria & Almouzni 2013). This is in accordance with Goodarzi & Jeggo 
(2008) (Goodarzi et al. 2008); Sun et al. 2009 (Y. Sun et al. 2009) and Ayrapetov 
(Ayrapetov et al. 2014). Goodarzi et al. demonstrate that DSB repair in heterochromatic 
regions requires ATM, to disrupt the binding of KAP1 to heterochromatin by 
phosphorylating KAP1, especially at later stages of the DNA repair. Sun et al. 2009 showed 
that Tip60, which activates ATM, requires its chromodomain to bind to H3K9 methylation 
present at the site of damage for its acetyltransferase activity. In the absence of H3K9 
methylation, there is the reduced recruitment of ATM to DSBs. However, H2AX is still 
phosphorylated by DNA-PKcs. Their data also suggest that there is no change in global 
levels of H3K9 methylation, therefore in a non-defective environment, Tip60 is recruited 
to sites of damage where H3K9 methylation is already present i.e., heterochromatin. 
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However, Ayrapetov et al. (2014) demonstrate that even though there is no global 
increase in H3K9 methylation levels, there was an increase in levels close to the site of 
damage. Their ChIP data at a targeted DSB suggested that H3K9me3 levels mirror that of 
γH2AX: Increase in H3K9me2/3 levels peak at about 1.5 KB from either side of the DSB 
and with lower levels about 200 KB. No such effect is seen in undamaged chromatin. 
 
Figure 5.2 shows a significant difference in H3K9me2 levels 24 hours after treatment with 
IR (with a p-value of 0.02). Goodarzi et al. demonstrate that at later time-points after 
damage, the percentage of breaks repaired with the NHEJ pathway decreases and skews 
towards HR-mediated repair. Goodarzi et al. also see that the late-repairing breaks tend 
to be in a heterochromatic environment. This is a result that was echoed in Natale et al. 
(2003), where even though they report γH2AX mainly being present in euchromatin, the 
signals that persist at later time points were mainly from heterochromatin. This begs the 
question, are we pulling out γH2AX from regions of heterochromatin that are repaired 
late, or does the proportion of histone H3 methylation at the site of damage steadily 
increase due to chromatin remodelling, i.e., is this pre-existing H3K9 methylation, or 
damage-induced?   
 
As regards to acetylation of H3K9, multiple studies have shown that there is a marked 
decrease in a DNA damage environment. In a screen involving immuno-based assays that 
tracked changes in HPTMs about DNA damage, Tjeertes et al. (2009) observed a decrease 
in H3K9ac after only fifteen minutes. They treated U2-OS with phleomycin for 2 hours 
and released the cells back into phleomycin-free medium. Cea et al. (2016) observed that 
SIRT6, the HDAC responsible for deacetylating H3K9ac, was shown to be crucial for 
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preventing the proliferation of multiple myeloma cells by destabilising the mitogen-
activated protein kinase (MAPK) pathway which promotes cell cycle progression (Cea et 
al. 2016). SIRT6 binds to the promoter of MAPK and deacetylases H3K9 the transcriptional 
start site. The knockdown of SIRT6 also resulted in increased sensitivity to DNA-damaging 
agents such as doxorubicin and melphalan (Cea et al. 2016). Gupta et al. (2016) treated 
the human malaria parasite Plasmodium falciparum with MMS and noticed a similar 
response akin to that of Tjeertes et al. (2009); a decrease in both H3K9ac and H3K56ac. 
Tjeertes et al. and Cea et al. both used immune-based assays which will be more sensitive 
to detecting smaller levels of the acetylated peptides.  
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Figure 5.2. Increase in Histone H3K9 Dimethylation 
  
 
 
  
 
 
  
a) 
b) 
c) 
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Figure 5.2. Legend: Increase in Histone H3K9 Dimethylation 
 
a) Time-course analysis of H3K9 post-translational modification changes. LCLs were 
irradiated with 20 Gy ionizing radiation. H3K9 modification percentages were 
quantified by measuring fragment ions for doubly-charged precursors. List of 
peptides used for quantification:  
I. KSTGG[ac]KAPR 
II. [me1]KSTGG[ac]KAPR,x 
III. [me2]KSTGG[ac]KAPR 
IV. [me3]KSTGG[ac]KAPR,  
V. [ac]KSTGG[ac]KAPR,  
VI. KSTGGKAPR,  
VII. [me1]KSTGGKAPR,  
VIII. [me2]KSTGGKAPR  
IX. [me3]KSTGGKAPR 
X. [ac]KSTGGKAPR.  
Error bars correspond to standard deviation. N = 3 biological replicates. 
 
b) Increased H3K9me2 at the site of damage: 15 mins, 30 mins and 24 hour time 
points indicate that there is a significant difference in regards to H3K9me2 at the 
site of damage relative to global average before damage (T0 Start). Two-tailed T-
tests were carried out on all time points against undamaged global values. 
 
c) (LHS) MS/MS fragmentation of doubly charged precursors for residues 
corresponding to modified KSTGGKAPR peptide. Fragment ions involved in 
quantitation are highlighted on the peptide sequence: b1, b6, b7, y2, y3, y5, y6, 
y7, and y8. 
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5.2.3 There is no difference in Histone H3K27 methylation levels post DNA damage 
Histone H3K27 methylation is another repressive mark of chromatin. In the native cell 
environment in the absence of damage, H3K9 methylation is found at highly repetitive 
sequences such as at telomeric and pericentromeric sites so the location in the genome 
at which H3K9 is expected to occupy would be entirely consistent with one cell type to 
another (Lomberk et al. 2006). In comparison, from one cell to another, H3K27 
methylation occupies different genes due to cell differentiation contextually requiring 
silencing of genes (Beisel & Paro 2011). 
 
The literature suggests that there should be an increase in H3K27 methylation, especially 
the trimethyl modification (Campbell et al. 2014). At the site of damage, PRC2 will 
trimethylate H3K27. H3K27me3 recruits PRC1 which will ubiquitinate H2AK119 in a PARP-
dependent manner (H. Wang et al. 2004; Campbell et al. 2014). H3K27me3 can recruit 
more PRC1 and PRC2 in both replication and repair which in turn methylates H3K27 on 
adjacent nucleosomes. Therefore it is a self-propagating modification (H. Wang et al. 
2004). Campbell et al. (2014) notice that the recruitment of PRC1 and PRC2 to the site of 
damage occurs in an H2AX/PIKK kinases independent manner.  
 
MacroH2A.1 can be found in two regions of the genome in equal proportions: sites that 
are hyperacetylated (H2AK5, H2BK12, K15, K20, K120, H3K4, H3K14, K18, and H4K91) 
indicative of expressive sites; and H3K27me3 which as mentioned is a site of facultative 
heterochromatin (H. Chen et al. 2014). The region of the genome that would contain 
nucleosomes H3K27me3 and MacroH2A.1 can span 500 KB in length (Gamble et al. 2010) 
The two domains strictly do not overlap. This is critical in regards to our H3K27 data for 
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two reasons (Figure 5.3): if we are enriching nucleosomes with a γH2AX antibody, then 
it's less likely that we are going to be pulling out MacroH2A.1 as they would not 
necessarily be occupying the same nucleosomes. Also, γH2AX after ionising radiation are 
mainly found in euchromatic regions rather than heterochromatic regions (Cowell et al. 
2007). Inevitably, enrichment of H3K27me3 may be reduced from the onset. 
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Figure 5.3: No difference in Histone H3K27 methylation levels post DNA damage 
 
 
 
 
 
 
 
  
a) 
b) 
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Figure 5.3: No difference in Histone H3K27 methylation levels post DNA damage 
a) Pulse chase analysis of H3K27 post-translational modification changes. LCLs 
irradiated with 20 Gy ionizing radiation. H3K27 modification percentages were 
quantified by measuring fragment ions for triply charged precursors. List of 
peptides used for quantification:  
I. KSAPATGGVKKSAP 
II. KSAPATGGV[me1]KKSAP 
III. KSAPATGGV[me2]KKSAP 
IV. KSAPATGGV[me3]KKSAP 
V. [me1]KSAPATGGVKKSAP 
VI. [me1]KSAPATGGV[me1]KKSAP 
VII. [me1]KSAPATGGV[me2]KKSAP 
VIII. [me1]KSAPATGGV[me3]KKSAP 
IX. [me2]KSAPATGGVKKSAP 
X. [me2]KSAPATGGV[me1]KKSAP 
XI. [me2]KSAPATGGV[me2]KKSAP 
XII. [me2]KSAPATGGV[me3]KKSAP 
XIII. [me3]KSAPATGGVKKSAP 
XIV. [me3]KSAPATGGV[me1]KKSAP 
XV. [me3]KSAPATGGV[me2]KKSAP 
Error bars correspond to standard deviation. N = 3 biological replicates. 
 
b) (LHS) MS/MS fragmentation of triple charged precursors for residues 
corresponding to modified KSAPATGGVKKSAP peptide. Fragment ions involved in 
quantitation are highlighted on the peptide sequence: b1, b2, y11, y12, and y13.  
(RHS) Intensity of weakest sample analysed with pseudo-SRM MS/MS 
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5.2.4. There is no difference in Histone H3K36 di-/trimethylation levels post DNA 
damage 
A difference of one methylation on histone H3K36 can reportedly result in the DDR being 
guided towards a different repair pathway. In mammalian systems, histone H3K36me2 
recruits NHEJ repair proteins in the presence of a break. Fnu et al. (2011) demonstrated 
that at the site of damage, H3K36 is dimethylated in a Metnase dependent manner. After 
the induction of DSBs, they did not see an increase in the trimethylated form. However, 
after inducing a site-specific break using I-SceI endonuclease followed by ChIP of both 
metnase and H3K36me2, they saw an overlapping enrichment of the two (neither were 
present before damage). Overexpression of Metnase resulted in increased enrichment of 
Ku70, DNA LigIV and phosphorylated NBS1 which are proteins involved in the NHEJ 
pathway (Fnu et al. 2011). 
 
H3K36 is trimethylated by the HMT SETD2/HYPB. When H3K36 possesses a triple 
methylated modification, it can push the repair pathway choice towards HR-mediated 
repair. Pfister et al. (2010) demonstrated that by either knocking down SETD2, 
overexpressing KDM4A (KDMT for H3K36me3) or by introducing H3.3 that was mutated 
at Lysine 36 with a methionine would all lead to the same result: reduced recruitment of 
Rad51 and RPA to the DSB. LEDGEF binds to H3K36me3 with its PWWP domain, which in 
turn recruits CtIP. CtIP instigates DSB end resection which is a requirement for HR-
mediated repair to take place. (Pfister et al. 2014). Pfister et al. did not see a change in 
levels of H3K36me3, even at the DSB. Fnu et al. (2011) did not notice any change in 
H3K36me3 local levels either, but they did see a sharp increase in H3K36me2 which 
would steer the repair pathway towards NHEJ. 
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Cao et al. (2015) (Cao et al. 2015) show that at the site of damage and in the presence of 
H3K36me2, ATM phosphorylates KDM2. Once phosphorylated KDM2 loses its chromatin 
binding ability, and as a consequence H3K36me2 levels increase at the site of damage. 
JMJD-5 KDM8 is shown to be required to keep levels of H3K36me2 in check for HR-
mediated late repairs of breaks to take place unimpeded in C. elegans (Amendola et al. 
2017). From our data (Figure 5.4) we detect no change in H3K36me3; this is in agreement 
with both Pfister et al. and Fnu et al. However, we did expect to see an increase in 
H3K36me2. 
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Figure 5.4 No difference in Histone H3K36 di-/trimethylation post DNA damage 
 
 
 
 
 
 
 
 
  
a) 
b) 
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Figure 5.4 Legend: No difference in Histone H3K36 di-/trimethylation post DNA damage 
 
a) Pulse chase analysis of H3K27 post-translational modification changes. LCLs 
irradiated with 20 Gy ionizing radiation. H3K27 modification percentages were 
quantified by measuring fragment ions for triply charged precursors. List of 
peptides used for quantification:  
I. KSAPATGGVKKSAP 
II. KSAPATGGV[me1]KKSAP 
III. KSAPATGGV[me2]KKSAP 
IV. KSAPATGGV[me3]KKSAP 
V. [me1]KSAPATGGVKKSAP 
VI. [me1]KSAPATGGV[me1]KKSAP 
VII. [me1]KSAPATGGV[me2]KKSAP 
VIII. [me1]KSAPATGGV[me3]KKSAP 
IX. [me2]KSAPATGGVKKSAP 
X. [me2]KSAPATGGV[me1]KKSAP 
XI. [me2]KSAPATGGV[me2]KKSAP 
XII. [me2]KSAPATGGV[me3]KKSAP 
XIII. [me3]KSAPATGGVKKSAP 
XIV. [me3]KSAPATGGV[me1]KKSAP 
XV. [me3]KSAPATGGV[me2]KKSAP 
Error bars correspond to standard deviation. N = 3 biological replicates. 
 
b) (LHS) MS/MS fragmentation of triplu charged precursors for residues 
corresponding to modified KSAPATGGVKKSAP peptide. Fragment ions involved in 
quantitation are highlighted on the peptide sequence: b1, b2, y11, y12, and y13.  
(RHS) Intensity of weakest sample analysed with pseudo-SRM MS/MS 
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5.2.5. There is a decrease in H3K79me1 at sites local to damage 
Histone H3K79 is unique in that it is the only histone residue that is methylated by a non-
SET domain methyltransferase, the HKMT DOT1L. Generally, levels of methylation 
through the cell cycle tend to be low. Levels for the me0, me1, me2 and me3 are around 
88%, 5-11%, 1.5% and <0.1% respectively (Sweet et al. 2010). The MS/MS signal for the 
trimethylated form of H3K79 was below the levels of detection. Previous studies showed 
that H3K79me2 levels are low during S-phase but become elevated upon DSB (Wakeman 
et al. 2012) (Sweet et al. 2010). H3K79me2, along with several other residues, are 
required for the docking of 53BP1 to the site of damage. DOT1 requires Bat3 to co-localise 
at Histone H3. If either one of Bat3 or Dot1 is knocked down, there is reduced 53BP1 foci 
at DSBs; even though 53BP1 has a higher affinity for H4K20me2 (Wakeman et al. 2012). 
In addition, H2BK120Ubi was also shown to be crucial for the DOT1L to be able to bind to 
H3. H2BK120Ubi alters the stoichiometry between DOT1L and the H3K79me binding site, 
resulting in increased affinity. (Zhou et al. 2016). 
 
However, it is difficult to ascertain whether our result of decreased monomethylation is 
due to the H3K79me1 being demethylated or methylated further (Figure 5.5). The least 
convoluted explanation would be that H3K79 methylation plays a critical role in 
constitutive heterochromatin formation and as mentioned γH2AX is mainly found in 
areas of the genome that are more transcriptionally active (Cowell et al. 2007). However, 
this interpretation is difficult to reconcile with the unchanged global and γH2AX-
associated K9me2,me3 and K27me3 profiles we record. To control for the possible lack 
of overlap between γH2AX and H3K79 methylation we would need to use a α-H2AX 
antibody when enriching for nucleosomes from cells that have been treated with IR. The 
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idea being that H2AX should be more evenly distributed throughout the genome 
compared to the phosphorylated form. 
 
Another possible interpretation for the decrease in H3K79me1 levels is that the 
H3K79me1 are being “promoted” to methylated rank. The reasoning is because Dot1L’s 
method of action in generating H3K79me2 is through methylating unmethylated or 
monomethylated H3K79 residues. Therefore, if H3K79me1 is being methylated further 
then there would be a decrease in monomethylation. The issue with this interpretation 
is that we do not have data to suggest that there is a change in the H3K79me2. There are 
no known demethylases for K79. 
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Figure 5.5. Decrease in H3K79me1 at sites local to damage 
 
 
 
 
 
 
  
a) 
b) 
c) 
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Figure 5.5. Legend: Decrease in H3K79me1 at sites local to damage 
 
a) Pulse chase analysis of H3K79 post-translational modification changes. LCLs 
irradiated with 20 Gy ionizing radiation. H3K79 modification percentages were 
quantified by measuring fragment ions for doubly charged precursors. List of 
peptides used for quantification:  
a. EIQDFKTDLR 
b. EIQDF[me1]KTDLR 
c. EIQDF[me2]KTDLR 
 
Error bars correspond to standard deviation. N = 3 biological replicates. 
 
b) Decreased H3K79me1 at the site of damage: 5 mins, 15 mins, and 30 mins time 
points indicate that there is a significant difference in regards to H3K79me1 at the 
site of damage relative to global average before damage. 
 
c) (LHS) MS/MS fragmentation of doubly charged precursors for residues 
corresponding to modified EIQDFKTDLR peptide. Fragment ions involved in 
quantitation are highlighted on the peptide sequence: b8, y2, y4, y6, y7, and y8.  
(RHS) Intensity of weakest sample analysed with pseudo-SRM MS/MS 
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5.2.6. There is a decrease in H4K20me1 at local sites of damage 
Methylation of histone H4K20 has been implicated in several biological processes. Similar 
to H3K9 methylation, H4K20 trimethylation is a hallmark of constitutive heterochromatin. 
Suv420 is a histone methyltransferase responsible for spreading H4K20 methylations 
marks downstream of Suv39 (Jones et al. 2008). Therefore, H4K20 methylation will be 
found in abundance at pericentromeric and telomeric regions.  53BP1 can be 
promiscuous in where it docks on the nucleosome after a DSB. However, 53BP1 has a 
very high affinity for H4K20me2 via its Tudor domain (Panier & Boulton, 2014). 
H4K20me2 levels are at 85% within the genome (Pesavento et al. 2007) which then begs 
the question of why does 53BP1 not continuously bind to H4K20me2 outside of the 
context of DSBs. L3MBTL1 and KDM4A will compete with 53BP1 until damage 
recognition, where RNf168 is responsible for deactivating both L3MBTL1 and KDM4A 
binding to H4K20me2. In turn, allowing 53BP1 to bind to the nucleosome in the presence 
of DSBs (Mallette et al. 2012). Additionally, 53BP1 binding requires the damage-
dependent RNF169 ubiquitination of H2A K13/K15 (Fradet-Turcotte et al. 2013). 
 
A decrease in H4K20me1 was observed similar to what is seen with H3K79me1 levels 
decreasing at local levels, there are various explanations (Figure 5.6). H4K20me1 is 
getting methylated further towards H4K20me2. H4K20 methylation is also found more in 
constitutive heterochromatin (Cowell et al. 2007) so it is possible that there would be a 
decreased overlap in the genomic regions where H4K20me2 and γH2AX also occupy. 
H4K20me1 has been shown to associate with H3K9me3 in a repressive manner (Barski et 
al. 2007) This could be tested with a α-H2AX antibody similar to H3K79.  It has been 
suggested that MMSET can methylate H4K20. In response to DNA damage, there is 
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increased localised methylation at the site of DSB even though there is not an overall 
growth in global levels of H4K20 methylation. If MMSET is downregulated there is a 
significant decrease of H4K20 methylation leading to declining of 53BP1 recruitment at 
the site of damage (Pei et al. 2011b). 
 
At DSBs induced with the I-SceI break site, Pei et al. (2011) observe an increase of 
H4K20me1/me2/me3. When they used IR to induce DNA damage at lower levels, they 
detect an increase in H4K20me2 signal. However, when they used lower levels of IR they 
did not see an increase in H4K20me2 local levels with Western blotting; the implication 
was that H4K20me2 increases due to low levels of IR were being concealed by the high 
levels of H4K20me2 within the genome. In this assay, the LCLs were irradiated with a 
large dose of radiation, it is possible that the high levels of H4K20me2 present within the 
genome already present would be obscuring any changes that took place due to damage. 
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Figure 5.6. Decrease in H4K20me1 at local sites of damage in irradiated LCLs 
 
 
 
 
 
 
 
a) 
b) 
c) 
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Figure 5.6. Legend: Decrease in H4K20me1 at local sites of damage in irradiated LCLs 
 
a) Pulse chase analysis of H4K20 post-translational modification changes. LCLs 
irradiated with 20 Gy ionizing radiation. H420 modification percentages were 
quantified by measuring fragment ions for singly charged precursors. List of 
peptides used for quantification:  
a. KVLR 
b. [me1]KVLR 
c. [me2]KVLR 
d. [me3]KVLR 
 
Error bars correspond to standard deviation. N = 3 biological replicates. 
 
b) Decreased H4K20me1 at the site of damage relative to global: 15 mins, 30 mins, 
and 60 mins time points indicate that there is a trend in regards to decreased 
H4K20me1 at the site of damage relative to global average before damage. 
 
 
c) (LHS) MS/MS fragmentation of singly charged precursors for residues 
corresponding to modified KVLR peptide. Fragment ions involved in quantitation 
are highlighted on the peptide sequence: b1, b2, b3, y2, and y3.  (RHS) Intensity 
of weakest sample analysed with pseudo-SRM MS/MS    
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5.2.7. Small increase in Histone H4 Lysine acetylation post DNA damage 
H4K16 acetylation is an HPTM that plays a crucial role in the DDR. MOF is the HAT 
responsible for acetylating the vast majority of H4K16 within the genome (G. G. Sharma 
et al. 2010). Even though it is an acetylated modification, H4K16ac is not associated with 
active transcription. When MOF was knocked down, there were reduced levels of γH2AX. 
In addition, the formation of γH2AX foci were retarded (G. G. Sharma et al. 2010). They 
show that the HAT activity of MOF was also required for inducing ATM activity (G. G. 
Sharma et al. 2010). Mice cells exhibited reduced viability when MOF had reduced 
association with chromatin in Zmpste24-deficient mice (Krishnan et al. 2011). 
 
The increase in H4 lysine acetylation that was observed (Figure 5.7a) is possibly due to 
ATM being required at late repairing breaks, so there is a spike in MOF activity later on in 
the time points. However, it is not a significant difference as the error bars are 
overlapping. H4K16ac also plays a role in pathway choice. As mentioned, late repairing 
breaks undergo repair through the HR-mediated pathway in an ATM-KAP1-dependent 
manner. However, apart from the 24-hour time point, there is no noticeable difference, 
and the data are quite noisy. This result is contradictory to what has been seen in previous 
studies where H4K16ac is required in the DDR: Sharma et al. (2010) irradiated 293T cells 
with 6 Gy of IR. Two hours post-IR treatment, there was an increased association of MOF 
with DSBs. 
  
Another role that H4K16ac has in the DDR is once repair of the DSB has taken place, it is 
responsible for initiating dephosphorylation of γH2AX (Neumayer & Nguyen 2014). TPX2 
plays a role in controlling γH2AX levels post DNA damage, and depletion of TPX2 will 
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result in decreases in acetylation of H4K16. Knockdown of SIRT1 (HDAC of H4K16ac) 
results in increased H4K16ac leading to decreased γH2AX. Therefore, it is possible that at 
the site decreased levels of H4K16ac would be detected. However, these findings go 
against a magnitude of studies of what has been reported prior to Sharma et al. and other 
studies. Krishnan et al. (2012) also show that H4K16ac depletion could result in early cell 
death. It is possible to conceive that the cells were very sick as a result of being irradiated 
with 20Gy of gamma irradiation. The high ionising radiation may have induced apoptosis 
as their repair machinery were overwhelmed with the amount of radiation that the cells 
were subjected to 2Gy of ionising radiation in humans is lethal. Another reason to be 
sceptical of the data is that the H4K16 acetylation is a modification involved in the DDR 
that is conserved from mammalian to malaria (P. falciparum) (Gupta et al. 2016).  
 
HAT1, responsible for acetylating H4K5ac, is involved in mammalian DNA damage repair 
and is commonly overexpressed in cancer cell lines (Yang et al. 2013). HAT1 depletion 
impedes HR-mediated repair but not NHEJ repair. Not detecting any changes H4K5ac 
levels post-DNA damage (Figure 5.7b) goes against what was seen in other studies, which 
further increased our scepticism with the H4 acetylation. 
 
Total acetylation levels across four H4 lysine residues post DNA damage were measured 
(Figure 5.7c). Histone H4 has a rich lysine cluster at N-terminal tail that has been reported 
to have increased signal in lysine acetylation post-DSB. Several histone acetyltransferases 
can acetylate the residues. The histone H4 residues H4K5, K8, K12 and K16, were 
quantified for acetylation simultaneously i.e. four acetylation modifications on histone 
H4 tail. H4 acetylation increases have been reported in numerous studies across different 
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systems. The other factor for that being an expected result is that γH2AX tends to locate 
around euchromatin and lysine acetylation is normally indicative of more open chromatin 
environment. In yeast, the HAT1 homologue, ESA1, was shown to be required for efficient 
repair of DSBs. In esa1 mutants, the cells have increased sensitivity to camptothecin, and 
the Histone H4 tails are hypoacetylated (Bird et al. 2002).  In gcn5 mutants, the cells were 
also shown to be sensitive to constant exposure of the HO endonuclease and cleavage. 
In ChIP experiments, Gcn5 would be found to enrich proximally to the break site. They 
found increased levels of acetylation 0.6KB away from the HO site. At 2KB from the DSB 
was not as much of an increase in acetylation. The role of HATS in the DDR is conserved 
from yeast to humans. HATS have been shown to play a critical role in HR-mediated repair 
(Yang et al. 2013).   
 
We finally quantified the enrichment of unacetylated histone H4 across the genome and 
local to the site of damage (Figure 5.7d). What we see is a marked decrease of non-
acetylated histone H4 lysines in the 24-hour time point, which is not a surprise as it 
mirrors what was seen before. Late repairing breaks may give an indication as to why 
there is a decrease in HK16 deacetylation as those breaks need to be repaired via HR-
mediated repair (Tamburini & Tyler 2005). 
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Figure 5.7. Small increase in Histone H4 Lysine acetylation post DNA damage 
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Figure 5.7. Legend: Small increase in Histone H4 Lysine acetylation post DNA damage 
 
a) Time-course of H4K16ac post-translational modification changes. LCLs irradiated 
with 20 Gy ionizing radiation. H4K16ac modification percentages were quantified 
by measuring fragment ions for doubly charged precursors. List of peptides used 
for quantification: KSTGG[ac]KAPR, [me1]KSTGG[ac]KAPR, [me2]KSTGG[ac]KAPR 
[me3]KSTGG[ac]KAPR, [ac]KSTGG[ac]KAPR, KSTGGKAPR, [me1]KSTGGKAPR, 
[me2]KSTGGKAPR [me3]KSTGGKAPR, and [ac]KSTGGKAPR. Error bars correspond 
to standard deviation. N = 3 biological replicates.  
 
b) Pulse chase analysis of H4K5 post-translational modification changes. LCLs 
irradiated with 20 Gy ionizing radiation. H4K5ac modification percentages were 
quantified by measuring fragment ions for singly and doubly charged precursors. 
Error bars correspond to standard deviation. N = 3 biological replicates. 
 
c) Pulse chase analysis of H4 quadruple acetylation changes. LCLs irradiated with 20 
Gy ionizing radiation. H4Kx4ac modification percentages were quantified by 
measuring fragment ions for singly and doubly charged precursors. Error bars 
correspond to standard deviation. N = 3 biological replicates. 
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Figure 5.7. Small increase in Histone H4 Lysine acetylation post DNA damage 
(Continued) 
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Figure 5.7. Legend: Small increase in Histone H4 Lysine acetylation post DNA damage 
 
d) Pulse chase analysis of H4 no-acetylation changes : LCLs irradiated with 20 Gy 
ionizing radiation. H4Kx0ac modification percentages were quantified by 
measuring fragment ions for singly and doubly charged precursors. Error bars 
correspond to standard deviation. N = 3 biological replicates. 
 
e) (LHS) MS/MS fragmentation of doubly charged precursors for residues 
corresponding to modified GKGGKGLGKGGAKR peptide. Fragment ions involved 
in quantitation are highlighted on the peptide sequence: b5, b6, b8, b9, b10, b12, 
b13, y4, y5, y6, and y8.  (RHS) Intensity of weakest sample analysed with pseudo-
SRM MS/MS 
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5.2.8. H3K14 acetylation does not change post-DNA damage at either local or global 
levels 
Histone H3K14 acetylation has previously been reported to increase, decrease or not 
decrease at all where changes in HPTM levels as a consequence of DNA damage were 
assessed. Both Yang (2013) and Tamburini (2005) reported an increase in the I-SceI and 
HO cutting sites respectively. Kim (2008) reported a global increase of H3K14 acetylation 
but a local decrease following IR treatment. Tjeertes et al. (2009) on the other hand did 
not see any reproducible change following induction of damage with either of 
camptothecin, phleomycin, IR, MMS, UV, or H2O2 in U2-OS cell line. 
 
The H3K14 analysis  (Figure 5.8) produces some of the most convincing data amongst the 
HPTMs that were assayed because the error bars are much tighter: adding a significant 
degree of certainty that H3K14 acetylations do not change following IR damage at the 
least since no other other damaging agents were used. No changes were detected at 
neither global levels or local levels and neither at early time points or late time points. 
25% of H3K14 is acetylated, regardless of enrichment of at local levels of γH2AX or global 
levels. When measured, global H3K14 acetylation levels in U2-OS cells did not exhibit any 
changes before or after damage (Figure 5.8c). A small increase of acetylation levels was 
detected compared to the LCLs: 25% and 30% for LCLs and U2-OS, respectively. The slight 
difference could be accounted for with the extraction methods (acid extraction in U2-OS 
cells) and the cell line expressing slightly different levels of acetylation. However, the 
results are entirely consistent.    
When developing Drosophila larvae, H3K14ac (along with H3K23) had the highest levels 
of an acetylated residue (Henry et al. 2016). Both H3K14 and H3K23 were observed in 
having the highest proportion of acetylation in the genome for the LCLs before and after 
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damage. Henry et al. irradiated larvae would result in a slight variance of H3K14 
acetylation levels of 1% (Henry et al. 2016). When either one of WRN or BLM were 
mutated, which are involved homologous recombination and NHEJ respectively, there 
was a significant increase in H3K14 acetylation compared to the wild-type upon 
irradiation (Henry et al. 2016). Even though H3K14ac level does not change in response 
to DNA damage in different cell lines and organisms, it still shows that it is crucial for the 
DDR. Previously, it was shown that H3K14ac was required for the ubiquitination of γH2AX 
(Ikura et al. 2007) and (Zhu & Wani 2010). It is also important to consider that just 
because DSBs heterochromatin tends to be repaired via HR in an ATM-Artemis-KAP1 
dependent manner, the epigenetic environment does not change to ensure chromatin 
fidelity, then it is possible that H3K14ac is required to remain constant before and after 
DNA damage to keep fidelity of more active sites of the genome and as a constantly 
present site for DDR with bromodomains to dock to. 
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Figure 5.8. H3K14 acetylation does not change post-DNA damage at either local or 
global levels 
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Figure 5.8. Legend H3K14 acetylation does not change post-DNA damage at either local 
or global levels 
 
a) Pulse chase analysis of H3K14 post-translational modification changes. LCLs 
irradiated with 20 Gy ionizing radiation. H3K14 modification percentages were 
quantified by measuring fragment ions for doubly charged precursors. List of 
peptides used for quantification:  
a. KSTGG[ac]KAPR 
b. [me1]KSTGG[ac]KAPR, 
c. [me2]KSTGG[ac]KAPR 
d. [me3]KSTGG[ac]KAPR,  
e. [ac]KSTGG[ac]KAPR,  
f. KSTGGKAPR,  
g. [me1]KSTGGKAPR,  
h. [me2]KSTGGKAPR  
i. [me3]KSTGGKAPR 
j. [ac]KSTGGKAPR.  
k. Error bars correspond to standard deviation. N = 3 biological replicates. 
 
 
b) (LHS) MS/MS fragmentation of doubly charged precursors for residues 
corresponding to modified KSTGGKAPR peptide. Fragment ions involved in 
quantitation are highlighted on the peptide sequence: b1, b6, b7, y2, y3, y5, y6, 
y7, and y8.  (RHS) Intensity of weakest sample analysed with pseudo-SRM MS/MS 
 
c) Analysis of H3K14 post-translational modification changes in U2-OS before 
damage and 60 minutes after damage. Histones were enriched with acid 
extraction. U2-OS were irradiated with 20 Gy ionizing radiation. H3K14 
modification percentages were quantified by measuring fragment ions for 
doubly charged precursors. List of peptides used for quantification identical to 
(a). 
  
 
  
 223 
5.2.9. Acetylation of H3K18 increases at a local level following DNA damage  
Sirt7 is responsible for deacetylating H3K18ac (Vazquez et al. 2016) (Tong et al. 2016). It 
has been documented that Sirt7 plays an important role in the DDR. Vazquez et al. (2016) 
demonstrated that Sirt7-knock out mice went through accelerated ageing. They also saw 
that Sirt7 was crucial for genome integrity and controlling cell cycle progression. There 
were increased polyploidy cells in later passages of Sirt7-/- cells.  
By deleting Sirt7, Vazquez et al. also demonstrate a significant decrease in 53BP1 
localisation to DSBs after with induction of DNA damage. They also report that H3K18ac 
must be deacetylated for 53BP1 recruitment to the site of damage. To mimic the 
deacetylated and acetylated lysine residues, they mutated K18 to arginine and glutamine, 
respectively. The K18Q mutant exhibited similar levels of 53BP1 recruitment to DSBs to 
that of the Sirt7 knockout. On the other hand, the K18R mutant had increased levels of 
53BP1 recruitment to the break site. The presence of H3K18ac may impede the 
interaction of 53BP1 with its docking sites: H4K20me2 and H2AK15ub. There is disruption 
of 53BP1 binding to H4K20me2 if the same histone H4 also contains H4K16ac. A 
necessary salt bridge interaction with 53BP1 on Glu 1551 has been reported. The 
acetylation of H4K20me2 hinders the interaction. Glu 1551 happens to be located in the 
Tudor domain of 53BP1 (Tang et al. 2013). There was also a reported increase in H3K18ac 
in yeast as upon induction of a DSB with an endonuclease (Tamburini & Tyler 2005). 
If H3K18ac is increased at later time points (Figure 5.9), and H3K18ac has been shown to 
disrupt 53BP1 binding, it suggests that later time points may be going through HR-
mediated repair as before. Dicer has been shown to regulate H4K16ac in the genome. 
Dicer which is a crucial element of heterochromatin formation in both yeast and 
mammalian systems (Fukagawa et al. 2004), was also implicated in the DNA damage 
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response. Dicer’s RNase function was crucial for the foci formation of several DDR 
proteins. Dicer generates ncRNA in heterochromatin formation for silencing regions in a 
constitutive manner (Fukagawa et al. 2004). Dicer and DROSHA could generate non-
coding RNA from newly transcribed RNA generated from the site of damage (Francia et 
al. 2012). Dicer also was shown to have an electrostatic affinity to Sirt7 (P.-Y. Zhang et al. 
2016). 
When HEK293T and HCT116 cells were treated with cisplatin, doxorubicin, or IR, there 
was increased expression of Dicer. The increased expression of Dicer resulted in an 
increase in Sirt7 in the cytoplasm, i.e. away from chromatin. When either one of Dicer or 
Sirt7 were targeted with co-IPs, they would both enrich together in the eluate (P.-Y. 
Zhang et al. 2016). If Dicer has a role in both an early role in recruiting 53BP1 but then 
also possibly suppressing its recruitment by the way on inhibiting the Sirt7 
acetyltransferase activity of H3K18ac, it then raises the question of when exactly within 
the DDR does the switch in role take place.  When ATM phosphorylates KAP1, KAP1 can 
repel the NuRD nucleosome and deacetylating complex from chromatin (Murray et al. 
2012). 53BP1 is recruited to DSBs regardless of whether the repair is to take place via 
NHEJ or HR. The first response of DDR is to ligate the strands together via NHEJ, but if this 
takes too long, the DDR switches over to HR (Panier & Boulton, 2014). So whether the 
increase in H3K18ac is from late repairing breaks which require HR is difficult to say with 
certainty. The uncertainty is due to lysine acetylation denoting a more open environment 
and the risk being that with HR-mediated repair, the resection would result in 
nucleosomes and when they are restored they would require heterochromatin HPTM 
marks to be restored otherwise there could be whole chromosomal structural changes, 
particularly in the centromere and telomeres.  
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Figure 5.9. Acetylation of H3K18 increases at a local level following DNA damage  
 
 
 
 
 
 
 
  
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
1.60
1.80
2.00
T0
T5
T15	
T30	
T60	
T24
unmod Ac
P	=	0.05
EL
U
TI
O
N
	%
/	
ST
A
R
T%
a) 
b) 
c) 
 226 
 
Figure 5.9. Legend Acetylation of H3K18 increases at a local level following DNA damage  
 
a) Pulse chase analysis of H3K18 post-translational modification changes. LCLs 
irradiated with 20 Gy ionizing radiation. H3K18 modification percentages were 
quantified by measuring fragment ions for doubly charged precursors. List of 
peptides used for quantification:  
a. [ac]KQLATKAAR 
b. KQLAT[ac]KAAR 
c. KQLATKAAR 
d. [ac]KQLAT[ac]KAAR 
e. Error bars correspond to standard deviation. N = 3 biological replicates. 
 
b) Increased H3K18ac at the site of damage: All time points up to 60 minute indicate 
there is a trend but no significant difference. The 24 hour time points indicate 
that there is a significant difference in regards to H3K18ac at the site of damage 
relative to global average before damage. Two-tailed T-tests were carried out on 
all time points relative to their reciprocate time point 
 
c) (LHS) MS/MS fragmentation of doubly charged precursors for residues 
corresponding to modified KQLATKAAR peptide. Fragment ions involved in 
quantitation are highlighted on the peptide sequence: b1, b3, y5, y6, and y8.  
(RHS) Intensity of weakest sample analysed with pseudo-SRM MS/MS 
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5.2.10. Acetylation of H3K23 increases at a local level following DNA damage 
We observe an increase in H3K23 acetylation (Figure 5.10) similar to that of Tamburini 
(2005) who saw an increase in acetylation levels near damage with an HO-endonuclease 
site. As mentioned, developing Drosophila larvae have extraordinary levels of H3K23ac: 
highest levels of acetylation of any residue within the genome. Treatment of the larvae 
γ-irradiation would result in a slight variance of H3K23 acetylation levels of 1% (Henry et 
al. 2016). In WRN mutants, an exonuclease and helicase critical for homologous 
recombination, there was a significant decrease in H3K23 acetylation compared to the 
wild-type upon irradiation. BLM is a helicase responsible for hindering unintended 
homologous recombination. Henry et al. reported when BLM is mutated, H3K23 
acetylation was shown to increase approximately by 1.25% (Henry et al. 2016). It has 
been demonstrated that H3K23 acetylation is required for ubiquitination at lysine 5 of 
γH2AX, in a Tip60 dependent manner. The ubiquitination is required to expel γH2AX at 
the damage site so that the chromatin can be remodelled to be accessible for DNA repair 
proteins. 
 
KAT6B is a member of the MYST family of HATs responsible for H3K23 acetylation. Simo-
Riudalbas et al (2015)  demonstrated that when KAT6B was knocked down with shRNA, 
and the cells were treated with irinotecan (DNA damaging agent) they find that there is 
a drop off of recruitment of ATM at the site of damage and in turn a direct loss of γH2AX. 
Tip60 is another member of MYST-family of HAT that has been directly responsible for 
activating ATM at DSBs (Y. Sun et al. 2005). It has yet to be determined whether KAT6B 
may be involved in the acetylation of ATM at later time points. H3K23ac was always found 
to be present at regions of the genome that also contained H3K4me2 and H3K36me3 in 
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both Arabidopsis and rice (Lu et al. 2015). As the damage persists and the cells' DDR fail 
to repair, after some time the cell will undergo apoptosis, so it could also be possible that 
there is rampant overexpression of apoptotic genes, especially when the cells have been 
treated with 20 Gy of ionising radiation. TRIM24 is a reader of H3K23ac along with 
unmethylated H3K4 on the same histone tail. TRIM24 co-activates oestrogen receptor α 
(ER-α) (Tsai et al. 2010) in breast cancer cells. ER-α is in turn known to recruit other HATs 
such as GCN5, CBP/p300. Also, ER-α has also been shown to actively increase 
transcription of tumour suppressor p53 in DNA damaged environment induced by 
camptothecin (Berger et al. 2012). However, drawing that conclusion leads to even more 
questions as ERα to recruiting: DDR proteins involved in HR, NHEJ, lesion repair 
mechanisms, cell cycle proteins, and apoptosis itself.   
 
It is not possible for acetylation and methylation to occur on the same residue. H3K23 
methylation in Tetrahymena thermophila was shown to be present in pericentromeric 
regions of the chromosome associated, i.e. regions related to constitutive 
heterochromatin (Papazyan et al. 2014). In meiosis, H3K23me3 was shown to be crucial 
for preventing meiotic induced DSBs by limiting access to Spo11. When EZL3, the KMT 
responsible for H3K23 methylation, was deleted DSBs were observed occurring in 
pericentromeric regions that would not normally occur. Evolutionary, it would not be 
beneficial to induce meiotic DSBs at regions of the chromosome crucial for structural 
integrity as it could result in chromosomal translocations and aberrations. However, it 
could be speculated that a rise in H3K23ac would result in increased HR-induced DSB, it 
helps explain why there is a global increase of H3K23ac across the genome: late repairing 
breaks require HR for repair. 
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Figure 5.10. Acetylation of H3K23 increases at a local level following DNA damage 
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Figure 5.10. Legend: Acetylation of H3K23 increases at a local level following DNA 
damage 
 
a) Pulse chase analysis of H3K23 post-translational modification changes. LCLs 
irradiated with 20 Gy ionizing radiation. H3K23 modification percentages were 
quantified by measuring fragment ions for doubly charged precursors. List of 
peptides used for quantification:  
a. [ac]KQLATKAAR 
b. KQLAT[ac]KAAR 
c. KQLATKAAR 
d. [ac]KQLAT[ac]KAAR 
e. Error bars correspond to standard deviation. N = 3 biological replicates. 
  
b) Are (LHS) MS/MS fragmentation of doubly charged precursors for residues 
corresponding to modified KQLATKAAR peptide. Fragment ions involved in 
quantitation are highlighted on the peptide sequence: b1, b3, y5, y6, and y8.  
(RHS) Intensity of weakest sample analysed with pseudo-SRM MS/MS  
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5.2.11. Decrease in H2AZ following ionizing radiation 
Histone H2AZ is a variant of H2A that differs considerably to canonical H2A, sharing only 
60% homology with canonical H2A (Y. Xu et al. 2012). H2AZ has been implicated in being 
essential for expression of genes and is found at the nucleosomes that precede and follow 
the transcriptional start site (TSS) (Bargaje et al. 2012). Genes that did not possess H2AZ 
at their transcriptional start site resulted in decreased expression compared to genes that 
had a higher proportion of H2AZ near their TSS, i.e., there is a correlation of H2AZ 
proximity and gene expression (Bargaje et al. 2012). H2AZ occupancy at transcriptional 
start sites was also observed in Arabidopsis (Coleman-Derr & Zilberman 2012). H2AZ has 
been reported to be recruited to sites of DNA damage and quickly overturned within five 
minutes. The irradiated LCLs exhibited a drop in H2AZ levels at the site of damage (Figure 
5.11). A higher resolution time course would be required; a more intricate set up that 
omits centrifugation as by the time the cells are spun down the time-sensitive events 
have already taken place before the cells could be snap-frozen. Xu et al first reported an 
exchange of H2AZ at the site of damage in p400 ATPase-dependent manner (Y. Xu et al. 
2012). They induced a DSB at a single point in the genome with p84-zing finger nuclease, 
and their ChIP data showed that there was an exchange of H2AZ very quickly at the 
damage site. There was no loss of H2AX, so H2AZ was not swapped for γH2AX at the site 
of damage. In the presence of damage, histone H2AZ would spread approximately 10-
50KB away from the DSB in either direction. H2AZ exchange is critical for HR-mediated 
repair (Y. Xu et al. 2012). Anp32 (H2AZ unique chaperone) was also showed to be 
essential for evicting H2AZ from the genome (Gursoy-Yuzugullu et al. 2015) (Alatwi & 
Downs 2015). When Anp32 was knocked down, or its H2AZ chaperone activity was 
inactivated, there was reduced acetylation of histone H4. The loss could be directly 
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attributed to the presence of H2AZ at the DSB which was reported to be transiently 
present.  Depletion of Anp32 also resulted in a decrease of HR, as H2AZ could not be 
evicted. Rad51 and RPA foci were reduced by more than half when compared to wild-
type. Cells that had both H2AZ with Anp32 co-depleted resulted in rescuing of HR-
mediated repair. Consequently, Rad51 and RPA foci formation were rescued to wild-type 
levels. H2AZ increases and eviction seem to occur as an early response to DNA damage. 
What we see from our data is that there is a loss of H2AZ from the site of damage by 
about fifteen minutes. The issue is that H2AZ levels appear to increase again. As 
mentioned, before γH2AX formation takes place in more transcriptionally active regions 
of the genome (Cowell et al. 2007). Thus the transient increase in H2AZ levels may be 
explained by global levels of H2AZ not increasing but nascent H2AZ along TSS being pulled 
down along with the γH2AX, thus inflating the value. At the earlier time points, we are 
actively seeing the H2AZ being evicted. The presence of H2AZ at the site of damage is 
very short lived which is a problem in this assay with DOE: H2AZ is fully removed by ten 
minutes after the induction of damage (Gursoy-Yuzugullu et al. 2015) (Alatwi & Downs 
2015). Only one-time point was collected either side of the ten-minute mark. To 
investigate levels of H2AZ at the quickest of time points, we would need to collect short 
time points and thus not allowing the cells to recover as much. 
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Figure 5.11. Decrease in Histone H2AZ following ionizing radiation 
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Figure 5.11. Legend Decrease in Histone H2AZ following ionizing radiation 
 
a) Pulse chase analysis of H2AZ abundance the site of damage. LCLs irradiated with 
20 Gy ionizing radiation. H2AZ modification percentages were quantified by 
measuring fragment ions for singly charged precursors and measuring H2AZ 
against control peptides. List of peptides used for quantification:  
a. YRPGTVALR [Histone H3 41-49] 
b. YQKSTELLIR [Histone H3 54-63]  
c. VTIMPKDIQLAR [Histone H3 118-129] 
d. DAVTYTEHAKR [Histone H4 68-78] 
Error bars correspond to standard deviation. N = 3 biological replicates. Transient 
decrease at of H2AZ at the site of damage: At the 15 min time point relative to 
the 5 min there is a decrease  indicate there is a trend but no significant 
difference.  
 
b) (LHS) MS/MS fragmentation of singly charged precursors for residues 
corresponding to modified HLKSR peptide. Fragment ions involved in quantitation 
are highlighted on the peptide sequence: b1, b2, b3, b4, y2, y3, and y4.  (RHS) 
Intensity of weakest sample analysed with pseudo-SRM MS/MS 
 
  
 235 
5.2.12. Undetected Known DDR-related Histone post-translational modifications 
In our studies, there were certain histone post-translational modifications that have been 
reported to change in response to damage that we failed to detect, let alone quantify. 
These include acetylation of H3K56, H3K4 methylation, phosphorylation of H3S10, and 
ubiquitination of both H2AK13/K15 and H2AK118/K119. 
 
In previous studies, H3K56 acetylation has been shown to be reduced upon induction of 
DNA damage in various species: S. cerevisiae, P. falciparum and mammalian systems 
(Yuan et al. 2014) (Gupta 2016) and (Tjeertes 2009). In yeast, changes in H3K56ac levels 
were detectable via mass spectrometry at both the site of damage and genomic levels 
(Ozdemir et al. 2005). In addition, Unnikrishan et al. developed a yeast strain that was 
transformed with a non-integrative plasmid that was designed to be pulled down for 
mass spectrometric analysis of the histone proteins associated with the plasmid 
(Unnikrishnan et al. 2010).  However, attention is focussed on to mammalian cells, 
reported changes in H3K56ac levels as a result of DNA damage have always been with 
immuno-based methods (Tjeertes 2009) and (Yuan et al. 2014). When Zhang et al. carried 
out a post-translational modification proteomic screen on histones prepared from calf 
thymus cells, they received data that was too ambiguous to assign actual acetylation to 
the H3K56ac (L. Zhang et al. 2003). In a screen to determine how universal is the histone 
code across species, Garcia et al. (2006) demonstrate the discrepancy in the mass 
spectrometric detection of H3K56ac across eukaryotes directly. In both S. cerevisiae and 
T. thermophila, H3K56ac was detected in proteomic and immuno-based assays. However, 
even though there was a detection of H3K56ac in human cells with both proteomic and 
immuno-based assays, it was detected with low abundance. In mice cells, they do not 
 236 
even detect H3K56ac in either proteomic or immuno-based assay. It could be possible 
then, that even though H3K56ac has been a highly characterised HPTM, especially in 
regards to its role in transcription and DNA damage, it is possible that it is only present in 
the genome at very low levels. As we saw in chapter 3 with regards to H2AXY142 
phosphorylation, it is possible that some modifications are present at levels below the 
detection threshold of the instrument. Even though immuno-based assays require a 
degree of caution, they do have the advantage of not requiring copious amounts of the 
epitope compared to mass spectrometry which can be sensitive to sample preparation 
techniques or there not being enough of the peptide of interest sample in the first place. 
 
In asynchronous cells, it is quite difficult to determine whether there are changes in 
H3S10p since the modification occurs mainly in mitosis and within an asynchronous 
population, only a minuscule proportion of the cells would be present in M-phase (A. K. 
Sharma et al. 2015)(Tjeertes 2009). To overcome the cell cycle artefact masking potential 
changes in H3S10 phosphorylation, Sharma (2015) and Tjeertes (2009) resorted to 
synchronising the cells to G1 cells and inducing damage. Sharma et al. synchronised with 
serum starvation and induced damage with either 2.5Gy and 15Gy, and with both 
treatments, they see an inverse correlation of H3S10P with γH2AX, where there is a rapid 
decrease in H3S10P up to 8 hours upon treatment with DNA damage. Then levels of 
H3S10P start to recover while levels of γH2AX started to drop. At 24 hours there is full 
recovery of H3S10P. However, even though Tjeertes et al. (2009) saw an increase in 
H3S10P during mitosis, they were not able to detect changes in H3S10P levels when 
synchronised cells were treated with phleomycin. Also, there were no changes in 
phosphorylation at H3T11, H3S28, and H3.3S31. We were not able to detect H3S10P 
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levels, and this could be attributed to a few points that concur with Tjeertes and Sharma: 
this study used cells that were asynchronous, so levels of H3S10 phosphorylation would 
have been very small, to begin with. H3S10P and γH2AX have an intrinsic nature to not 
occupy the same nucleosomes or genomic regions thus even if there were any changes 
to phosphorylation of H3S10P following damage, nucleosome enrichment via γH2AX 
would not pick up the changes compared to a different histone such as H4. Even if we do 
not take into consideration that Tjeertes saw no changed of H3S10P levels following 
phleomycin treatment, there is still the issue of ionisation efficiency. As previously shown, 
adding a phosphorylation modification to a peptide can significantly reduce the ability for 
the MS/MS to even pick up the peptide (Figure 3.1).   
 
The H3K4 data was problematic for various reasons. One particular issue with the H3K4 
peptide was that it was incredibly hydrophilic and the would be the first to be eluted from 
the nano-LC into the Orbitrap. The early elution becomes a hindrance to quality data 
collection as the retention times for the different masses would drift slightly. Having 
many overlapping retention times or peptides with low abundance would be lost in the 
noise. We had low detection H3K4 peptides. The low detection of H3K4 modified 
peptides could be attributed to H3K4 peptides needing to be derivatized to prevent 
trypsin cutting at unmodified or monomethylated H3K4 lysine resides. When propionic 
based derivatization is added to the sample preparation before proteomic analysis, 
another step is added where peptides can be lost. Maile et al. reported similar issues with 
detecting with H3K4 PTM (Maile et al. 2015). Maile et al. demonstrated that sample 
preparation preceding proteomic analysis leads to unequal recovery of identical peptides 
where the single difference are different PTMs on the same residue i.e. a different 
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residue on the same histone peptide will result in large discrepancies in recovery and 
ionisation efficiencies (Figure 3.1). They generated synthetic peptides corresponding to 
the first 18 residues of histone H3, except for the K4 residue which either possessed no 
modification, mono-, di-, trimethylation, acetylation, with and without phosphorylation 
at threonine 6. They noticed that the synthetic peptides that carried one of the H3K4me2, 
H3K4me3 with either/or phosphorylated H3T6 would only be recovered at 10% levels of 
equivalent peptides containing no modification or H3K4ac. H3K4me1 would have a 
recovery at twice the levels of both unmodified and acetylated H3K4. Low ionisation 
efficiency and recovery after propionic derivation does not help with the proteomic assay 
of modifications that are present at very low levels within the genome. H3K4me3  has 
been characterised to be present at the start of transcriptional start sites (Ji et al. 2015). 
However, these sites are very few when taken into consideration the genome as a whole. 
H3K4 methylation has been implicated in the DNA damage response, so it is unfortunate 
we were not able to apply the γH2AX-IP-MS at this round. Maile et al. (2015) 
demonstrated that switching from a propionic based method to a PIC based method in 
the second step of derivatisation (Methods and Materials) would allow for an increased 
relative abundance of the more hydrophobic peptides, resulting in improved ionisation 
efficiency. However, if this approach was to be utilised for HPTM extracted from an in-
vivo sample, the two derivatisation methods might have to be used concurrently to allow 
for weighting of ionisation efficiency discrepancies that result from using two different 
reagents on the same peptides. 
 
In our study, we do not detect any ubiquitination with a degree of certainty. When trying 
to attribute the peaks to masses corresponding to known ubiquitination sites in the mass 
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spec-quantifications analytical software, the signal-noise ratio was far too low. At least 
with the modifications, we quantified above, there were clear peaks that were way above 
background levels to pick from. Ubiquitination of H2AK13/K15 has been shown to be 
essential for 53BP1 loading at the site of damage. 53BP1 recognises H2AK15 
ubiquitination via its UDF motif. Following MDC1 recruitment to the site of damage in a 
γH2AX dependent manner, the E3 ligases RNF8 and RNF168 are subsequently recruited 
to the DSB. As a result (Panier & Boulton, 2014). RNF8 and RN168 are responsible for 
ubiquitinating H2K15 (Panier & Boulton, 2014). The H2AK118/119 residues are 
ubiquitinated in a manner dependent on various members of Polycomb group complexes 
(PcG), particularly those from PRC1 and PRC2. RNF8 works with UBC13 to 
monoubiquitinate H2AX and H2A (Gieni et al. 2014). UBC1 will When Ring2 and EZH2 
activity was suppressed by either knockdown or loss of function there was increased 
sensitivity to ionising radiation (Gieni et al. 2014). Ring2 and EZH2 are part of PRC1 and 
PRC2, respectively. Ubiquitination of H2AK119 can occur at both sites of damage and at 
chromatin that has been repressed in a PRC-1 silenced manner. PRC1 silences the 
Drosophila transcription factor Ubx indirectly by via the ubiquitination of H2AK119 (H. 
Wang et al. 2004). The ubiquitinating activity of RNF168 is required for the accumulation 
of K63 polyubiquitin at H2AK15. The K63 polyubiquitin site will, in turn, be recognised by 
RAP80, BRCA1 recognises RAP80 at the site of damage and initiates HR-mediated 
pathway (Gieni et al. 2014). 
 
So if ubiquitination of lysine residues has been explicitly shown to be involved in the DDR, 
then why do we not detect any ubiquitin with an element of certainty that allows for 
quantification. Again, this is not due to one particular reason but a combination of 
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multiple factors. In the nuclear extraction step of the sample preparation, NEM is added 
to ensure there is no extracellular deubiquitination of ubiquitinated sites. However, 
during method development, it was observed that Mnase would have its nuclease activity 
impeded in the presence of high concentration. So to resolve this issue, we transiently 
decrease the levels of NEM and other inhibitors so that the Mnase can digest the DNA in 
the chromatin. Another factor is that with Mnase digestion the temperature must be 
approximately 37 °C.  However, NEM is highly sensitive to increased temperatures and 
will completely degrade within about half an hour at room temperature. Therefore, the 
during Mnase digestion step, NEM should be replaced regulary while the digestion is 
taking place to prevent loss of nascent ubiquitination. The next issue could be found in 
the sample preparation following the immunoprecipatation. For a bottom-up approach 
in proteomics, we utilise trypsin to digest the protein-enriched samples so that peptides 
fragment better and masses can be more accurately obtained with the Orbitrap. 
However, with the pseudo-SRM targeted method that were utilised, the expected mass 
needs to be known in kD up to four significant figures, prior to injection. The mass of the 
peptide can be determined from the sequences that can be obtained from many online 
resourches such as Uniprot. The C-terminal of ubiquitin ends with the amino acid 
sequence: KESTLHLVLRLRGG (G. Xu & Jaffrey 2013). The glycines will be covalently bound 
to lysine. When trypsin cuts to completion, only the last two glycines will remain as 
trypsin digests at arginine and lysines that do not possess large modifications. However, 
it is possible that incomplete trypsin digestion can lead a sequence of LRGG remaining on 
a ubiquitinated lysine. 
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Regardless, the presence or absence of LRGG- sequence along with GG- sequence does 
not complicate statistical analysis, as their signals could be pooled together. The levels of 
H2A ubiquitination could be artificially deflated if all the different possible permutations 
of ubiquitination tryptic-artefacts are not accounted for during a targeted proteomic 
screen. Of course,  when one is carrying out a trypsin digestion they do not do so with 
the intention of expecting there to be partial trypsin digestion. 
The final factor that can be analysed is over-propionylation resulting in unintended side 
reaction with the peptide at the derivatisation. Apart from analysing γH2AX, all the other 
residues that were analysed were prepared with a derivatisation step. The peptides are 
propionylated before and after trypsin digestion. The first propionylation step is used to 
ensure equal lengths of an amino-acid sequence are produced as trypsin will cut at lysine 
residues that are not modified or only possess a monomethylation. The second is to 
ensure that new N-termini are also propionylated. Meert et al. (2016) demonstrated that 
there is a fine line between over-derivatisation which can result in nonspecific 
propionylation at serine, threonine and tyrosine residues, and under-derivatisation, 
which will lead to irregular peptide sequences for quantification. Even though there was 
a step that was used to ensure reversal of over-propionylation with the addition of 
hydroxylamine (HA). The HA and propionylation can then interfere with the trypsin 
digestion, so there is a fine balance of not overshooting with either. 
An alternate derivatisation described by Fiedler et al. (2013) was to derivatise the 
ubiquitinated lysines directly by swapping out the ubiquitinated lysines with a 
glycosylated lysine. The glycosylated lysine reaction could be used for identification of 
new ubiquitination site along with quantification of the ubiquitination site. The new lysine 
residue has very high chemical mimicry of the old residue after successful trypsinization. 
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This technique could be utilised before trypsinisation without the requirement of a 
propionic derivatisation if you are only interested in ubiquitination. 
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Chapter 6: Concluding Discussion 
 
The results of this thesis build on of proteomics by developing methods suitable for 
answering questions about changes in HPTMs in a damaged chromatin environment, 
which was not previously attempted at such scale. A brief synopsis of the results from the 
preceding chapters will be outlined, which will be followed by a holistic discussion into 
the significance of the method developed, outlining where it could be improved and what 
possibilities lie in the future with the method. 
6.1 Summary of Results 
The initial aim was to carry out a mass spectrometry-based global analysis of HPTM 
changes that occur as a result of the DDR. Established acid extraction protocols were used 
to prepare histones. However, it became abundantly clear that, apart from detecting 
changes in γH2AX levels, acid extraction followed by global quantification was not very 
useful for detecting nuanced changes in other HPTMs which are DNA damage-dependent 
(Chapter 3). It was theorised that since most HPTMs do not going to give a strong damage 
response signal at a local level, it would be even more difficult to detect at a global level 
as many factors could affect the detection of changes in HPTM levels. For example, 
H3K9me3 can be found in the centromere as part of the constitutive heterochromatin 
(that is localised to that region of the chromosome). If H3K9me3 levels were found to 
either increase or decrease by 1% after damage, such a subtle change would likely be 
masked by centromeric H3K9me3. On the other hand, detecting changes in γH2AX levels 
was more straightforward. Levels of γH2AX before and after damage were quantified 
using the same method. Subsequently followed up the analysis by quantifying the 
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abundance of H2AX compared to other H2A variants in multiple cell lines. Even though 
there was a slight discrepancy amongst the cell lines, the differences were still within a 
range that could be attributed to cell line specific abundances. However, when mass 
spectrometry quantification of phosphorylated H2AX-Y142 was attempted, it transpired 
that earlier studies had possibly exaggerated the levels of phosphorylated H2AX-Y142 
due to the antibodies used against the modification (Xiao et al. 2008). The basic levels of 
Y142 phosphorylation were below the levels of detection with our methods. To ensure it 
was not a technical or instrumental error, we used synthetic peptides that corresponded 
to a trypsinised C-terminal H2AX peptide which carried the phosphorylation on the 
Tyrosine 142 residue. We were able to detect it even when spiked into an acid extract 
mixture from U2-OS cells. As a result of not detecting more changes that occur because 
of the DDR, we chose to develop a method that could detect nuanced changes that are 
more proximal to the site of damage. In Chapter 4, several avenues were chosen for 
developing such a method. At first, we attempted to use a DDR protein that localises with 
damaged chromatin. 53BP1 was selected but even though 53BP1 was successfully tagged 
with FLAG, levels of 53BP1 could not be detected that would be sufficient for a 
proteomics study of chromatin dynamics during the DDR. We then opted for the 
approach of pulling down nucleosomes directly. γH2AX was chosen as it is a well-
characterised marker of DNA damage. Since we were introducing an immunoassay step 
to the proteomics-based method, we tested the feasibility of this approach with several 
control steps to ensure the best antibody was chosen. We devised a system that would 
enrich for phosphorylated H2AX and therefore pull-down chromatin specifically from 
damaged regions. With this new system, which we called γH2AX-IP-MS, we were then 
able to analyse HPTM changes at a more nuanced level. In Chapter 5, we detected 
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enrichment of γH2AX signal but not H2AX as a whole in comparison to other variants, i.e. 
the ratio of H2AX enriched was similar to that of a global enrichment. We eradicated non-
specific binding of histones to the γH2AX antibody in Chapter 4, and the putative 
explanation for this result is that the long chain of nucleosomes that we used to IP from 
was populated with other histone variants rather just H2AX alone. This issue explains and 
sets the stage for most of the data that was accrued the first time around. What was 
important to see, even if the system did not work as expected at its maiden attempt, was 
that there is still a difference between local and genomic levels for HPTMs before and 
after damage. We detected small changes in heterochromatin dynamics in H3K9me2, no 
change in H3K14ac levels in response to DNA damage, and an increase in H3K18ac at the 
24-hour time point. There also seems to be a small inclination for H2AZ to be evicted 
from the nucleosome. This difference in levels highlights that the system is feasible and 
showing glimpses of its potential. Once the technical issues that inevitably follow any new 
novel methodology have been removed from the system, γH2AX-IP-MS can become a 
powerful utility to analyse HPTMs in the light of DNA damage. The system would also not 
just be limited to the DDR but could work in other environments such as transcription as 
it was designed to be modular from the onset of conception. 
6.2 Design of Experiment Audit 
In this section, we explore possible alterations to the method that could result in cleaner 
signal and increased yield of data. These improvements to the system are intended to 
take place both before and after the IP, as the IP itself has been optimised. 
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6.2.1 LCLs: Use more cells and a lower dosage of γ ray 
When we started irradiating cells, we decided to treat the cells with 20 Gy, with the idea 
being that we would get a large response from the cells in regards to the DNA damage. 
In hindsight, this level of irradiation would have been too much for the cells to cope with. 
20 Gy is above and beyond being excessive as 2-4.5 Gy is lethal. As a response to this, we 
should lower the dosage to a more physiological response which would be less than 2-
4.5 Gy (Levin et al. 1992; Mole 1984). The question then arises of what would the 
academic merit even be to dose cells with such large amounts of radiation? Most of the 
world’s human population is subjected to an annual dose of radiation ranging between 
1-10 mGy, which comes from background radiation (World Health Organisation 2016). 
In some rare circumstances, there are scenarios where the dosage of radiation would 
exceed the average. For example, during radiotherapy, a tumour could be subjected to 
an IR course of 1.8-3 Gy over a 6-8 week period, which would give a final accumulated 
dose of up to 75-80 Gy (Prise 2017).  Some residents who were close to the Chernobyl 
Power Plant disaster had their thyroid glands exposed to several Gy of ionizing radiation  
and some of the powerplant workers received an excess of 240 Gy over a two year period. 
As a result, they died shortly after as a consequence of acute radiation sickness. (World 
Health Organisation 2016). Apart from these special rare cases, it would be highly 
unusual for a cell to be subjected to such high doses of radiation. Not only would such 
large doses of radiation result in the severe fragmentation of the DNA strands, it would 
also lead to many of the nuclear proteins being impacted by the radiation. Setting aside 
that damaged proteins could build up into hazardous material such as amyloidosis (Pepys 
2006) the other issue is that the repair proteins themselves would be compromised. As 
mentioned, radiation can cause damage to the proteasome in addition to the DNA strand 
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(Radman 2016). Even if there was no damage to DNA itself, if the proteasome was wiped 
out, the cell would not be able to survive because even though the instructions remain 
intact, there are no readers available to read the instruction (Radman 2016). It then 
stands to reason to question the efficacy of radiating the cells with large doses.  
 
The other factor to take into consideration when using large amounts of radiation is that 
it will result in a staggered response from the different actors in the DDR. It has been 
shown that the rate of phosphorylation of H2AX will occur at a much faster rate compared 
to other factors coming into play such as 53BP1 (Asaithamby & D. J. Chen 2009). It is 
important to note that the DDR proteins are not drawn from an infinite pool of proteins 
anticipating to be recruited.  There is a limited amount of DDR proteins, so blasting the 
cells with an immense amount of radiation will not give an accurate indication of what is 
taking place at the site of damage if the DDR proteins have not been given a chance to 
respond to damage in a canonical physiological manner. For example, if at 20 Gy the cell 
has ten times as much γH2AX compared to a cell that has been irradiated with 2 Gy but 
the amount of 53BP1 and chromatin modifiers were saturated at 2 Gy, then all that would 
have achieved is the generation of more noise in the pull-down. Therefore, the more 
appropriate solution would be to lower the dosage of radiation by tenfold for example 
and increase the number of cells ten times. The issue with this readjustment of dosage 
to cells would be handling a significant amount of cells. However, it would mitigate 
against generating new γH2AX that are at sites that are lagging in the other aspects of 
the DDR. 
 
 248 
6.2.2. Exclusively Use S1; replenish S2 with more Mnase 
S1 is the initial supernatant that is mainly composed of mononucleosomes and 
dinucleosomes, upon treating the nuclei with Mnase. The S2 is made up of nucleosome 
chains that contain several nucleosomes: 7-8. In Chapter 3 we show that H2AX variance 
has no more than 5% of all H2A variants. A rough estimate would show that upon 
digestion, nucleosome chains that are eight nucleosomes long are generated. There 
woulds 16 H2A histones in that chain. If there is non-symmetric deposition, then 1 in 16 
histones (two histones per nucleosomes) equates to 6.25% which is similar numbers to 
what we saw with genomic levels of H2AX. With hindsight, using chains of 8 nucleosomes 
meant that the proportion of histone H2AX was not dissimilar to that of global levels, 
which explains the small increase in H2AX levels we saw in Chapter 5 but a markedly more 
substantial increase in γH2AX levels in the eluates. This was an error in the DOE as the 
initial intention was to obtain as much histone signal as possible. It also seemed logical at 
the time that nucleosomes that may not possess an H2AX variant would still exhibit HPTM 
changes as a result of the DDR. In future experiments, the best approach would be to 
only use the S1 supernatant rather than pooling the S1 and S2 together. 
 
6.2.3. Derivatisation 
A potential issue is that the derivatisation step was working on different amounts of 
protein for both the eluate and input. For the in-gel derivatisation step, 5 μg of protein 
was used. However, the final eluate after a γH2AX IP would be several magnitudes smaller 
than 5 μg. This difference in amounts could result in either over-derivatisation of the 
eluate or under-derivatisation of the input. Downstream of this, the mass spectrometry 
data could lead to possessing different patterns of modified proteins as a result of the 
inconsistency. Both samples were derivatised in-gel, and this can also lead to asymmetric 
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losses of the samples. To account for these possible discrepancies, masses (m/z) could be 
targeted that demonstrate over or under derivatisation. The idea is to target an as high 
derivatisation as possible to eliminate any small inconstancies swinging the data one way 
or another.  
6.2.4 Controls to test region of the genome for Mnase activity 
Another possible shortfall for Mnase is that it may not be digesting uniformly across the 
whole of the genome. Mnase cuts regions of the genome slower when those particular 
region are less accessible (Mieczkowski et al. 2016). Therefore, to account for the 
variability of the Mnase digestion of chromatin, there are several control tests that could 
be added to ensure the Mnase digestion’s lack of uniformity does not affect the results 
downstream. 
6.2.4.1. Acid Extraction 
Acid extractions are useful for extracting all of the histones in an indiscriminate fashion. 
When carrying out a nuclei isolation, some nuclei would be aliquoted for an acid 
extraction. Acid extractions are a better control for global HPTMs as the acid extraction 
can capture histone from all parts of the genome unlike that of Mnase alone. If an acid 
extraction from equivalent time points were run with the idea to look for the same 
transitions, it would give a more accurate account of the global levels of HPTMs. 
6.2.4.2. H2AX 
In the γH2AX-IP-MS method, only nucleosome chains that contained γH2AX were 
enriched. However, if under the same conditions, some of the samples were 
immunoprecipitated with an α-H2AX antibody, the α-H2AX antibody would act as a 
control for where H2AX is deposited in the genome. This approach would give better data 
of the proportion of H2AX that is pulled down, rather than extrapolating the same data 
from γH2AX-MS-IP. The direct data would give a more accurate reading of where H2AX is 
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deposited. If the γH2AX-IP were cross-checked against the H2AX-IP, it would highlight 
whether there is discriminate regional phosphorylation of H2AX. For example, with a 
H2AX-IP-MS, if we were to see increased levels of euchromatin or heterochromatin 
compared to global levels, it would highlight that there is discrepancy in the regions that 
are being analysed globally and locally. 
6.2.4.3. Carrying out H4-IP-MS  
 
Histone H4 only has one variant (The UniProt Consortium, 2017) which is advantageous 
for this application because it would be deposited into every nucleosome, therefore, it 
can be found in every region of the genome. If the same procedure of 
immunoprecipitating γH2AX as described previously were carried out on Histone H4, it 
would result in better representation in the region of the genome where Mnase has had 
its most efficacy. Histone H3 does not possess much sequence differences within its 
variance. However, using histone H4 exclusively would eliminate all doubts because with 
Histone H3 there is always the question of whether the antibody of choice is 
discriminatory towards H3.1 instead of H3.3 for example. Therefore, if Mnase is able to 
digest everywhere uniformly, H4-IP-MS should give the same data for HPTMs as AE-MS 
but practically the data will not be the same and Mnase will instead cut more frequently 
at open sites. This would not be a test of whether Mnase cuts at more open sites or not. 
That has already been documented (Mieczkowski et al. 2016). This would be an assay in 
measuring Mnase cutting variance of the sample from one batch to the next. It is also 
possible to use this method to normalise γH2AX data at a global level in comparison to 
acid extraction. 
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6.3. Future Applications 
6.3.1. H2AX Symmetry 
 
Histone symmetry is when two copies of a single variant of a histone occupy the same 
nucleosome. Similarly, HPTM symmetry would be when both of the same variants within 
a single nucleosome carry the same modification. To answer the question of whether a 
single variant occupies a nucleosome or there are multiple variants deposited in the same 
nucleosome would be very difficult if not outright impossible with immunoassays. This is 
an example of where proteomics can outright answer questions that are not possible with 
immunoassays. Voight et al. (2013) used mass spectreomtry to demonstrate that 
H3K27me3 is symmetrically modified on some nucleosomes and asymmetrically modified 
on other nucleosomes. They also demonstrated that antagonistic modifications could not 
occupy the same histone tail, but they could occupy the same nucleosome by being 
situated on sister histones. 
To add to this, with the use of single-molecule imaging, Shema et al. (2016) found that 
the overwhelming majority of nucleosomes are asymmetrically modified. The authors 
only detected one H3K4me3 on histone H3 in the nucleosome, and they found the same 
result for H3K27me3. These studies indicate that HPTM asymmetry is a phenomenon 
with potentially interesting biological functions. Therefore, symmetry in both 
nucleosome deposition and modification of tails can affect the signalling of the histone 
code. Many questions would arise in regards to H2AX: would H2AX be deposited with a 
twin H2AX in the same nucleosome or be deposited alongside another H2A variant? If 
H2AX is not deposited alongside another H2AX, is the other H2A deposited a specific 
variant or is H2AX randomly deposited with any other variant? H2AX has also been shown 
to interact directly with 53BP1: would the number of H2AX affect the docking of a 53BP1 
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at a given nucleosome? If the answer is that there is symmetric deposition sometimes, 
but the genome exhibits asymmetric deposition at other sites, would there be a 
correlation between where the symmetry and asymmetry take place? For example, 
would more open sites of the genome be more susceptible to symmetric deposition, i.e. 
more dense with H2AX? For this experiment, both α-H2AX and α- γH2AX could be used. 
If an α-H2AX-IP were carried out on an S1 so that only mono-dinucleosomes were 
enriched, if H2AX were deposited symmetrically then the percentage signal for H2AX 
would be between 50-100% compared to total H2AX variance. Similarly it is not difficult 
to imagine that if H2AX is deposited symmetrically will it also phosphorylate 
symmetrically? The stoichiometry could have effects on 53BP1 docking.  53BP1 forms a 
dimer at the site of damage. Does each molecule require its own phosphorylated H2AX 
and ubiquitinated H2A to dock to? It is also possible that only one of each modification 
occupies the same nucleosome, i.e. a nucleosome during the DDR will host one H2A 
K13/K15 ubiquitination and one γH2AX.  
6.3.2. Modular DOE 
 
When this system was being conceptualised, it was intended to be modular from the 
onset. Just because the system was optimised with γH2AX, it does not mean that it could 
not be reproducible with any characterised antibody for a particular modification, variant 
or protein of interest. As long as the validation as described in Chapter 4 is repeated for 
each new protein of interest, the system could be applied to other questions that are not 
just exclusive to DDR. Examples include assessing HPTM changes with an antibody for 
H3S10 phosphorylation or H3K36 methylation. The system is not just limited to HPTM. It 
could be used to assess different histone variants such as H2AZ. In conjunction with 
SILAC, H2AZ could be analysed to determine where the histones migrate to after being 
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rapidly evicted from the nucleosome. It would also answer the question of whether new 
H2AZ are generated, or old ones are recycled during the DNA damage response. 
Assessing histone variants could be repeated for histone H3.3 or macroH2A.1. 
6.3.3. Late Repairing Breaks 
Goodarzi et al. (2008) showed that in ATM-mediated repair of breaks occur, take place in 
the more difficult to access regions of the genome, i.e. heterochromatin, in a CAP1 
dependent manner. The heterochromatin specific breaks are more likely to be repaired 
via HR. A γH2AX pulldown should show that there is increased H3K9me3, which is a 
marker of heterochromatin. Since HR is taking place, there should also be increased 
H3K36me3 signal. The question then arises of whether these modifications are old and 
were always present in the genome or whether they are new modifications which 
occurred sometime after the DNA break. The γH2AX-IP-MS system could be coupled with 
SILAC to answer questions in regard to the origin and timescale of the modifications: it 
would be possible to discern whether the modifications were old or new, i.e. did the 
breaks occur in regions of heterochromatin or did the region become heterochromatic 
ad-hoc. It would also help to clarify whether the histones were present prior to the break 
or if the histones were deposited after damage taking place. These results would then 
lead to mechanistic questions further along: if the PTM are old, then they were present 
before the onset of damage. Resulting in an explanation where the modifications are 
heterochromatic in origin. However, if the modifications are new, that would imply that 
the regions have been marked for a particular reason. It could be to signal for repair later 
on, or it could be to silence the region until repair of the site is possible.  
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Appendices 
Appendix I: Table of enriched phosphorylated non-histone peptides. (Chapter 3) 
  
Protein Description Peptide Sequence 
28 kDa heat- and acid-stable phosphoprotein 
OS=Homo sapiens GN=PDAP1 PE=1 SV=1 
SLDSDESEDEEDDYQQK 
28 kDa heat- and acid-stable phosphoprotein 
OS=Homo sapiens GN=PDAP1 PE=1 SV=1 
SLDSDESEDEEDDYQQK 
40S ribosomal protein S3 OS=Homo sapiens 
GN=RPS3 PE=1 SV=2 
DEILPTTPISEQK 
40S ribosomal protein S6 OS=Homo sapiens 
GN=RPS6 PE=1 SV=1 
RLSSLR 
40S ribosomal protein S6 OS=Homo sapiens 
GN=RPS6 PE=1 SV=1 
RLSSLR 
60S acidic ribosomal protein P2 OS=Homo 
sapiens GN=RPLP2 PE=1 SV=1 
KEESEESDDDMGFGLFD 
60S acidic ribosomal protein P2 OS=Homo 
sapiens GN=RPLP2 PE=1 SV=1 
KEESEESDDDMGFGLFD 
60S ribosomal protein L12 OS=Homo sapiens 
GN=RPL12 PE=1 SV=1 
IGPLGLSPK 
Alpha-adducin OS=Homo sapiens GN=ADD1 
PE=1 SV=2 
SPGSPVGEGTGSPPK 
Apoptosis inhibitor 5 OS=Homo sapiens 
GN=API5 PE=1 SV=3 
ASEDTTSGSPPKK 
Apoptosis inhibitor 5 OS=Homo sapiens 
GN=API5 PE=1 SV=3 
ASEDTTSGSPPKK 
Apoptotic chromatin condensation inducer in 
the nucleus OS=Homo sapiens GN=ACIN1 PE=1 
SV=2 
LSEGSQPAEEEEDQETPSR 
Apoptotic chromatin condensation inducer in 
the nucleus OS=Homo sapiens GN=ACIN1 PE=1 
SV=2 
KISVVSATK 
Apoptotic chromatin condensation inducer in 
the nucleus OS=Homo sapiens GN=ACIN1 PE=1 
SV=2 
RLSQPESAEK 
Arginine/serine-rich coiled-coil protein 2 
OS=Homo sapiens GN=RSRC2 PE=1 SV=1 
EQSEVSVSPR 
Bcl-2-associated transcription factor 1 
OS=Homo sapiens GN=BCLAF1 PE=1 SV=2 
FNDSEGDDTEETEDYR 
Bcl-2-associated transcription factor 1 
OS=Homo sapiens GN=BCLAF1 PE=1 SV=2 
DLFDYSPPLHK 
Bcl-2-associated transcription factor 1 
OS=Homo sapiens GN=BCLAF1 PE=1 SV=2 
IDISPSTLR 
Bcl-2-associated transcription factor 1 
OS=Homo sapiens GN=BCLAF1 PE=1 SV=2 
LKDLFDYSPPLHK 
Bcl-2-associated transcription factor 1 
OS=Homo sapiens GN=BCLAF1 PE=1 SV=2 
SPEIHR 
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Bromodomain-containing protein 3 OS=Homo 
sapiens GN=BRD3 PE=1 SV=1 
SESPPPLSDPK 
Centrin-2 OS=Homo sapiens GN=CETN2 PE=1 
SV=1 
RMSPKPELTEEQK 
Chromatin complexes subunit BAP18 
OS=Homo sapiens GN=BAP18 PE=1 SV=1 
VYEDSGIPLPAESPK 
Chromobox protein homolog 1 OS=Homo 
sapiens GN=CBX1 PE=1 SV=1 
KADSDSEDKGEESKPK 
Chromobox protein homolog 1 OS=Homo 
sapiens GN=CBX1 PE=1 SV=1 
KADSDSEDKGEESKPK 
Chromobox protein homolog 1 OS=Homo 
sapiens GN=CBX1 PE=1 SV=1 
KADSDSEDKGEESKPK 
Chromosome alignment-maintaining 
phosphoprotein 1 OS=Homo sapiens 
GN=CHAMP1 PE=1 SV=2 
KPGPPLSPEIR 
Coiled-coil domain-containing protein 137 
OS=Homo sapiens GN=CCDC137 PE=1 SV=1 
VQAGPGSPR 
Coiled-coil domain-containing protein 86 
OS=Homo sapiens GN=CCDC86 PE=1 SV=1 
AGLGSPERPPK 
Coiled-coil domain-containing protein 86 
OS=Homo sapiens GN=CCDC86 PE=1 SV=1 
QPEYSPESPR 
Coiled-coil domain-containing protein 86 
OS=Homo sapiens GN=CCDC86 PE=1 SV=1 
LGGLRPESPESLTSVSR 
Cyclic AMP-dependent transcription factor 
ATF-2 OS=Homo sapiens GN=ATF2 PE=1 SV=4 
MPLDLSPLATPIIR 
Cyclin-dependent kinase 3 OS=Homo sapiens 
GN=CDK3 PE=1 SV=1 
IGEGTYGVVYK 
DNA damage-binding protein 2 OS=Homo 
sapiens GN=DDB2 PE=1 SV=1 
SRSPLELEPEAK 
DNA mismatch repair protein Msh6 OS=Homo 
sapiens GN=MSH6 PE=1 SV=2 
SEEDNEIESEEEVQPK 
DNA repair protein complementing XP-C cells 
OS=Homo sapiens GN=XPC PE=1 SV=4 
VIKDEALSDGDDLR 
DNA topoisomerase 2-beta OS=Homo sapiens 
GN=TOP2B PE=1 SV=3 
FDSNEEDSASVFSPSFGLK 
DNA topoisomerase 2-beta OS=Homo sapiens 
GN=TOP2B PE=1 SV=3 
VVEAVNSDSDSEFGIPK 
Drebrin OS=Homo sapiens GN=DBN1 PE=1 
SV=4 
SPSDSSTASTPVAEQIER 
E3 ubiquitin-protein ligase TRIP12 OS=Homo 
sapiens GN=TRIP12 PE=1 SV=1 
SESPPAELPSLR 
Elongation factor 1-beta OS=Homo sapiens 
GN=EEF1B2 PE=1 SV=3 
DDDDIDLFGSDDEEESEEAKR 
Elongation factor 1-beta OS=Homo sapiens 
GN=EEF1B2 PE=1 SV=3 
DDDDIDLFGSDDEEESEEAK 
Endoplasmin OS=Homo sapiens GN=HSP90B1 
PE=1 SV=1 
EESDDEAAVEEEEEEK 
Eukaryotic translation initiation factor 5B 
OS=Homo sapiens GN=EIF5B PE=1 SV=4 
KQSFDDNDSEELEDK 
Eukaryotic translation initiation factor 5B 
OS=Homo sapiens GN=EIF5B PE=1 SV=4 
NKPGPNIESGNEDDDASFK 
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Forkhead box protein K2 OS=Homo sapiens 
GN=FOXK2 PE=1 SV=3 
EGSPAPLEPEPGAAQPK 
Fos-related antigen 2 OS=Homo sapiens 
GN=FOSL2 PE=1 SV=1 
RSPPAPGLQPMR 
Fos-related antigen 2 OS=Homo sapiens 
GN=FOSL2 PE=1 SV=1 
SPPAPGLQPMR 
Heat shock protein beta-1 OS=Homo sapiens 
GN=HSPB1 PE=1 SV=2 
QLSSGVSEIR 
Heat shock protein HSP 90-alpha OS=Homo 
sapiens GN=HSP90AA1 PE=1 SV=5 
ESEDKPEIEDVGSDEEEEK 
Heat shock protein HSP 90-alpha OS=Homo 
sapiens GN=HSP90AA1 PE=1 SV=5 
ESEDKPEIEDVGSDEEEEKK 
Heat shock protein HSP 90-beta OS=Homo 
sapiens GN=HSP90AB1 PE=1 SV=4 
IEDVGSDEEDDSGK 
Heat shock protein HSP 90-beta OS=Homo 
sapiens GN=HSP90AB1 PE=1 SV=4 
EKEISDDEAEEEKGEK 
Heat shock protein HSP 90-beta OS=Homo 
sapiens GN=HSP90AB1 PE=1 SV=4 
IEDVGSDEEDDSGKDK 
Heat shock protein HSP 90-beta OS=Homo 
sapiens GN=HSP90AB1 PE=1 SV=4 
IEDVGSDEEDDSGKDK 
Hepatoma-derived growth factor OS=Homo 
sapiens GN=HDGF PE=1 SV=1 
AGDLLEDSPK 
Hepatoma-derived growth factor OS=Homo 
sapiens GN=HDGF PE=1 SV=1 
RAGDLLEDSPK 
Heterogeneous nuclear ribonucleoprotein A1 
OS=Homo sapiens GN=HNRNPA1 PE=1 SV=5 
SESPKEPEQLR 
Heterogeneous nuclear ribonucleoprotein D0 
OS=Homo sapiens GN=HNRNPD PE=1 SV=1 
NEEDEGHSNSSPR 
Heterogeneous nuclear ribonucleoprotein D0 
OS=Homo sapiens GN=HNRNPD PE=1 SV=1 
NEEDEGHSNSSPR 
Heterogeneous nuclear ribonucleoprotein K 
OS=Homo sapiens GN=HNRNPK PE=1 SV=1 
DYDDMSPR 
Heterogeneous nuclear ribonucleoprotein U 
OS=Homo sapiens GN=HNRNPU PE=1 SV=6 
AKSPQPPVEEEDEHFDDTVVCLDTYNCDLHF
K 
Heterogeneous nuclear ribonucleoproteins 
C1/C2 OS=Homo sapiens GN=HNRNPC PE=1 
SV=4 
NDKSEEEQSSSSVK 
Heterogeneous nuclear ribonucleoproteins 
C1/C2 OS=Homo sapiens GN=HNRNPC PE=1 
SV=4 
EAEEGEDDRDSANGEDDS 
Heterogeneous nuclear ribonucleoproteins 
C1/C2 OS=Homo sapiens GN=HNRNPC PE=1 
SV=4 
VSGNTSR 
High mobility group nucleosome-binding 
domain-containing protein 3 OS=Homo sapiens 
GN=HMGN3 PE=1 SV=2 
RKSPENTEGK 
High mobility group protein HMG-I/HMG-Y 
OS=Homo sapiens GN=HMGA1 PE=1 SV=3 
EEEEGISQESSEEEQ 
High mobility group protein HMG-I/HMG-Y 
OS=Homo sapiens GN=HMGA1 PE=1 SV=3 
KQPPVSPGTALVGSQK 
 275 
High mobility group protein HMG-I/HMG-Y 
OS=Homo sapiens GN=HMGA1 PE=1 SV=3 
EEEEGISQESSEEEQ 
High mobility group protein HMG-I/HMG-Y 
OS=Homo sapiens GN=HMGA1 PE=1 SV=3 
SSQPLASK 
High mobility group protein HMG-I/HMG-Y 
OS=Homo sapiens GN=HMGA1 PE=1 SV=3 
EEEEGISQESSEEEQ 
High mobility group protein HMG-I/HMG-Y 
OS=Homo sapiens GN=HMGA1 PE=1 SV=3 
KQPPVSPGTALVGSQK 
High mobility group protein HMG-I/HMG-Y 
OS=Homo sapiens GN=HMGA1 PE=1 SV=3 
QPPVSPGTALVGSQK 
High mobility group protein HMGI-C OS=Homo 
sapiens GN=HMGA2 PE=1 SV=1 
KPAQEETEETSSQESAEED 
High mobility group protein HMGI-C OS=Homo 
sapiens GN=HMGA2 PE=1 SV=1 
QQQEPTGEPSPK 
High mobility group protein HMGI-C OS=Homo 
sapiens GN=HMGA2 PE=1 SV=1 
KQQQEPTGEPSPK 
HIRA-interacting protein 3 OS=Homo sapiens 
GN=HIRIP3 PE=1 SV=3 
ESEQESEEEILAQK 
Histone H1.0 OS=Homo sapiens GN=H1F0 PE=1 
SV=3 
GVGASGSFR 
Histone H1.2 OS=Homo sapiens GN=HIST1H1C 
PE=1 SV=2 
KAAGGATPK 
Histone H1.4 OS=Homo sapiens GN=HIST1H1E 
PE=1 SV=2 
GTGASGSFK 
Histone H1.4 OS=Homo sapiens GN=HIST1H1E 
PE=1 SV=2 
SETAPAAPAAPAPAEKTPVK 
Histone H1.4 OS=Homo sapiens GN=HIST1H1E 
PE=1 SV=2 
KAPKSPAK 
Histone H1.4 OS=Homo sapiens GN=HIST1H1E 
PE=1 SV=2 
KASGPPVSELITK 
Histone H1.4 OS=Homo sapiens GN=HIST1H1E 
PE=1 SV=2 
ASGPPVSELITK 
Histone H1.4 OS=Homo sapiens GN=HIST1H1E 
PE=1 SV=2 
KATGAATPK 
Histone H1.4 OS=Homo sapiens GN=HIST1H1E 
PE=1 SV=2 
APKSPAK 
Histone H1x OS=Homo sapiens GN=H1FX PE=1 
SV=1 
AGGSAALSPSK 
Histone H1x OS=Homo sapiens GN=H1FX PE=1 
SV=1 
AGGSAALSPSKK 
Histone H2AX OS=Homo sapiens GN=H2AFX 
PE=1 SV=2 
KATQASQEY 
Histone H2AX OS=Homo sapiens GN=H2AFX 
PE=1 SV=2 
ATQASQEY 
Histone H3.2 OS=Homo sapiens GN=HIST2H3A 
PE=1 SV=3 
KSTGGKAPR 
Histone H3.2 OS=Homo sapiens GN=HIST2H3A 
PE=1 SV=3 
KSTGGKAPR 
Histone H3.2 OS=Homo sapiens GN=HIST2H3A 
PE=1 SV=3 
STELLIR 
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Histone H4 OS=Homo sapiens GN=HIST1H4A 
PE=1 SV=2 
RISGLIYEETR 
Interferon-inducible double-stranded RNA-
dependent protein kinase activator A 
OS=Homo sapiens GN=PRKRA PE=1 SV=1 
EDSGTFSLGK 
Interleukin enhancer-binding factor 3 
OS=Homo sapiens GN=ILF3 PE=1 SV=3 
RPMEEDGEEKSPSK 
Interleukin enhancer-binding factor 3 
OS=Homo sapiens GN=ILF3 PE=1 SV=3 
RPMEEDGEEKSPSKK 
LIM domain and actin-binding protein 1 
OS=Homo sapiens GN=LIMA1 PE=1 SV=1 
ASSLSESSPPK 
LIM domain and actin-binding protein 1 
OS=Homo sapiens GN=LIMA1 PE=1 SV=1 
ETPHSPGVEDAPIAK 
LIM domain and actin-binding protein 1 
OS=Homo sapiens GN=LIMA1 PE=1 SV=1 
ETPHSPGVEDAPIAK 
MARCKS-related protein OS=Homo sapiens 
GN=MARCKSL1 PE=1 SV=2 
GDVTAEEAAGASPAK 
Methyl-CpG-binding protein 2 OS=Homo 
sapiens GN=MECP2 PE=1 SV=1 
AETSEGSGSAPAVPEASASPK 
Neuroblast differentiation-associated protein 
AHNAK OS=Homo sapiens GN=AHNAK PE=1 
SV=2 
GGVTGSPEASISGSK 
Neuroblast differentiation-associated protein 
AHNAK OS=Homo sapiens GN=AHNAK PE=1 
SV=2 
GHYEVTGSDDETGK 
Nuclear ubiquitous casein and cyclin-
dependent kinase substrate 1 OS=Homo 
sapiens GN=NUCKS1 PE=1 SV=1 
NSQEDSEDSEDKDVK 
Nuclear ubiquitous casein and cyclin-
dependent kinase substrate 1 OS=Homo 
sapiens GN=NUCKS1 PE=1 SV=1 
VVDYSQFQESDDADEDYGR 
Nuclear ubiquitous casein and cyclin-
dependent kinase substrate 1 OS=Homo 
sapiens GN=NUCKS1 PE=1 SV=1 
DDSHSAEDSEDEKEDHK 
Nuclear ubiquitous casein and cyclin-
dependent kinase substrate 1 OS=Homo 
sapiens GN=NUCKS1 PE=1 SV=1 
DSGSDEDFLMEDDDDSDYGSSK 
Nuclear ubiquitous casein and cyclin-
dependent kinase substrate 1 OS=Homo 
sapiens GN=NUCKS1 PE=1 SV=1 
NSQEDSEDSEDKDVK 
Nuclear ubiquitous casein and cyclin-
dependent kinase substrate 1 OS=Homo 
sapiens GN=NUCKS1 PE=1 SV=1 
NSQEDSEDSEDKDVK 
Nuclear ubiquitous casein and cyclin-
dependent kinase substrate 1 OS=Homo 
sapiens GN=NUCKS1 PE=1 SV=1 
ATVTPSPVK 
Nuclear ubiquitous casein and cyclin-
dependent kinase substrate 1 OS=Homo 
sapiens GN=NUCKS1 PE=1 SV=1 
EEDEEPESPPEK 
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Nuclear ubiquitous casein and cyclin-
dependent kinase substrate 1 OS=Homo 
sapiens GN=NUCKS1 PE=1 SV=1 
EEDEEPESPPEKK 
Nuclear ubiquitous casein and cyclin-
dependent kinase substrate 1 OS=Homo 
sapiens GN=NUCKS1 PE=1 SV=1 
TSTSPPPEK 
Nuclear ubiquitous casein and cyclin-
dependent kinase substrate 1 OS=Homo 
sapiens GN=NUCKS1 PE=1 SV=1 
KDDSHSAEDSEDEKEDHK 
Nuclease-sensitive element-binding protein 1 
OS=Homo sapiens GN=YBX1 PE=1 SV=3 
NEGSESAPEGQAQQR 
Nucleolar and coiled-body phosphoprotein 1 
OS=Homo sapiens GN=NOLC1 PE=1 SV=2 
VADNSFDAK 
Nucleolar and coiled-body phosphoprotein 1 
OS=Homo sapiens GN=NOLC1 PE=1 SV=2 
ASSPFR 
Nucleolar protein 56 OS=Homo sapiens 
GN=NOP56 PE=1 SV=4 
EELMSSDLEETAGSTSIPK 
Nucleolin OS=Homo sapiens GN=NCL PE=1 
SV=3 
KVVVSPTK 
Nucleolin OS=Homo sapiens GN=NCL PE=1 
SV=3 
KVVVSPTKK 
Nucleolin OS=Homo sapiens GN=NCL PE=1 
SV=3 
VVVSPTK 
Nucleolin OS=Homo sapiens GN=NCL PE=1 
SV=3 
VVVSPTKK 
Nucleolin OS=Homo sapiens GN=NCL PE=1 
SV=3 
KVVVSPTKK 
Nucleophosmin OS=Homo sapiens GN=NPM1 
PE=1 SV=2 
SIRDTPAK 
Nucleophosmin OS=Homo sapiens GN=NPM1 
PE=1 SV=2 
DELHIVEAEAMNYEGSPIK 
Palladin OS=Homo sapiens GN=PALLD PE=1 
SV=3 
IASDEEIQGTK 
PC4 and SFRS1-interacting protein OS=Homo 
sapiens GN=PSIP1 PE=1 SV=1 
QSNASSDVEVEEK 
Pinin OS=Homo sapiens GN=PNN PE=1 SV=4 EIAIVHSDAEK 
Plasminogen activator inhibitor 1 RNA-binding 
protein OS=Homo sapiens GN=SERBP1 PE=1 
SV=2 
DELTESPK 
Polycomb protein EED OS=Homo sapiens 
GN=EED PE=1 SV=2 
CKYSFK 
Prelamin-A/C OS=Homo sapiens GN=LMNA 
PE=1 SV=1 
LRLSPSPTSQR 
Prelamin-A/C OS=Homo sapiens GN=LMNA 
PE=1 SV=1 
ASSHSSQTQGGGSVTK 
Prelamin-A/C OS=Homo sapiens GN=LMNA 
PE=1 SV=1 
LSPSPTSQR 
Prelamin-A/C OS=Homo sapiens GN=LMNA 
PE=1 SV=1 
LRLSPSPTSQR 
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Prelamin-A/C OS=Homo sapiens GN=LMNA 
PE=1 SV=1 
LRLSPSPTSQR 
Pre-mRNA-splicing factor 38B OS=Homo 
sapiens GN=PRPF38B PE=1 SV=1 
RSLSPR 
Probable 28S rRNA (cytosine(4447)-C(5))-
methyltransferase OS=Homo sapiens 
GN=NOP2 PE=1 SV=2 
GTDTQTPAVLSPSK 
Probable 28S rRNA (cytosine(4447)-C(5))-
methyltransferase OS=Homo sapiens 
GN=NOP2 PE=1 SV=2 
GTDTQTPAVLSPSK 
Prostaglandin E synthase 3 OS=Homo sapiens 
GN=PTGES3 PE=1 SV=1 
DWEDDSDEDMSNFDR 
Proteasome subunit alpha type-3 OS=Homo 
sapiens GN=PSMA3 PE=1 SV=2 
ESLKEEDESDDDNM 
Protein DEK OS=Homo sapiens GN=DEK PE=1 
SV=1 
EESEEEEDEDDEEEEEEEK 
Protein ELYS OS=Homo sapiens GN=AHCTF1 
PE=1 SV=3 
SVENQESVEIINDLK 
Protein ELYS OS=Homo sapiens GN=AHCTF1 
PE=1 SV=3 
EVSPSDVR 
Protein ELYS OS=Homo sapiens GN=AHCTF1 
PE=1 SV=3 
EVSPSDVR 
Protein FAM117B OS=Homo sapiens 
GN=FAM117B PE=1 SV=2 
KKGSHK 
Protein IWS1 homolog OS=Homo sapiens 
GN=IWS1 PE=1 SV=2 
NQASDSENEELPKPR 
Protein IWS1 homolog OS=Homo sapiens 
GN=IWS1 PE=1 SV=2 
AAVLSDSEDEEK 
Protein LSM14 homolog A OS=Homo sapiens 
GN=LSM14A PE=1 SV=3 
SSPQLDPLR 
Protein PAXX OS=Homo sapiens GN=C9orf142 
PE=1 SV=2 
LAAAEETAVSPR 
Protein SON OS=Homo sapiens GN=SON PE=1 
SV=4 
ESDQTLAALLSPK 
Putative 40S ribosomal protein S10-like 
OS=Homo sapiens GN=RPS10P5 PE=5 SV=1 
AEAGAGSATEFQFR 
Ras GTPase-activating protein-binding protein 
1 OS=Homo sapiens GN=G3BP1 PE=1 SV=1 
SSSPAPADIAQTVQEDLR 
Regulation of nuclear pre-mRNA domain-
containing protein 2 OS=Homo sapiens 
GN=RPRD2 PE=1 SV=1 
DVEDMELSDVEDDGSK 
Regulator of chromosome condensation 
OS=Homo sapiens GN=RCC1 PE=1 SV=1 
SPPADAIPK 
Ribosomal L1 domain-containing protein 1 
OS=Homo sapiens GN=RSL1D1 PE=1 SV=3 
ATNESEDEIPQLVPIGK 
Ribosomal L1 domain-containing protein 1 
OS=Homo sapiens GN=RSL1D1 PE=1 SV=3 
AAESETPGKSPEK 
RNA-binding protein 10 OS=Homo sapiens 
GN=RBM10 PE=1 SV=3 
LASDDRPSPPR 
RNA-binding protein 39 OS=Homo sapiens 
GN=RBM39 PE=1 SV=2 
IGLPHSIK 
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RNA-binding protein Raly OS=Homo sapiens 
GN=RALY PE=1 SV=1 
GRLSPVPVPR 
RNA-binding protein with serine-rich domain 1 
OS=Homo sapiens GN=RNPS1 PE=1 SV=1 
RFSPPR 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
KETESEAEDNLDDLEK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
KVELSESEEDK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
AASPSPQSVR 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
KVELSESEEDKGGK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
SPSPAPPPR 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
TASPPPPPK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
HRPSPPATPPPK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
SRVSVSPGR 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
RLSPSASPPR 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
RYSPSPPPK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
RVSHSPPPK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
KETESEAEDNLDDLEK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
KVELSESEEDKGGK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
EKTPELPEPSVK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
AASPSPQSVR 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
APQTSSSPPPVR 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
KVELSESEEDK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
TASPPPPPK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
VSVSPGR 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
KEKTPELPEPSVK 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
TRHSPTPQQSNR 
Serine/arginine repetitive matrix protein 1 
OS=Homo sapiens GN=SRRM1 PE=1 SV=2 
KEKTPELPEPSVK 
Serine/arginine repetitive matrix protein 2 
OS=Homo sapiens GN=SRRM2 PE=1 SV=2 
SGSSQELDVKPSASPQER 
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Serine/arginine repetitive matrix protein 2 
OS=Homo sapiens GN=SRRM2 PE=1 SV=2 
GRSPSPKPR 
Serine/arginine repetitive matrix protein 2 
OS=Homo sapiens GN=SRRM2 PE=1 SV=2 
AGMSSNQSISSPVLDAVPR 
Serine/arginine repetitive matrix protein 2 
OS=Homo sapiens GN=SRRM2 PE=1 SV=2 
AQTPPGPSLSGSK 
Serine/arginine repetitive matrix protein 2 
OS=Homo sapiens GN=SRRM2 PE=1 SV=2 
TSPPLLDR 
Serine/arginine repetitive matrix protein 2 
OS=Homo sapiens GN=SRRM2 PE=1 SV=2 
ENSFGSPLEFR 
Serine/arginine repetitive matrix protein 2 
OS=Homo sapiens GN=SRRM2 PE=1 SV=2 
SRASPATHR 
Serine/arginine repetitive matrix protein 2 
OS=Homo sapiens GN=SRRM2 PE=1 SV=2 
ENSFGSPLEFR 
Serine/arginine repetitive matrix protein 2 
OS=Homo sapiens GN=SRRM2 PE=1 SV=2 
ELSNSPLR 
Serine/arginine repetitive matrix protein 2 
OS=Homo sapiens GN=SRRM2 PE=1 SV=2 
SRLSLR 
Serine/arginine-rich splicing factor 11 
OS=Homo sapiens GN=SRSF11 PE=1 SV=1 
DYDEEEQGYDSEKEK 
Serine/arginine-rich splicing factor 11 
OS=Homo sapiens GN=SRSF11 PE=1 SV=1 
KPIETGSPK 
Serum response factor-binding protein 1 
OS=Homo sapiens GN=SRFBP1 PE=1 SV=1 
SLDFPQNEPQIK 
Serum response factor-binding protein 1 
OS=Homo sapiens GN=SRFBP1 PE=1 SV=1 
EYFDDSTEER 
Signal-induced proliferation-associated 1-like 
protein 1 OS=Homo sapiens GN=SIPA1L1 PE=1 
SV=4 
TLSDESIYNSQR 
Signal-induced proliferation-associated 1-like 
protein 1 OS=Homo sapiens GN=SIPA1L1 PE=1 
SV=4 
LIDLESPTPESQK 
Small acidic protein OS=Homo sapiens 
GN=SMAP PE=1 SV=1 
SASPDDDLGSSNWEAADLGNEER 
Sororin OS=Homo sapiens GN=CDCA5 PE=1 
SV=1 
APSPTKPLR 
Spectrin beta chain, non-erythrocytic 1 
OS=Homo sapiens GN=SPTBN1 PE=1 SV=2 
RPPSPEPSTK 
Splicing factor 45 OS=Homo sapiens 
GN=RBM17 PE=1 SV=1 
RPDPDSDEDEDYER 
Src substrate cortactin OS=Homo sapiens 
GN=CTTN PE=1 SV=2 
TQTPPVSPAPQPTEER 
Src substrate cortactin OS=Homo sapiens 
GN=CTTN PE=1 SV=2 
LPSSPVYEDAASFK 
Stathmin OS=Homo sapiens GN=STMN1 PE=1 
SV=3 
ESVPEFPLSPPK 
Suppressor of SWI4 1 homolog OS=Homo 
sapiens GN=PPAN PE=1 SV=1 
VGGSDEEASGIPSR 
Target of EGR1 protein 1 OS=Homo sapiens 
GN=TOE1 PE=1 SV=1 
AADSDDGAVSAPAASDGGVSK 
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Targeting protein for Xklp2 OS=Homo sapiens 
GN=TPX2 PE=1 SV=2 
SSDQPLTVPVSPK 
THO complex subunit 4 OS=Homo sapiens 
GN=ALYREF PE=1 SV=3 
QQLSAEELDAQLDAYNAR 
Thyroid hormone receptor-associated protein 3 
OS=Homo sapiens GN=THRAP3 PE=1 SV=2 
IDISPSTFR 
Thyroid hormone receptor-associated protein 3 
OS=Homo sapiens GN=THRAP3 PE=1 SV=2 
ASAVSELSPR 
Transcription factor AP-1 OS=Homo sapiens 
GN=JUN PE=1 SV=2 
AKNSDLLTSPDVGLLK 
Transcription factor AP-1 OS=Homo sapiens 
GN=JUN PE=1 SV=2 
LASPELER 
Transcription factor jun-B OS=Homo sapiens 
GN=JUNB PE=1 SV=1 
DATPPVSPINMEDQER 
Transcription initiation factor TFIID subunit 12 
OS=Homo sapiens GN=TAF12 PE=1 SV=1 
LSPENNQVLTK 
Transcriptional repressor protein YY1 
OS=Homo sapiens GN=YY1 PE=1 SV=2 
EEVVGGDDSDGLR 
Treacle protein OS=Homo sapiens GN=TCOF1 
PE=1 SV=3 
TSQVGAASAPAKESPR 
Treacle protein OS=Homo sapiens GN=TCOF1 
PE=1 SV=3 
AALAPAKESPR 
Treacle protein OS=Homo sapiens GN=TCOF1 
PE=1 SV=3 
LGAGEGGEASVSPEK 
Treacle protein OS=Homo sapiens GN=TCOF1 
PE=1 SV=3 
KLSGDQPAAR 
U4/U6.U5 tri-snRNP-associated protein 1 
OS=Homo sapiens GN=SART1 PE=1 SV=1 
RVSEVEEEKEPVPQPLPSDDTR 
U4/U6.U5 tri-snRNP-associated protein 2 
OS=Homo sapiens GN=USP39 PE=1 SV=2 
EVDEDSEPER 
UAP56-interacting factor OS=Homo sapiens 
GN=FYTTD1 PE=1 SV=3 
LVGATATSSPPPK 
Uncharacterized protein C15orf52 OS=Homo 
sapiens GN=C15orf52 PE=1 SV=1 
SPPTQVAISSDSAR 
Uncharacterized protein CXorf67 OS=Homo 
sapiens GN=CXorf67 PE=2 SV=1 
SGSPDPEVPSR 
Zinc finger CCCH domain-containing protein 14 
OS=Homo sapiens GN=ZC3H14 PE=1 SV=1 
DLVQPDKPASPK 
Zinc finger protein 185 OS=Homo sapiens 
GN=ZNF185 PE=1 SV=3 
QSSPSGSEQLVR 
Zinc finger protein 22 OS=Homo sapiens 
GN=ZNF22 PE=1 SV=3 
FDSSFSR 
Zinc finger protein 579 OS=Homo sapiens 
GN=ZNF579 PE=1 SV=2 
ESESEEAEAGAAELR 
Zinc finger protein 740 OS=Homo sapiens 
GN=ZNF740 PE=1 SV=1 
AGSPDVLR 
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Appendix II: Hatimy, A.A. et al., 2015. Histone H2AX Y142 phosphorylation is a low 
abundance modification. International Journal of Mass Spectrometry, 391, pp.1–7.
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